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Abstract 
 
DNA and RNA oligonucleotides are molecules of great interest due to their potential 
application as antisense and RNAi drugs. Currently, solid phase synthesis (SPS) is the 
method of choice for their synthesis due to its simplicity, automation, and simple 
intermediate purification. However, large scale synthesis is challenging due to its 2-
phase reaction medium. This research investigates a novel method – Membrane 
Enhanced Oligonucleotide Synthesis (MEOS) – for the synthesis of DNA 
oligonucleotides. This novel process combines synthesis on a soluble polymeric 
support with the emergent separation technology Organic Solvent Nanofiltration 
(OSN). The synthesis of support-bound oligonucleotide dimers was first attempted 
using linear MeOPEG112 as the soluble support, and ceramic and cross-linked 
polyimide OSN membranes. The performance of OSN membranes was characterised 
prior to synthesis in order to selected membranes with appropriate performance 
properties. Poor process yields lead to the development of novel branched PEG 
supports. PEG silyl ethers, phosphate and carboxylic esters were prepared in a novel 
methodology using an OSN membrane for the separation of the branched PEG from 
excess PEG diol. The use of branched PEGs resulted in an increase of the MEOS 
process yields in the range of ~3 to 6 fold. Best results for the MEOS process were 
obtained in the synthesis of a fully unprotected dimer, dApdA, using a 3-arm PEG 
carboxylic ester with MW of ~ 9,000 g mol-1 [benzene-1,3,5-(CO2-PEG67)3]. The 
synthesis of DNA monomers using OSN was also investigated. This investigation 
also describes a novel synthetic method for the synthesis of heterobifunctional PEGs. 
PEGs of MW of ~ 2,000 g mol-1 were prepared and characterised with 
monophthalimide, monoamine, and monoazide functionalities. Overall, this research 
investigates the use of OSN in two different applications for organic synthesis, 
namely the synthesis of DNA oligonucleotides and derivatised (branched and linear) 
PEGs.  
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Nomenclature 
Symbols 
Ci,p  Concentration of solute i in the permeate (g m-3) 
Ci,r  Concentration of solute i in the retentate (g m-3) 
Ci,r0  Concentration of solute i in the retentate at t= 0 (g m-3) 
mi,r  Mass of solute i in the retentate (g) 
mi,r0  Mass of solute i in the retentate at t = 0(g) 
Qf  Volumetric flow rate of the feed stream (m3 s-1)   
Qp  Volumetric flow rate of the permeate stream (m3 s-1) 
Q  Volumetric flow rate (m3 s-1) 
Ri  Rejection of solute i (%) 
R'i  Rejection of solute i (-) 
Vr  Volume of the retentate (m3) 
ρf  Density of the feed stream (kg m-3) 
ρp  Density of the permeate stream (kg m-3) 
ρr  Density of the retentate stream (kg m-3) 
 
Abbreviations 
A  Adenine 
Bn  Benzyl 
Bz  Benzoyl   
C  Cytosine  
Ce  Cyanoethyl 
CPG  Controlled pore glass 
dA  Deoxyadenosine 
DCC  Dicyclohexylcarbodiimide 
DCM  Dichloromethane 
DIC  Diisopropylcarbodiimide 
DMAP  4-Dimethylaminopyridine 
DMF  Dimethylformamide 
Dmt  4, 4'-Dimethoxytrityl 
DNA  Deoxyribonucleic acid 
DSPE  Distearoylphosphatidylethanolamine 
Imperial College London 
 18
EDA  1,2-Ethanediamine 
EtOAc  Ethyl acetate 
EtOH  Ethanol 
G  Guanine 
HDA  1,6-Hexanediamine  
HELP  High efficiency liquid phase  
HPLC  High performance liquid chromatography 
iBu  Isobutyl 
IPA  Isopropanol 
LNA  Locked nucleic acids 
LPS  Liquid phase synthesis 
MeOH  Methanol  
MEOS  Membrane enhanced oligonucleotide synthesis 
Mmt  4-Monomethoxytrityl 
MOE  2-Methoxyethyl 
MS  Mass spectroscopy 
MsCl  Methanesulfonyl chloride 
MSNT  1-(mesitylene-2-sulfonyl)-3-nitro-1,2,4-triazole 
MTBE  Methyl tert-butyl ether 
MW  Molecular weight (g mol-1) 
MWCO Molecular weight cut off 
NF  Nanofiltration 
NMI  N-Methylimidazole 
NMP  N-methyl-2-pyrrolidone 
NMR  Nuclear magnetic resonance 
OSN  Organic solvent nanofiltration 
PADS  Phenylacetyl disulfide 
PEG  Polyethylene glycol 
Phth  Phthalimide 
PI  Polyimide 
PNA  Polyvinyl alcohol 
Pom  Pivaloyloxymethyl 
PS  Polystyrene 
PS-DVB Polysterene divinylbenzene   
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PTC  Phase transfer catalyst 
py  pyridinium 
PyTFA pyridinium trifluoroacetate 
RNA  Ribonucleic acid 
RNAi  Ribonucleic acid interference    
SolPS  Solution phase synthesis 
SPS  Solid phase Synthesis 
T  Thymine 
TFA  Trifluoroacetic acid 
TFAA  Trifluoroacetic anhydride 
THF  Tetrahydrofuran 
TLC  Thin layer chromatography 
TMC  Transition metal catalyst 
TOL  Toluene 
TsCl  toluene-4-sulfonyl chloride 
U  Uracil 
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1. Introduction 
 
1.1 Introduction 
Oligonucleotides and peptides have become a subject of increasing interest in recent 
years due to their potential applications as therapeutic agents. Advances in 
formulation and delivery techniques have also refocused interest on peptides as drug 
candidates. This in turn has challenged industry and academia to develop technologies 
to manufacture peptides and oligonucleotides at the scale of metric tons per year 
(Andersson et al., 2000; Reese, 2005; Reese, 2002; Sanghvi, 2000). DNA and RNA 
oligonucleotides are molecules of great importance because of their application in 
molecular biology and medicine. The interest in their application as antisense drugs 
(Crooke, 1999; Sanghvi, 2000; Stein and Cheng, 1993) and the discovery of the novel 
RNA interference (RNAi) mechanism (Fichou and Ferec, 2006; Fire et al., 1998; 
Manoharan, 2004; Vilgelm, 2006) have further increased the attention on these 
molecules. Several oligonucleotides are currently in different stages of clinical trials 
for the treatment of several diseases, from viral infections to cancers and 
inflammatory disorders (Persidis, 1999; Sanghvi, 2000) and the prospect of approval 
of more antisense drugs, especially systemic drugs, has increased the need to develop 
improved technologies for the synthesis of oligonucleotides (Ravikumar et al., 2006; 
Reese, 2002). 
 
Currently, chemical synthesis of peptides (Andersson et al., 2000) and 
oligonucleotides (Sanghvi, 2000) is based on solid phase synthesis (SPS), developed 
in the 1960s by B. Merrifield. SPS allows for the stepwise coupling of monomers and 
purification of the intermediate product in a simple and fast synthesis procedure. 
However, it presents drawbacks related to the fact that synthesis takes place in a two 
phase reaction medium, and consequent low mass transfer leads to the need for 
reagents in large excess. Alternative strategies exist in the forms of solution phase 
synthesis (SolPS) (Reese and Yan, 2002; Reese and Song, 2003; Seliger, 1993) and 
liquid phase synthesis (LPS) (Bagno et al., 1998; Bonora et al., 2000; Bonora et al., 
1990; Gravert and Janda, 1997). In both, the reaction takes place in a single phase, 
allowing for higher reaction rates. However, both methods necessitate the use of 
separation techniques – for the purification of the product in between coupling 
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reactions – that are cumbersome and difficult to scale up. While SolPS usually applies 
chromatographic methods, LPS takes advantage of attaching the product to a soluble 
polymer support, then uses precipitation/recrystalisation techniques. 
 
The main purpose of this research project was to study the applicability of a novel and 
emergent separation technology, organic solvent nanofiltration (OSN), to the 
development of a new process for the synthesis of oligonucleotides. The new process, 
Membrane Enhanced Oligonucleotide Synthesis (MEOS) seeks to take advantage of 
the best features of the currently available processes by utilising OSN technology as a 
replacement for the solid resin used in SPS while carrying out the reactions in 
solution.  
 
The need to develop more efficient soluble supports for the synthesis of 
oligonucleotides using OSN membranes, lead to the generation of an idea for a novel 
method for the synthesis of heterobifunctional polymers. This extended this research 
to a second objective, complementary to the initial idea, which was the study of OSN 
membranes for the synthesis of branched and heterobifunctional polymers. 
 
1.2 Thesis structure and overview 
The research in this thesis is presented in a way that tries to follow a logic 
development of the MEOS process. It starts from the investigation of OSN to the 
building blocks of DNA, follows with the presentation and development of the 
MEOS, and finishes with the research regarding heterobifunctional PEGs. Each 
chapter presents individual and almost independent research steps that were taken in 
order to achieve lesser goals leading to the major goal of this research: the study on 
the feasibility of OSN as a reliable and efficient separation technology in the field of 
organic synthesis, and in particular, the synthesis of oligonucleotides and 
heterobifunctional polymers. 
 
The remainder of Chapter 1 reviews the background literature to this research, and 
finishes by presenting the project objectives and research strategy. 
 
Chapter 2 describes the use of OSN membranes to the synthesis of oligonucleotide 
building blocks, nucleoside phosphoramidites. Commercially available and laboratory 
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prepared OSN membranes were screened and characterised for such application, and 
an example of their application to the synthesis of a nucleoside phosphoramidite is 
presented. 
 
Chapter 3 describes the use of OSN membranes for the synthesis of oligonucleotide 
dimers on linear soluble polymeric supports. Examples using ceramic and polymeric 
OSN membranes are presented. 
 
Chapter 4 presents the synthesis of branched polyethylene glycol (PEG) supports for 
oligonucleotide synthesis. A polyimide membrane is used for the purification of 
several branched supports with different molecular weight (MW) and chemistries. 
The branched PEGs are characterised by mass and NMR spectroscopy. 
 
Chapter 5 deals with the application of the branched supports developed in the 
previous chapter to the synthesis of oligonucleotide dimers. 
 
Chapter 6 presents a novel method for the synthesis of heterobifunctional polymers, 
focusing on the synthesis of 3 examples of modified PEG.  
 
Chapter 7 highlights the main conclusions of this research and discusses future, 
developments and challenges for the MEOS process, and the use of OSN membranes 
in the synthesis of heterobifunctional polymers. 
 
1.3 Oligonucleotides: definition, characterisation, and applications 
Oligonucleotides are short-chain single-stranded sequences of DNA and RNA. The 
building blocks of DNA and RNA oligonucleotides are nucleotides, which are 
phosphate esters of nucleosides.  Nucleosides are composed of two components: a 
nitrogen heterocyclic base (B, Figure 1.1) and a pentose sugar. The structure of 
natural nucleotides can be seen in Figure 1.1.  The major nitrogen bases can be 
divided in two groups: bicyclic purines (adenine (A) and guanine (G)) and 
monocyclic pyrimidines (cytosine (C), thymine (T) and uracil (U)). While A, G and C 
are found in both DNA and RNA molecules, T is almost exclusively in DNA, while U 
replaces it in RNA. Another major difference between the building blocks of DNA 
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and RNA oligonucleotides lies in the pentose sugar (R, Figure 1.1). Unlike DNA, 
RNA presents a –OH group attached to the second carbon. 
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Figure 1.1 - Structure of natural nucleotides: B= A, G, C, T, U; R= -H, -OH 
 
Chemically, oligonucleotides are poly(nucleotides) linked by an internucleotide 
phosphodiester between the 3’- and the 5’- of the pentose sugar. Figure 1.2 presents 
the general structure of natural DNA (1) and RNA (2) oligonucleotides. 
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Figure 1.2 - Structure of natural oligonucleotides: 1, DNA oligonucleotide, B= A, G, 
C, T; 2, RNA oligonucleotide, B= A, G, C, U 
 
DNA and RNA oligonucleotides are of great interest because of their application in 
molecular biology techniques (Amarnath and Broom, 1977; Caruthers, 1985; Itakura 
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et al., 1984; Marshall and Boymel, 1998) and as antisense drugs (Crooke, 1999; 
Sanghvi, 2000; Stein and Cheng, 1993; Uhlmann and Peyman, 1990). RNAi is 
another recent technology based on short-chain nucleic acids, which has increased the 
interest in RNA molecules (Fichou and Ferec, 2006; Manoharan, 2004; Vilgelm, 
2006). These synthetic antisense oligonucleotides and RNAi molecules bind 
specifically to complementary target nucleic acids, providing a means to regulate gene 
expression. Several oligonucleotides candidate drugs are in different stages of clinical 
trials for the treatment of viral infections (Hepatitis C, CMV-induced retinis), cancers 
(non-small cell lung cancer, ovarian cancer, non-Hodgkin’s lymphoma, breast cancer) 
and inflammatory disorders (ulcerative colitis, psoriasis) (Persidis, 1999; Sanghvi, 
2000). Attention has been focused on the preparation of oligonucleotides bearing 
modified internucleotide linkages or modified bases in order to enhance stability to 
nucleases and increase cellular uptake (Christodoulou, 1993). The phosphorothioate 
derivatives (3, Figure 1.3), in which a sulfur atom replaces one of the non-bridging 
oxygen atoms of the internucleotide linkage, are one the most intensively investigated 
molecules (Agrawal and Iyer, 1995; Cheruvallath et al., 2000; Scremin and Bonora, 
1993). Apart from other modifications in the internucleotide linkage modifications in 
the pentose sugar have also been investigated (Figure 1.3); 2’-O-Me (4), 2’-F (5), 
LNA (6). 2’-O-methoxyethyl (MOE) phosphorothioates (7), constitute promising 
candidate for antisense therapeutics (Xie et al., 2005).  
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Figure 1.3 - Structure of modified oligonucleotides: 3, phosphorothioate; 4, 5, 6, and 
7, 2’- modifications; B= A, G, C, T, U 
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1.4 Synthesis of oligonucleotides 
Chemical synthesis of oligonucleotides has constituted one of the most challenging 
problems in the field of synthetic organic chemistry in the last decades 
(Christodoulou, 1993). Methods for the synthesis of oligonucleotides and analogues 
can be classified according to the chemistry used to form the internucleotide ester 
bond (phosphodiester, phosphotriester, phosphoramidite and H-phosphonate methods) 
and according to the nature of the 3’- or 5’-OH protecting group (solid phase 
synthesis, SPS; solution  phase synthesis, SolPS; and liquid phase synthesis, LPS). 
SPS using the phosphoramidite approach has been the method of choice for 
oligonucleotide drugs due to ease and speed of operation, automated protocols and 
high quality of the crude oligonucleotides it produces (Marshall and Boymel, 1998; 
Reese and Song, 2003; Sanghvi, 2000) and will continue to be used in the preparation 
of the relatively small quantities of material required by molecular biologists (Reese, 
2005). Following the approval of the first antisense drug, Vitravene, by the FDA and 
EMEA (Sanghvi, 2000) and the prospect of the approval of more drugs, synthesis of 
bulk quantities of high quality oligonucleotides are required1, but the need for 
improved methods  is even more pressing (Ravikumar et al., 2006). While SPS has 
provided the quantities required for clinical trials, SolPS (Reese and Song, 2003; 
Sanghvi, 2000) or a combination of both are likely to have longer term advantages 
(Bonora et al., 1990; Reese, 2005).  
 
                                                 
 
 
 
 
 
 
 
 
 
1 Cheruvallath et al. (2000) stated that is it roughly estimated that for a systemic 
dosing for the treatment of a chronic disease, about 700 to 900 kg of drug per year 
would be required to meet demand 
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1.4.1 The phosphodiester method 
The phosphodiester method, developed by Khorana and co-workers, largely 
dominated the field of oligonucleotide synthesis in the early years. The coupling 
reactions involved the addition of nucleoside phosphate monoesters, and the 
internucleotide phosphodiester functions were kept unprotected during the coupling 
reactions (Figure 1.4). Dicyclohexylcarbodiimide (9, DCC), mesitylenesulfonyl 
chloride and triisopropylbenzenesulfonyl chloride were used as coupling reagents 
with reasonable success (Narang, 1983).  
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Figure 1.4 - Example of the phosphodiester method: B= T; 8, TsCl; 9, DCC; i, AcOH-
H2O (4:1) (v/v); ii, NaOH, H2O (Reese, 2002) 
 
The phosphodiester method was adapted both to the stepwise and block synthesis of 
moderately high MW DNA oligonucleotides (Reese, 2002) and with reasonably good 
yields (ca. 50-70%) (Reese, 2005). However, side-reactions, long reaction times, 
drastically decreasing yields as the chain length increases – leading to large excess 
reagents – and time-consuming purification procedures via anion-exchange column 
chromatography (Narang, 1983; Reese, 2002) made this approach tedious and it was 
more or less abandoned in the 1970s (Reese, 2005). Moreover, an important feature 
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introduced at the time was the replacement of the trityl (Tr) 5´-OH protecting group – 
acidic conditions for its removal were enough to promote the cleavage of the 
glycosidic bond between the sugar and the nitrogen base – by 4-monomethoxytrityl 
(Mmt) and 4,4’-dimethoxytrityl (Dmt) (Figure 1.5). Nowadays, the acid labile Dmt 
group is used almost exclusively for the protection of 5´-OH group in oligonucleotide 
synthesis (Narang, 1983; Reese, 2002).   
 
MeO
R
 
Figure 1.5 - 5´-OH protecting groups. R = -H, Mmt; R = OMe, Dmt 
 
Khorana and co-workers also gave much attention to the protection of the exocyclic 
amino groups of A, C, and G, in order to avoid side-reactions. Acyl protecting groups 
were designed to remain stable for long periods under the conditions of synthesis, but 
were removed by treatment with concentrated ammonia at the end of synthesis. These 
are still the most popular protecting groups, benzoyl being used to protect A and C, 
while iso-butyryl is used to protect G. 
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Figure 1.6 - Protected nitrogen bases 
 
The studies of Khorana and co-workers made a great contribution to the elucidation of 
the genetic code by using chemically synthesised dimer, trimer and tetramer 
sequences, and later, the total synthesis of two tRNA genes was carried out by 
enzymatically joining chemically-synthesised DNA oligonucleotide sequences 
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(Reese, 2005). These studies provided the basis for many of the fundamental 
developments in molecular biology and biotechnology that have, since then, taken 
place (Reese, 2005). 
 
1.4.2 The phosphotriester method 
The phosphotriester method (Figure 1.7) revolutionised the field of the chemical 
synthesis of oligonucleotides by realising the need to protect the internucleotide 
phosphodiester groups during synthesis (Christodoulou, 1993).  
 
Difficulties in synthesis and purification of relatively large oligonucleotides were 
often aggravated by the presence of negative charges associated with the 
internucleotide phosphate linkage (Amarnath and Broom, 1977). Thus the choice of 
the protecting group is a matter of crucial importance in the phosphotriester method. 
Such groups should be (Reese, 2002):  
(i) easy to introduce;  
(ii) stable under the reaction conditions; and,  
(iii) removable at the end of the synthesis under conditions in which the desired 
product is stable.  
 
Several internucleotide bond protecting groups have been designed. An extensive 
review can be found elsewhere (Amarnath and Broom, 1977; Reese, 2002). Several 
coupling reagents have also been proposed throughout the years. In the last decades, 
1-(mesitylene-2-sulfonyl)-3-nitro-1,2,4-triazole (MSNT) (Figure 1.8) became 
established as the coupling reagent of choice both in SolPS and SPS, due to rapid, 
relatively clean and efficient coupling reactions (Reese, 2002). 
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Figure 1.7 - Example of the phosphotriester method: B= ABz, GiBu, CBz, T, U; R= 5'-
OH protecting group; R'= internucleotide phosphate protecting group; R''= 3'-OH 
protecting group (Reese, 2005) 
 
Me Me
Me
SO O
N
N
N
NO2
 
Figure 1.8 - Coupling reagent for the phosphotriester method: 1-(mesitylene-2-
sulfonyl)-3-nitro-1,2,4-triazole (MSNT) 
 
The phosphotriester method has been applied in both SPS and SolPS. However, this 
chemistry is traditionally adopted for SolPS because of the more advantageous 
stability and solubility properties of the building blocks (Bonora et al., 2001). The 
main advantages of the phosphotriester method include:  
(i) the opportunity for large-scale synthesis (50-75g);  
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(ii) significantly shorter time periods compared to the phosphodiester method, 
especially in the purification steps;  
(iii) higher yields of around 95 % using almost stoichiometric quantities of 
reactants. This is probably due to the absence of any endo-P-O- groups in 
the oligonucleotide chain, therefore avoiding chain scission and 
pyrophosphate formation (Narang, 1983); and, 
(iv) stability of the building blocks. 
 
Neverthless, the phosphotriester method is not free of disadvantages. 5’-O-sulfonation 
is often obtained (up tp 2 %) and side-reactions with the nucleobases are also 
observed, decreasing the yields of syntheses. Aditionally, 95 % coupling yields, is an 
impractible value for synthesis of longmers, due to accumulative effects. For an 
efficient synthesis in high yield, 99+ % coupling yields are absolutely necessary. 
 
1.4.3 The phosphoramidite method 
The development of nucleoside phosphoramidite derivatives for the synthesis of DNA 
oligonucleotides was first described in Beaucage and Caruthers, 1981). This method 
emerged as a modification of the “phoshorodichloridite” coupling procedure earlier 
reported by Letsinger and co-workers (Beaucage, 1993). Letsinger and coworkers 
found that P(III) species were considerably more reactive than the corresponding P(V) 
phosphorylating agents (Narang, 1983; Reese, 2005). Thus, two monomers could be 
coupled together in a matter of minutes rather than hours (Narang, 1983). Originally, 
the chloridite building blocks used were very unstable under oxidative and 
hydroscopic conditions. In order to overcome these problems, N,N-
dimethylaminophosphoramidites were introduced and found to be easy to prepare by 
standard procedures, relatively stable to hydrolysis and air oxidation, and possible to 
store as dry, stable powders (Beaucage and Caruthers, 1981).   
 
An example of a coupling reaction using the phosphoramidite method is depicted in 
Figure 1.9. 2-Cyanoethyl-N,N-diisopropylphosphoramidites (10) have been found to 
be more suitable building blocks than N,N-dimethylaminophosphoramidites and have 
been used virtually universally in phosphoramidite-based SPS (Reese, 2002; Sanghvi, 
2000).  
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Figure 1.9 - Example of the phosphoramidite method: B= ABz, GiBu, CBz, T, U; R= 5’-
OH protecting group; R’= 3’-OH protecting group; 10, 2-cyanoethyl-N,N-
diisopropylphosphoramidite; 11, 1H-tetrazole 
 
At the end of the coupling reaction, the internucleotide trivalent P-bond is oxidised to 
the required phosphotriester by aqueous iodine (Narang, 1983) or by non-aqueous 
oxidation – such as tert-butyl-hydroperoxide (TBHP) – that allows for the reaction 
medium to remain in anhydrous conditions (Hayakawa et al., 1986). For the synthesis 
of medicinally valuable phosphorothioates, the phosphate group is reacted with a 
sulfurisation reagent such as 3H-1,2-benzodithiol-3-one 1,1-dioxide (Beaucage 
reagent) or phenylacetyl disulfide (PADS) (Cheruvallath et al., 2000). 
 
Due to the decrease in coupling efficiency with increasing chain length, the 
phosphodiester and phosphotriester methods often used dimers and trimers as building 
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blocks for the synthesis of long chain oligonucleotides. Because coupling efficiencies 
are very high using phosphoramidite chemistry there is no need to use block synthesis 
even for the preparation of long deoxyoligonucleotides, 50 to 100 bases long. As a 
result, instruments for DNA synthesis can be quite simple because only four ports 
(deoxyadenosine, deoxyguanine, deoxycytidine and thymidine monomers) are 
required, instead of the 16 or 64 ports that would be required if dimers and trimers 
were used (Caruthers, 1985). 1H-Tetrazole has been for many years the activator of 
choice. However, due to safety and cost considerations during large scale synthesis, or 
low activation of 2’-OH protected RNA oligonucleotides, alternatives, such as 
pyridinium trifluoroacetate (pyTFA) (Eleuteri et al., 2000), 4,5-dicyanoimidazole 
(DCI) (Vargeese et al., 1998) or various acid salts of azole derivatives have been 
investigated (Hayakawa et al., 2001). 
 
Automated synthesis using the phosphoramidite approach has been the method of 
choice for oligonucleotide synthesis due to high coupling efficiency per nucleoside 
(>99 %), very fast reaction times (<30 s) and relative stability of the monomers 
(Marshall and Boymel, 1998).  
 
1.4.4 The H-phosphonate method 
Like the phosphotriester method, the H-phosphonate method for oligonucleotide 
synthesis was first reported from Todd´s Cambridge laboratories in the 1950s 
(Froehler, 1993; Reese, 2002). However, its real significance only became apparent in 
the 1980s, when applied to the SPS. A schematic of the H-phosphonate method is 
shown in Figure 1.10. 
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Figure 1.10 - Schematic of the H-phosphonate method: B= ABz, GiBu, CBz, T, U; R= 
5'-OH protecting group; R'= 3'-OH protecting group; R''= O- or S; 12, pivaloyl 
chloride; i, Oxidation or sulfurisation agent 
 
Synthesis of DNA oligonucleotides via the H-phosphonate method consists of a 5’-
OH deprotection reaction, followed by a coupling reaction and an optional capping 
step, with washing steps in between reactions. One single oxidation at the end of the 
synthesis is used to convert the H-phosphonate linkages to phosphodiester linkages. In 
general, the shorter the cycle time, the better. Long cycle times can lead to the 
degradation of the oligonucleoside H-phosphonate diester backbone via hydrolysis of 
the diester. Deoxynucleoside H-phosphonates are commonly activated by pivaloyl 
chloride (12, Figure 1.10). Overactivation of the H-phosphonate leads to a number of 
undesirable by-products, and therefore, coupling reactions in excess of 1 min are 
generally more harmful than helpful (Froehler, 1993). 
 
Advantages of the H-phosphonate method include the short cycle times due to the fast 
coupling reaction, the optional capping step, and the fact that oxidation can take place 
only at the end of chain extension, rather than after each coupling step. Furthermore, 
the H-phosphonate monomers are easy to prepare and are stable to hydrolysis and 
oxidation, making these reagents easy to handle (Froehler, 1993). In comparison to 
the phosphoramidite method, this is a great advantage. H-phosphonate monomers are 
rather stable and easy to handle, while phosphoramidites are prone to air oxidation 
and hydrolysis. At a large scale synthesis, this constitutes a major advantage as well 
because anhydrous conditions are not so strict.  
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Although at the beginning it was mainly utilised for SPS, the H-phosphonate method 
has been applied to SolPS, due to development of a modified approach that reduced 
H-phosphonate diester´s susceptibility to base catalysed hydrolysis by in-situ addition 
of a sulfur transfer agent just after the coupling step that included S-protection (Reese, 
2002). This feature also allowed for the introduction of phosphorothioate bonds at the 
desired places in the oligoncleotide chain. H-phosphonate  has been successfully used 
in the synthesis of antisense drugs, as reported by Reese and Yan, 2002). 
 
1.4.5 Solid phase synthesis (SPS) 
The concept of SPS originated as a new approach to the synthesis of peptides. 
However, the principle has been generally applied throughout synthetic chemistry and 
to a variety of chemical reactions. The basic principle of SPS is to reversibly attach 
the oligonucleotide to an insoluble resin. While the growing oligonucleotide is kept in 
the solid phase, reactants are added in solution, allowing for a very simple procedure 
for the intermediate separation steps by filtration and solvent washing. The main 
advantages of this technology include (Itakura et al., 1984):  
(i) simple and fast isolation of the resin-bound product from soluble reagents 
and by-products;  
(ii) reagents can be used in large excess to drive reactions to completion;  
(iii) the whole synthesis takes place in one flask/vessel, minimising losses 
related to product handling; and,  
(iv) simplicity of operation and automation.  
 
The first nucleoside is usually functionalised at the 3´-OH by succinic anhydride and 
then coupled to the support. During chain assembly, several steps are repeated in a 
cyclic manner:  
(i) removal of 5´-OH protecting group of nucleoside/nucleotide with acid 
solution;  
(ii) solvent washing;  
(iii) coupling reaction, through the addition of reactive 3’-O-
phosphonucleoside derivative with the help of an activator;  
(iv) solvent washing;  
(v) oxidation/sulfurisation, depending on the chemistry used or product 
desired;  
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(vi) solvent washing;  
(vii) capping, to block unreacted 5’-OH groups.  
 
When the desired oligonucleotide chain is achieved, the product is released from the 
solid support and purified through chromatographic methods. 
 
DNA oligonucleotides of 100 or more bases have been synthesised using SPS 
(Beaucage, 1993; Marshall and Boymel, 1998). SPS has also been successful for the 
synthesis of very long (110 mer) RNA oligonucleotides (Shiba et al., 2007). Despite 
the success, SPS still presents limitations that especially hinder its scale up 
(Montserrat et al., 1994; Sanghvi, 2000). The very simple and efficient intermediate 
separation step has the drawback of depending on a heterogeneous medium, which 
leads to the use of a large excess of high-cost monomers in order to achieve high 
coupling efficiencies (Bonora et al., 2000; Montserrat et al., 1994). Four major types 
of solid supports (resins) are commonly used; polystyrene-divinylbenzene (PS-DVB) 
copolymer, composite support Wolfchem SR 107 (a macroporous Kieselguhr-
polydimethylacrylamide support), aminoalkylsilica and controlled pore glass (CPG) 
(Sonveaux, 1986). CPG, however, has been used as the preferred support, since 
sequential yields exceeding 99% can be achieved (Caruthers, 1985; Montserrat et al., 
1994).  
 
The nature of the solid support and support solvation determine the mass transfer 
conditions of the reaction. For large scale synthesis, PS-DVB has been proposed since 
it allows for a high support loading (from 80 to 330 μmol g-1) and the use of polar and 
non-polar solvents, since the resin swells in both types of solvents and allows 
reactants to access reactive sites with ease (Bardella et al., 1990; Montserrat et al., 
1994). However, it was found that a large excess of nucleoside phosphoramidites was 
still needed since the reaction kinetics only allowed for average coupling yields 
ranging from 94.1 to 97.8 %, and after long reaction times.  Coupling efficiencies 
below 100% result in the contamination of the final oligonucleotide with deletion 
products ((n-1)-, (n-2)-mer, etc), in which one or more nucleotides are absent and 
increasing difficulty in final product purification (Krotz et al., 1997).    
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Protocol optimization using CPG have lead to the reduction of the reagent excess 
down to 2 equivalents of phosphoramidites (Andrade et al., 1994), and 1.5-molar 
excess with +98.5% reaction yields (Krotz et al., 1997). However, these results were 
obtained on limited scale syntheses. Phosphorothioate oligonucleotides – the first 
generation of antisense grugs – are, nowadays, routinely synthesised on a Pharmacia 
OligoProcess DNA/RNA synthesiser at 150 mmol scale using only 1.75 molar excess 
of phosphoramidites (Capaldi et al., 1999). Neverthless, for larger scales, the 
challenge is still great. Although SPS allows for a very simple purification method, 
the nature of it also hinders cost-efficiency and large scale manufacture.  
 
Since the support is the most expensive single material in SPS (per g used) a decrease 
in its consumption can significantly reduce the cost of large scale synthesis. Tandem 
synthesis has been suggested in which synthesis of oligonucleotides linked in series 
on the same solid support is used. This technique (Figure 1.11) reduces the labour by 
reducing the time synthesisers must be set-up, and allowing multiple products to be 
handled as single sets. Using this method, tandem strings of 6-, 10- and 14-mer 
sequences; 24 base-long primers in either duplicate, triplicate or quadruplicate (total 
of 96 bases); and two complementary 20-mer sequences, which on cleavage 
spontaneously formed a double-stranded DNA, were prepared (Pon et al., 2001).  
 
Figure 1.11 - Tandem oligonucleotide synthesis (Source : Pon et al., 2001) 
NH3 
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1.4.6 Solution phase synthesis (SolPS) 
SolPS methods were used for the first synthesis of an internucleotide bond. However, 
the efficiency of the phosphoramidite method, together with the development and 
ability to automate SPS, put the latter into first place (Seliger, 1993). 
 
Considering oligonucleotide synthesis as a multistep process, the term “solution 
phase” will apply to those approaches where chain elongation is performed by 
repeating the operations (Seliger, 1993):  
(i) activation/condensation with a protected monomer or block;  
(ii) separation of the elongated chain from the starting materials, and;  
(iii) deprotection of the chain prior to the next addition; where (i) and (iii) are 
performed in solution and (ii) is usually achieved by chromatographic 
methods.  
 
The phosphotriester method has been the most widely used approach for synthesis in 
solution, although the interest and advantages of the H-phosphonate method have 
been reported recently (Reese and Yan, 2002; Reese and Song, 2003). Reese and Yan, 
2002) reported the efficient synthesis of VITRAVENE using block synthesis and H-
phosphonate chemistry. Flash column chromatography was used as the intermediate 
separation technology. Ravikumar et al., 1995) reported a very efficient protocol for 
SolPS using 1.2 molar excess of nucleoside phosphoramidites and with a reasonable 
yield of 85 %. However, the synthesis was limited to dimers. Flash chromatography 
was also used for separation steps. 
 
Although SPS has been the method of choice (Sanghvi, 2000) it is foreseeable that 
with the greatly increased scale in production required for medicinal applications of 
oligonucleotides is easier and less expensive to use solution phase technologies 
(Reese and Song, 2003). However, the use of chromatography as the separation step 
substantially hinders the application of SolPS for large scale synthesis, due to the 
inherent large solvent consumption, long time consumption, cost and scale limitations 
of chromatography. 
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Recently, a novel SolPS process based on simple extraction procedures has been 
reported (de Koning et al., 2006). The novelty of this process relies on the anchoring 
of the growing oligonucleotide in the organic phase by the use of lipophilic protecting 
groups on the nitrogen bases (including N3-pivaloyloxymethyl (Pom) protection in T), 
the cyanoethyl (CeO) internucleotide protecting group, and the adamantyl-acetic acid 
ester on the 3’-OH of the first nucleotide (Figure 1.12). All the reactants could then be 
removed by a series of extractive protocols, and the oligonucleotide from the excess 
monomers by a simple basic aqueous extraction. Firstly, it was observed that the CeO 
protection was not stable enough, reducing the intermediate yields, due to the loss of 
product solubility in the organic phase. Process optimization gave a 6-mer 
oligonucleotide with good purity and yields of 67 %. This method, however, suffers 
from 2 potential limitations. The use of base can lead to the removal of the base-labile 
CeO protection, as reported in the paper. Aditionally, quenching of the 
phosphoramidite prior to oxidation may lead to the hydrolysis of the phosphite 
triesters at the internucleotide bond and increases the need to ensure anhydrous 
conditions for following coupling steps. Although amenable to large scale synthesis, 
no reports of its application are known to the best of the authors knowledge. 
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Figure 1.12 – SolPS of oligonucleotides using extractive work-up (Source :de Koning 
et al., 2006) 
 
1.4.7 Liquid phase synthesis (LPS) 
In order to overcome the difficulties inherent to the SPS method whilst maintaining its 
best properties, the use of soluble polymeric supports for the synthesis of peptides has 
been proposed (Bayer and Mutter, 1972). The same approach, named liquid phase 
synthesis (LPS), has seen a revival for the synthesis of oligonucleotides through the 
work of Bonora and co-workers in a process named High Efficiency Liquid Phase 
(HELP) synthesis (Bonora et al., 2000; Bonora et al., 1990; Bonora et al., 2001; 
Colonna et al., 1991; Scremin and Bonora, 1993). 
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In the HELP process, PEG with a MW ranging from 5,000 to 20,000 g mol-1 was used 
as the soluble polymer support, coupled to the oligonucleotide chain through a 
succinate linkage. The support-bound growing oligonucleotide could be rapidly 
recovered from the reaction mixture by precipitation/crystalisation, thus allowing 
elimination of excess reagent and soluble by-products. At the same time, since all 
reactions were carried out in solution, cost savings, and easier scale up of the process 
is antecipated (Bonora et al., 2000). The HELP process has been applied using the 
phosphotriester (Bonora et al., 1990), phosphoramidite (Bonora et al., 1993; Scremin 
and Bonora, 1993) and H-phosphonate (Gravert and Janda, 1997) methods.  
 
Bonora and co-workers reported the successful synthesis of several oligonucleotides 
with success. An 8-mer was synthesised (using MeOPEG, MW ~ 5,000 g mol-1) with 
yield of 93 % and a 20-mer (MeOPEG, MW ~ 12,000 g mol-1) with yield of 85 % and 
average coupling yields of 99 % (Bonora et al., 1993). A 20-mer phosphorothioate 
oligonucleotide was also synthesised (MeOPEG, MW ~ 12,000 g mol-1) with 83 % 
yield and isolated yield (after full deprotection and purification) of 46 % (Bonora et 
al., 1993; Scremin and Bonora, 1993). A common observation of the HELP method 
was the minimal loss of material (less than 1 %) after each coupling step, resulting 
from the precipitation/crystalisation steps. Later, Bonora and co-workers investigated 
the use of phosphoramidite dimers as building blocks for the synthesis of a 8-mer 
(MeOPEG, MW ~ 5,000 g mol-1) and a 15-mer (MeOPEG, MW ~ 12,000 g mol-1), in 
order to improve the purity of final products. The yields obtained were, respectively 
90 % (74 % of overall recovery) and 58 % (66 %) (Bonora et al., 2000). 
 
In order to speed up the HELP process, and reduce costs and material losses, 
automation was investigated and the synthesis of a dimer yielded 88.7 % and 99 % 
yields for, respectively, attachment of the first nucleotide to PEG and coupling of the 
second nucleotide (Bagno et al., 1998). However, to the best of my knowledge, no 
reports of the synthesis of longer chains were published. 
 
Various other polymers were also reported for oligonucleotide synthesis (Gravert and 
Janda, 1997 and references herein). Polystyrene with MW ranging from 170,000 to 
270,000 g mol-1 was used as soluble support and precipitated by the addition of water. 
Although reaction rates were comparable to those of SolPS, product recovery was 
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problematic due to the increased water solubility that the attached oligonucleotide 
sequence confers on the product. Polyvinyl alcohol (PVA) was found to be a better 
support for oligonucleotide synthesis, since it provided increased solubilising power, 
better compatibility and higher loading capacity. Although high loading of 
oligonucleotides was achieved, only short length chains could be prepared before 
solubility properties started to be determined largely by the growing chain. A 
derivative of cellulose acetate provided a soluble support for the synthesis of 
oligonucleotides using the phosphotriester method. This polymer was chosen due to 
its solubility in pyridine, yet was precipitated by the addition of ethanol.  
 
1.4.8 Other synthetic methods 
Some alternative strategies for chemical synthesis of oligonucleotides have been 
proposed. Dueymes et al., 2005) described what can be interpreted as a variation of 
SPS. The synthesis of oligonucleotides is carried in solution, while the reagents are 
supported on a solid (Figure 1.13), allowing for the preparation of short 
oligonucleotides, purified by a simple filtration, without the chromatographic step. 
Prior to the following reaction step, the excess nucleoside phosphoramidite was 
converted into H-phosphonate, and removed after chain elongation by a basic aqueous 
work-up. 
 
 
Figure 1.13 – Coupling step of the polymer-supported reagents synthesis (Source: 
Dueymes et al., 2005) 
 
Mihaichuk et al., 2000) reported a novel process, reversing the traditional modality of 
SPS.  A suitable N4-protected nucleoside was covalently bound to a 2% PS resin 
support at the 5´-OH via a Dmt functional linkage (Figure 1.14). A resin-bound 
nucleoside 3´-OH nucleoside phosphoramidite is then prepared, and in this manner, 
the reactive resin may then serve as the solid support for the subsequent coupling. By 
coupling a solution phase 3´-O-protected oligonucleotide to the resin-bound amidite, 
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the advantages of traditional solid-phase synthesis, including facile removal of 
reagents and reactants, are retained (Mihaichuk et al., 2000; Pieken et al., 2001). 
 
 
Figure 1.14 – Scheme of the DMT PASS (Dimethoxytrityl Resin Product Anchored 
Sequential Synthesis) method (Source: Mihaichuk et al., 2000).  
 
A foreseeable disadvantage of the DMT method derives from the use of aqueous 
extraction to remove the excess nucleoside phosphoramidites. Although no hydrolysis 
step is required since the 5’-OH group of the monomers is not protected by a 
hydrophobic group, aqueous washes are potentially harmful for the following 
coupling reactions. 
 
1.5 Synthesis of nucleoside phosphoramidites 
As previously mentioned, the prospect of several antisense drugs being approved in 
the forthcoming years and the inherent increase in demand, have led to the need for 
improved processes (Ravikumar et al., 2006). In recent years, an increase in research 
regarding raw materials, reagents and process chemistries has been observed 
(Sanghvi, 2000). Nucleoside phosphoramidites, the preferred monomers for 
oligonucleotide synthesis, have been the subject of research as well, since they alone 
can contribute to over 33% of the cost of raw materials, and their synthesis on a large 
scale remains challenging and difficult (Sanghvi et al., 2000; Xie et al., 2005). 
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Nucleoside phosphoramidites are synthesised by phosphitylation of a nucleoside with 
a phosphitylation agent, in the presence of an activator. Most commonly, the preferred 
phosphoramidites are 2-cyanoethyl-N,N-diisopropylphosphoramidites (10, Figure 1.9) 
introduced by Beaucage and Caruthers (1981). These are very reactive species, giving 
high coupling yields, and have better stability than the earlier phosphorochloridites.  
 
Several methods for the synthesis of phosphoramidites are described in the literature, 
using a variety of phosphitylation agents, activators and techniques (Beaucage and 
Caruthers, 1981; Caruthers and Beaucage, 1983; Greiner and Pfleiderer, 1998; 
Sanghvi et al., 2000; Sinha, 2004; Xie et al., 2005). The most common 
phosphitylation agent is 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite (13, 
Figure 1.15), but because it is expensive and potentially explosive, 2-cyanoethyl-
N,N,N’,N’-tetraisopropylphosphoramidite (tetraphos, 14, Figure 1.15), which is 
relatively cheaper and safer, has been suggested as replacement in large scale 
processes (Sanghvi et al., 2000). 1H-Tetrazole (11, Figure 1.15) has been the activator 
of choice for many years, but its cost and explosive nature, and the associated 
difficulty in handling, have lead to the investigation for alternatives such as 
pyridinium salts (Sanghvi et al., 2000) or azole salts (Hayakawa et al., 2001; Sinha, 
2004).  Figure 1.15 shows the structure of some phosphoramidite synthesis. 
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Figure 1.15 - Structure of common phosphoramidite synthesis reagents 
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In order to predict by-product formation and product degradation, reaction 
mechanisms of phosphoramidite chemistry using 1H-tetrazole (11) (Dahl et al., 1987) 
and other activators have been thoroughly studied (Hayakawa et al., 2001; Sanghvi et 
al., 2000).  
 
The synthesis of phosphoramidites is not free of side reactions, since the acidity of the 
activator can cause the removal the acid-labile 5’-OH Dmt protecting group (Sanghvi 
et al., 2000). Depurination (removal of acid-sensitive purines) and formation of 
dimers can also happen (Sanghvi et al., 2000; Xie et al., 2005). Thus care in the 
choice of the activator used, and on the synthesis conditions is required, as it can 
highly impact the purification and isolation of the final product. 
 
Synthesis of phosphoramidites on larger scales is also challenging due to the difficulty 
in the final purification step. The conventional methods require considerable skill in 
order to perform lengthy and cumbersome work-up protocols (Sanghvi et al., 2000; 
Xie et al., 2005). Up to nine extractions can be performed in an extractive work-up 
(Sanghvi et al., 2000; Xie et al., 2005). At the same time, long operation times 
increase the contact of the phosphoramidites with water, leading to their potential 
degradation (Sanghvi et al., 2000; Xie et al., 2005). Silica gel flash chromatography 
has been applied (Sanghvi et al., 2000; Xie et al., 2005). But is discouraging since it 
is time consuming and difficult to scale up. Recently, Boam et al., 2006) applied OSN 
for the purification of oligonucleotide building blocks. This OSN application will be 
discussed later (Section 1.7). 
 
1.6 Organic Solvent Nanofiltration (OSN): definition 
The last decade has seen a growing interest in membrane separation processes in 
organic solvents due to the possibility of achieving separations with competitive 
performances to other separation processes, i.e. distillation, absorption, adsorption, 
extraction (Beerlage, 1994; Razdan et al., 2003). The key feature in membrane 
processes is the membrane, a semi-permeable barrier between two phases, allowing 
for the selective transport of components across the membrane (Figure 1.16).  
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Figure 1.16 - Schematic of a membrane separation process (Adapted from: Beerlage, 
1994) 
 
The driving force, necessary to allow mass transport across the membrane, defines the 
type of membrane process. Descriptions and characterisation of different membrane 
processes are given elsewhere (Mulder, 1997). Nanofiltration (NF) is a pressure-
driven separation process able to perform separations in the range of 200 to 1,000 g 
mol-1. The selectivity of a NF membrane towards a solute is usually defined by 
rejection (Ri, %) (Equation 2.1). Although most liquid phase applications of NF are 
currently limited to separations in aqueous systems, recent development of NF 
membranes that are able to operate in organic solvents have expanded the potential 
industrial applications of NF. Organic solvent nanofiltration (OSN) has raised an 
increasing academic and industrial interest with reported applications in the 
petroleum, food and beverages, and pharmaceutical and fine chemicals industries. 
Some of these applications will be described in Section 1.6.4.  
 
 
1.6.1 Classification and characterisation of OSN membranes  
OSN membranes can be divided in two groups: polymeric and inorganic membranes. 
Polymeric membranes can be symmetric or asymmetric, with the difference being that 
asymmetric membranes present a gradient in pore size between a top layer and a 
bottom layer. The top layer can also be non-porous (dense layer) or made from a 
different material. The latter are classified as composite membranes, as opposed to 
  
Membrane 
Driving force 
Feed Permeate 
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integral membranes, composed of a single material. The top layer determines the 
transport rate through the membrane, while the bottom layer provides support and 
mechanical strength. Symmetric membranes can be porous – formed either by long 
channel pores or by a porous spongy-type structure – or non porous (i.e. 
homogeneous film). Most polymeric OSN membranes have an asymmetric structure 
and are porous with a dense top layer.  
 
Polymeric OSN membranes usually have limited applicability to solvents, since they 
tend to swell, deform or dissolve, losing physical integrity (Van der Bruggen et al., 
2008). An OSN membrane requires a polymer that is: rigid, crystalline, thermally 
stable, resistant to compaction, inert and non-swollen by solvents and stable over long 
term use (Razdan et al., 2003). Chemical stability of a polymer is often related to its 
thermal stability. The higher the glass transition temperature, the more rigid the 
polymer is and, generally, the higher its stability in organic solvents (Beerlage, 1994). 
Factors that promote chemical stability include (Beerlage, 1994):  
(i) aromatic or heterocyclic backbone structures;  
(ii) absence of reactive groups such as unsaturated bonds, -OH groups, free –
NH groups or aliphatic groups;  
(iii) presence of high bond energies that can cause strong chemical bonds, e.g., 
C-F, C-Si, C-P;  
(iv) polybonding, i.e., atoms that are linked to the polymer chain with two or 
more bonds, which implies that the chains cannot be broken by the rupture 
of one single bond, e.g., in ladder polymers.  
 
Quite often, membrane resistance to organic solvents is increased by post-treatment, 
such as chemical cross-linking (Beerlage, 1994; See Toh et al., 2007a). 
 
Inorganic membranes are composed of materials that make them chemically and 
thermally more resistant than polymeric membranes. Four types can be distinguished: 
ceramic membranes, glass membranes, metallic membranes, and zeolitic membranes. 
Inorganic OSN membranes are made of ceramic materials, such as ZiO2, SiO2 or 
TiO2, and are usually prepared by the sol-gel process (Mulder, 1997). These 
membranes offer the advantage of superior chemical stability to organic solvents than 
polymeric membranes, they can withstand higher temperatures and they are generally 
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applicable in any organic solvent (Mulder, 1997). On the downside, they are often 
brittle, lowering their mechanical strength. 
 
1.6.2 Membrane formation and preparation  
Several techniques exist for the preparation of membranes: sintering, stretching, track-
etching, phase inversion, sol-gel process, vapour deposition, and solution cracking. A 
description of all methods can be found elsewhere (Mulder, 1997). Most OSN 
membranes applied so far are polymeric asymmetric membranes and are prepared by 
the phase inversion immersion precipitation method. A polymer solution is cast as a 
thin film on a suitable support, dried for a few seconds to create a dense top layer, and 
immersed in a coagulation bath containing a non-solvent. The exchange of solvent 
and non-solvent causes the phase separation and the precipitation of the polymer, 
therefore determining the morphology of the membrane, and thus its performance 
(Mulder, 1997). The fact that, for the formation of the membrane, the polymer has to 
be soluble in at least one solvent limits the choice of materials (Beerlage, 1994). 
Polyimides (PI) have been one of the preferred materials for the preparation of OSN 
membranes. OSN membranes based on polyimide (PI) have been prepared by phase 
inversion immersion precipitation for different applications (Alegranti, 1978; See-Toh 
et al., 2007; See-Toh et al., 2008; See Toh et al., 2007a; Strathmann, 1978; White et 
al., 1993). 
 
Composite membranes allow for each layer to be optimised in accordance to the 
performance and application desired.  A selective material is deposited on top of a 
porous support layer using different techniques (Mulder, 1997): dip-coating, spray 
coating, spin coating, interfacial polymerisation, in-situ polymerisation, and grafting. 
These different techniques mean that several materials can be used for the formation 
of membranes. Polyacrylonitrile (PAN) – highly solvent resistant – is commonly used 
for the support layer. PAN based membranes have been prepared for different 
applications (Hicke et al., 2002; Linder et al., 1991; Pasternak, 1993; Peinemann et 
al., 2001). 
 
1.6.3 Transport processes and modelling of OSN 
Despite a growing number of studies on the processes that control solvent fluxes and 
solute rejection during OSN, there is no model that is universally accepted (Peeva et 
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al., 2004). Efforts to model OSN have been divided between pore-flow, empirical and 
solution diffusion models. The pore flow model assumes that the membrane has stable 
pores and that the driving force for transport is the pressure gradient across the 
membrane (Silva et al., 2005). This approach has been used to describe the behaviour 
of uncharged solutes in desalination membranes (Desal-DK) (Bowen and Welfoot, 
2002), KOCH MPF membranes (Whu et al., 2000) and PDMS composite membranes 
(Robinson et al., 2004). In the solution diffusion model it is assumed that each 
molecule dissolves in the top layer and diffuses through the membrane driven by a 
pressure induced concentration gradient (Silva et al., 2005). This model has been 
found to be consistent with the fluxes of alkanes (normal and branched) and aromatics 
through PI membranes (White, 2002). Peeva et al. (2004) combined the solution 
diffusion model with the film theory, to account for the effects of concentration 
polarisation and non ideal solution behaviour, to describe the flux accross PI 
membranes.    
 
1.6.4 Applications of OSN 
Application of OSN in the pharmaceutical and fine chemicals industry has been 
focused on improving post-reaction processing and separation. Scarpello et al., 2002) 
reported successful separation of organometallic catalysts using commercially 
available membranes performing in different organic solvents, allowing for a non-
destructive method to recover usually expensive catalysts. Nair et al., 2002 
investigated a process to recover and recycle a phase transfer catalyst (PTC) and a 
Heck reaction transition metal catalyst (TMC) using the STARMEMTM 122 OSN 
membrane. Although for the TMC process some decline of membrane selectivity was 
observed, the PTC process was shown to be highly efficient with no membrane 
performance decrease and no reaction rate decline for 2 consecutive catalyst recycles. 
Other studies (at laboratory scale) also investigated the application of OSN 
membranes to homogeneous PTC recovery and re-use, indicating good results for PI 
STARMEMTM membranes (Luthra et al., 2001; Luthra et al., 2002). Synthesis of 
small molecule drugs usually requires multi-step reactions employing different 
solvents. Solvent exchange between different steps is generally carried out by 
conventional separation processes that can harm thermally-labile molecules. OSN, 
being a process that can be applied at room temperatue, can be used for these 
processes. Livingston et al., 2003) reported the use of an OSN membrane process, by 
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using STARMEMTM 122 to change the composition of two different systems from 
100% toluene (TOL) to 99.6% methanol (MeOH) and from 100% TOL to 99.7% 
ethyl acetate (EtOAc), with model solutes tetraoctylammonium bromide and 
tetrabutylammonium bromide, respectively. Sheth et al., 2003) showed that KOCH 
MPF-50 and MPF-60 OSN membranes could be applied to change from 100% ethyl 
EtOAc to 96+% MeOH using erythromycin as model solute. 
 
Applications in the petroleum refining industry have also been investigated. White 
and Nitsch, 2000) reported the development from laboratory to industrial scale of an 
OSN process (MAX-DEWAXTM) to recover cold solvents from lube oil in the solvent 
dewaxing process. PI membranes were prepared as previously published (White et al., 
1993) and used with extremely high and long-term stable performance – 99% purity 
of the recovered solvent. Reduced installation costs when compared to conventional 
technology, energy savings, increased base oil production, and improved dewaxed oil 
yields are amongst the benefits attributed to the new process (White and Nitsch, 
2000). Recently, White, 2006) reviewed the possible applications of membrane 
processes (namely, OSN and pervaporation) to the petroleum refining industry and the 
challenges of large scale development. 
 
1.7 Applications of membrane processes to the synthesis, purification and/or 
separation of oligonucleotides and nucleotides 
Application of membrane technology to the synthesis of biological molecules has 
been attempted. In the early 1970s, Bayer and co-workers developed a LPS method 
for the synthesis of peptides in which the removal of impurities between coupling 
reactions was performed using an ultrafiltration (UF) membrane (Bayer and Mutter, 
1972). The process has been patented (Bayer et al., 1973), and involves the synthesis 
of tetra and pentapeptides grown attached to PEG molecules with MW range from 
4,000 to 20,000 g mol-1 is described. Due to the non-availability of solvent resistant 
membranes at the time, the intermediate products had to be dried from their reaction 
organic solvent (dichloromethane) and re-dissolved in water for the filtration step. 
After that, the purified growing peptide was dried, azeotropically distilled to remove 
traces of water, and redissolved in the reaction solvent.  
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More recently, research at our Separation and Engineering Technology (SET) group, 
lead to the development of the Membrane Enhanced Peptide Synthesis (MEPS) 
process, for the synthesis of peptides using OSN membranes. The synthesis of 2 
pentapeptides – including the candidate drug Thymetopin with 94 % purity – has been 
already described (So et al., 2010).  A patent application has been filed for this 
process, that also describes examples for the synthesis of support-bound 
oligonucleotide dimers (Livingston et al., 2010). The examples described in the patent 
are part of this thesis (Chapter 3). 
 
Bonora et al. (2000) attempted to use a UF membrane for the purification of an 
oligonucleotide at the end of the synthesis and compare it with reverse phase and ion 
exchange chromatography. An 8-mer and a 15-mer oligonucleotide were purified 
using a membrane with molecular weight cut off (MWCO)2 of 1,000 g mol-1. It was 
found that the process was time consuming and the reported final recovery below 
80%. Data on the membrane, solvent used or other operational parameters were not 
disclosed. 
 
Boam et al. (2006) patented a process for the purification of monomers for 
oligonucleotide synthesis. Although a process for the purification of phosphoramidites 
and H-phosphonates is claimed, examples only describe the first scenario. 
STARMEMTM 240 OSN membranes (with MWCO of 400 g mol-1) are applied. Due 
to the non-resistance of available membranes to some solvents, such as 
                                                 
 
 
 
 
 
 
 
 
 
2 Molecular weight cut off (MWCO) is defined as the MW of the solute with 90 % rejection 
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dichloromethane (DCM) or dimethylformamide (DMF), the need for solvent 
exchange prior to the OSN step is anticipated, in certain embodiments. 
 
1.8 Polyethylene glycol (PEG): properties and application 
Polyethylene glycol (PEG) is a linear polyether with simple chemical structure 
(Figure 1.17) and available in several MWs. At MWs lower than 1,000 g mol-1, PEG 
is a colourless viscous liquid. Above that PEG is a waxy white solid. Its melting point 
varies with MW but approaches a plateau at ~ 67 0C. 
 
OHO OH
n
HO-PEGn-OH=
 
Figure 1.17 – Chemical structure of PEG. n= 1, 2, 3… to n 
 
PEG is a simple molecule but with unique properties that have made it an attractive 
focus of research to academia and industry over the years, especially regarding 
applications for organic synthesis, biotechnology and medicine. Harris, 1992) has 
reviewed PEG properties. The main ones that make it so attractive are: 
(i) non-toxicity towards cells, although it interacts with biological 
membranes; 
(ii) weak immunogenicity; 
(iii) non-antigenicity; 
(iv) ability to exclude other polymers in aqueous environments, thus rejecting 
proteins and forming 2-phase systems with other polymers; 
(v) it is amenable to chemical modification and when attached to other 
molecules and surfaces it has little effect on their chemistry, but controls 
solubility, size, and pharmacokinetics of drugs; and, 
(vi) unique solubility profile  (soluble in water, TOL, dichloromethane 
(DCM), and many organic solvents; insoluble in diethyl ether, hexane, and 
ethylene glycol). 
 
Several applications have been developed over the years for PEG. Polymer 
therapeutics – including polymer-protein and polymer-conjugates, as well as 
supramolecular drug-delivery systems – is one of the most attractive applications 
(Haag and Kratz, 2006; Hunter and Moghimi, 2002; Pasut and Veronese, 2009). 
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Several reports of improved therapeutic index3 and improved pharmacokinetics have 
been published over the years.  
 
Davis et al., 1979) described in their patent the improvement of blood circulation 
lifetime of proteins covalently attached to PEG. This technology, named PEGylation, 
has yielded several PEG-conjugates with therapeutic purposes. Haag and Kratz, 2006 
review several approved PEGylated proteins, which use PEG with MW ranging from 
2,000 to 40,000 g mol-1. Apart from proteins, the PEGylation of the insoluble drug 
Taxol® with PEG of MW 2,000 and 5,000 g mol-1 yielded a water soluble conjugate 
that still maintained its toxicity profile (Greenwald et al., 1995). PEG has also been 
used to construct supramolecular drug-delivery systems. Encapsulation of the 
anticancer drug doxorubicin (DOX) in a PEGylated liposome has been shown to 
improve DOX delivery to cancer cells and to allow for a more favourable toxicity 
profile (Strother and Matei, 2009). 
 
PEGs are also used as soluble polymer supports in the synthesis of several relevant 
molecules, such as peptides, oligonucleotides, oligosaccharides, and small molecules.  
Gravert and Janda (1997), review the polymers, chemistries, and separation and 
purification methods used in liquid phase organic synthesis. Relevant applications of 
linear PEG in the LPS of oligonucleotides have already been discussed in Section 
1.4.7.  
 
                                                 
 
 
 
 
 
 
 
 
 
3 The therapeutic index of a drug is defined as the ratio of the toxic dose to the therapeutic dose  
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The most typical PEG used in LPS is MeOPEG112 (MW ~ 5,000 g mol-1). Although 
soluble in many organic solvents and easily precipitated, it has the disadvantage of its 
rather poor loading (~ 200 μmol g-1). In order to overcome this and achieve higher 
synthetic yields, branched or multiarm PEG derivatives have been synthesised and 
used in LPS.  
 
PEG103 (MW ~ 4 600 g mol-1) has been mesylated and subsequently reacted with 
excess dimethyl 5-hydroxyisophthalate (18, Figure 1.18) and the latter functionalised 
to yield a 4-arm PEG with different functionalities (19-21). The imine derivative (21) 
was then used to synthesise β-lactams. In all the procedures, precipitation and cold 
washes with diethyl ether were used to isolate the intermediates, while the final 
product was purified by flash column chromatography (Benaglia et al., 1998). 
 
MsO PEGn OMs
O PEGn
RCH2CO2
RCH2CO2
PEG103
O
O2CCH2R
O2CCH2R
19, R= NHBoc
20, R= NH2
21, R= N=CHPh
OH
MeO2C CO2Me
18
 
Figure 1.18 – Synthesis of a multiarm PEG derivative  
 
In another approach, (Reed and Janda, 2000) used monoprotected BnOPEG – 
synthesised by anionic polymerisation of ethylene oxide (EO) with 2-
benzyloxyethanol initiation – coupled to a multifunctional cyclotriphosphazene (23, 
Figure 1.19), and subsequently hydrogenalysed to yield a 6-arm branched PEG with 
free –OH groups. Intermediate purification steps included ion-exchange resins and 
chromatography. This high-loading support (1,000 μmol g-1 for PEG 2,000 g mol-1) 
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then proved useful for LPS by further derivatisation into the triphenylphosphine 
conjugate and used with several examples of Mitsunobu etherification. 
 
BnOPEGn
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Cl
Cl Cl
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N P
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HOPEGn
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Figure 1.19 – Synthesis of a branched PEG derivative  
 
Several other multiarm and branched PEGs (as well as other polymers) and the 
procedures for their synthesis have been recently reviewed (Lapienis, 2009). 
 
As all the above mentioned applications develop, it becomes apparent that there is a 
need for PEGs, and other polymers, with one or both of two important properties:  
(i) mono-disperse molecular weight (MW) distribution, which allows full 
characterisation of single molecular entities instead of mixtures, and 
confers well defined physical properties (Hunter and Moghimi, 2002; 
French et al., 2009; Haag and Kratz, 2006); and,  
(ii) different functional groups at their termini, allowing for efficient 
attachment to different molecules (proteins, peptides, oligonucleotides, 
small molecule drugs, liposomes, and others), as well as cross-linking 
between different chemical species. 
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1.8.1 Synthesis of heterobifunctional PEGs 
Heterobifunctional PEGs are polymers in which both ends have functionalities that 
are different to each other (Figure 1.20). 
 
X-PEGn-Y 
Figure 1.20 – Structure of a heterobifunctional polyethylene glycol (PEG) molecule. 
n=1, 2, 3… to n  
 
Most commonly, PEG is used as MeOPEGn (Harris and Zhao, 2007), with the 
relatively inert methoxy group on one end and free –OH group available for 
modification. Although this molecule has found several applications in chemistry and 
biomedicine, it cannot be considered for applications in which PEG needs to be 
covalently bound to another molecule on both ends, via different linkages. 
 
Heterobifunctional PEGs are often difficult to synthesise. Two broad types of 
methods exist (Thompson et al., 2008): 
(i) ring-opening polymerisation of EO starting from a heterobifunctional 
anionic initiator, followed by termination with another functionality (a), 
Figure 1.21); and, 
(ii) derivatisation of one terminus, starting from PEG diol, followed by 
complex separation of the resulting mixture of unreacted PEG, mono-, and 
di-functional PEG (b), Figure 1.21). 
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Figure 1.21 – General schematic for the synthesis of heterobifunctional PEGs  
 
Both methods have recently been critically reviewed by Thompson et al., 2008). The 
difficulties in ring-opening polymerisation lie in very strict reactions conditions 
required to maintain the medium moisture-free. Presence of water will also initiate 
EO leading to the formation of PEG diol as a by-product, decreasing the MW of the 
product – leading to wider MW distributions – and compromising further chemistries 
and applications. This method also has the disadvantage of using toxic and explosive 
EO (Thompson et al., 2008; Zalipsky, 1993). 
 
Several synthetic strategies have been used in order to synthesise PEG with useful 
functionalities, such as thiol, carboxylic acids, amine, maleimide and others. Zeng and 
Allen, 2006) studied several thiolate initiators for the synthesis of HO-PEGn-S-
CH2CH2-COOH. Potassium 3-mercaptopropionic acid was shown to be the most 
successful allowing for PEG with MWs up to 20,000 g mol-1 and narrow 
polydispersity (1.07 – 1.15). Yokoyama et al., 1992) reported the synthesis of HO-
PEGn-NH2 using potassium bis(trimethylsilyl)amine as initiator, yielding polymers 
with polidispersity of ~ 1.1 and –OH/-NH2 ratios of 1. Bentley et al., 2002) disclosed 
a method using benzyloxide anion as initiator. Removal of the benzyl protection (or, 
in other embodiments of the invention, arylmethyl groups) was achieved by catalytic 
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hydrogenation or acid catalysed hydrolysis. Several other chemistries have been 
reviewed by Thompson et al., 2008) who stressed the need for research to focus on 
the development of appropriate initiatiors.  
 
However, this need represents a limitation in the development of a flexible method for 
the synthesis of heterobifunctional PEGs (or other polymers). The restrictions entailed 
in the choice of initiator may limit the synthetic manipulations that can be undertaken 
and introduces PEG diol impurities that arise from the starting material. 
 
Syntheses starting from PEG diol can be tedious, and require laborious purifications 
(Reed and Janda, 2000). The limitation derives from the statistical result of reacting 
PEG with equimolar quantities of functional reagent. The product is a mixture 
containing mono-, di-functionalised PEG, as well as unreacted PEG, starting material 
that limits the yields. Apart from that, separation is problematic because the difference 
in chemical and physical properties between the 3 species is minimal giving little 
upon which to base a fractionation method. This difference is even smaller with PEGs 
with high MW (Huang, 1992; Thompson et al., 2008).  
 
Huang and co-workers (Huang, 1992; Huang and Hu, 1993) described the synthesis of 
several heterobifunctionalised PEGs via a technique that uses PEG as starting material 
and in which, by grafting the reacted material to PVA, the solubility profile can be 
altered and precipitation procedures used for separation and purification. After 
reacting PEG with roughly equimolar amounts of functional reagent (with optimised 
conditions that minimise unreacted PEG), the monofunctional derivative was grafted 
to PVA via an isocyanate bond. Since PVA can be precipitated in non polar solvents 
(DCM or CHCl3) separation from di-functionalised PEG can be achieved. Subsequent 
chemistry on the free PEG end and cleavage from PVA allowed product isolation 
after 2 consecutive precipitation work-ups (to separate PVA and yield the 
heterobifunctional PEG as a solid). This procedure allowed the synthesis of several 
heterobifunctional PEGs (monoazide, monoamine) with MWs ranging from 400 to 
6,000 g mol-1.  
 
Other groups have tried chromatographic techniques to overcome this separation 
limitation. Philips and Snow, 1994) disclosed a method in which MeOPEG112 (5,000 
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g mol-1) was purified from PEG diol. The mixture was reacted with 4,4’-
dimethoxytrityl chloride, and the di-Dmt contaminant separated on a C-8 300 A 
reverse-phase preparative column. Post-separation, the Dmt protection was cleaved, to 
yield pure MeOPEG112. Zalipsky, 1993) described the synthesis of a PEGylated 
distearoylphosphatidylethanolamine (DSPE) derivative (PEG-DSPE) suitable for 
incorporation into liposomes. The first synthetic step involved the synthesis of the 
PEG-O-CONHCH2COOH intermediate by reaction with equimolar quantities of ethyl 
isocyanatoacetate in the presence of triethylamine (Et3N) followed by treatment with 
NaOH. The resulting mixture was purified using ion-exchange chromatography on a 
DEAE-Sephadex A-25column. More examples using chromatographic methods can 
be found in the aforementioned review (Thompson et al., 2008). 
 
1.9 Project definition and objectives 
The main purpose of this research project was to study the applicability of OSN to the 
development of a new paradigm in the field of oligonucleotide synthesis. This came 
from the identification of the limitations in current state-of-the-art technologies. 
 
SPS is the technology of choice in current oligonucleotide synthesis (Sanghvi, 2000). 
Despite its advantages in terms of speed and easy intermediate separation steps, the 2-
phase nature of the reaction limits the feasibility to scale up to multigram 
manufacture. Large quantities of monomers and high swelling solid supports, both 
costly, are required (Montserrat et al., 1994; Sanghvi, 2000). 
 
Since its first reported use for peptide synthesis (Bayer and Mutter, 1972) LPS has 
been suggested as a potential alternative to SPS. Reactions carried out in 
homogeneous solution allow for better mass transfer rates and faster reaction rates. 
Therefore, LPS is more amenable to scale up with cost savings. Bonora and co-
workers have published several papers regarding this method (Bonora et al., 2000; 
Bonora et al., 1990; Bonora et al., 2001; Colonna et al., 1991; Scremin and Bonora, 
1993) although industry has not so far adopted it. LPS relies on precipitation for the 
intermediate separations, which is not an appropriate method for multistep synthesis. 
That is because it tends to leave impurities trapped in the soluble polymer support, 
and the large solvent volumes used for quantitative precipitations  make automation 
and scale up difficult (Haag, 2001).  
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OSN is a new technology with great promise for the separation of molecules in 
organic media. It is the main objective of this project to apply it for oligonucleotide 
synthesis, building on previous work done in the SET research group on peptide 
synthesis (So et al., 2010). The principle of the Membrane Enhanced Oligonucleotide 
Synthesis (MEOS) process can be seen as a LPS method which applies OSN as the 
intermediate separation step. It is believed that it adds to the advantages of reactions 
performed in solution, the ability for large scale separations in OSN membrane 
modules. A simplified schematic of the MEOS process is presented in Figure 1.22.  
 
 
Figure 1.22 – Simplified schematic of the MEOS process. 
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The pursuit of the optimisation of the MEOS process lead to the development of a 
new objective for this research: the study of the application of OSN for the synthesis 
of branched PEGs and heterobifunctional PEGs. Synthesis of these 2 types of 
molecules can be difficult and laborious due to the separation steps needed in 
multistep synthesis. OSN was studied as a means to develop simple and scalable 
synthetic methods. 
 
Specific objectives to achieve the aims of this project were: 
(i) to characterise commercial membranes with regard to their performance 
parameters (MWCO curve, compound rejection, chemical resistance); 
(ii) to characterise OSN membranes prepared in the laboratory with regard to 
their performance parameters; 
(iii) to select the most appropriate membranes from those tested in (i) and (ii) 
in accordance to the needs of each specific process application; 
(iv) to investigate the performance of the selected membranes in the synthesis 
of nucleoside phosphoramidites, oligonucleotide dimers, and PEG 
derivatives (branched and linear heterobifunctional); and, 
(v) to characterise the structure of the compounds synthesised.  
 
1.10 Research Strategy 
In order to tackle the aims and objectives above, a research strategy was developed 
that can be summarised as follows: 
(i) OSN membranes were characterised on their performance parameters by 
using commonly published and standard methods for determination of 
MWCO curves. Polystyrene oligomers (See Toh et al., 2007b) were used 
for the characterisation over the NF range (200 to 1,000 g mol-1), while 
PEG was used for MW over 1,000 g mol-1. The selectivity of membranes 
with suitable MWCO for each of the specific applications was also 
characterised by studying the batch rejection of the relevant compounds 
present in the separation targeted. 
(ii) The use of the selected membranes was investigated for specific 
applications. Reactions were carried out and the real reaction mixtures 
purifed by OSN processes. The data collected from the characterisation of 
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the membrane was used to estimate the filtration volumes needed to 
achieve the desired purity of the compounds. A simple model based on 
mass balances to the diafiltration units was used for those calculations. The 
chemical structure of compounds synthesised was ascertained using 
appropriate analytical techniques. 
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2. Application of OSN to the synthesis of nucleoside 
phosphoramidites 
 
2.1 Summary 
This research focused on the study of the feasibility of using cross-linked PI OSN as 
an efficient alternative purification technology for the preparation of DNA monomers. 
DNA nucleoside phosphoramidites with standard protection were chosen as the model 
compounds for the proposed process, since these are the most popular building blocks 
used in current state-of-the-art SPS of oligonucleotides. Specifically, the synthesis and 
purification of 5’-O-Dmt-T phosphoramidites was investigated, since this is the 
smaller nucleoside phosphoramidite, therefore, providing the greatest challenge for 
molecular size-based OSN separation. The investigated process (Figure 2.1) proved to 
be feasible in the separation of low molecular weight species. However, it was 
observed the presence of an unidentified impurity that could not be removed by OSN. 
Such impurity was suggested to be a dimer with high MW, therefore, not removed by 
OSN. Process losses were also above desirable and lower than reported by 
competitive technologies, due to insufficient rejection of the nucleoside 
phosphoramidite.  
 
2.2 Introduction 
Research regarding the impact of nucleoside phosphoramidites on the synthesis of 
oligonucleotide synthesis has been mainly limited to developments in chemistries and 
novel, safer, and cheap reagents that can optimise reaction conditions and save costs. 
More specifically, the introduction of the cheaper and safer phosphitylation agent 2-
cyanoethyl-N,N,N’,N’-tetraisopropylphosphoramidite (tetraphos) and replacement of 
1H-tetrazole by pyridinium and azole salts (cheaper, safer, and less toxic) have been 
the greater breakthroughs (Sanghvi et al., 2000; Xie et al., 2005).  
 
Neverthless, protocols still use purification techniques that are not easily amenable to 
large scale synthesis. Most often, synthesis still requires laborious and time-
consuming multistep work-ups, which can potential decomposition of nucleoside 
phosphoramidites.  
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Xie et al. (2005) reported the optimisation of the synthesis protocol synthesis for 2’-
O-MOE nucleoside phosphoramidites using extractive work-ups. Pilot-scale synthesis 
using solvent exchange to MTBE with DMF/water washes yielded good results. 
However, it still exposed the product to potentially damaging water. Sanghvi et al., 
2000) reported the synthesis of nucleoside phosphoramidites in very high purity (97+ 
%, determined by HPLC and 31P-NMR) using pyridinium trifluoroacetate (pyTFA) as 
the activator. The work-up protocol was limited to normal phase silica flash 
chromatography. Although simple to execute at the laboratory scale, chromatography 
still presents challenges to large scale manufacture. 
 
OSN was described for the synthesis of nucleoside phosphoramidites in a disclosed 
patent (Boam et al., 2006). The process describes only the increase in the ratio 
between product and tetraphos, not disclosing data on the presence of other 
impurities. The process also applies STARMEMTM 240 OSN membranes (with 
MWCO of 400 g mol-1) which are not resistant to some aggressive solvents, such as 
DCM or dimethylformamide (DMF), therefore suggesting that a prior solvent 
exchange step may be required. 
 
2.2.1 Objectives 
The main objective of this Chapter was to develop a simple process for the synthesis 
of oligonucleotide monomers, comprising a scalable, simple, and low cost 1-step 
purification procedure to avoid multiplestep cumbersome, scale limited and time-
consuming work-ups and purification alternatives. The specific objectives included: 
(i) Preparation of several cross-linked OSN membranes with MW ~ 500 g 
mol-1 and characterisation of performance parameters (MWCO and 
compound rejection); 
(ii) Selection of an appropriate membrane and investigation of the feasibility 
of OSN as a purification technology for the synthesis nucleoside 
phosphoramidites; and, 
(iii) Analysis and characterisation of the chemical structure of the prepared 
nucleoside phosphoramidites. 
 
The overall objective can be summarised in the following process flowsheet. 
 
Imperial College London 
 64
 
Figure 2.1 – Process flowsheet for the synthesis of nucleoside phosphoramidites. 
 
2.3 Materials and Methods 
 
2.3.1 Materials 
All materials used for this research (including the remaining Chapters) are listed in 
Appendix A. 
 
2.3.2 Membrane preparation 
The membrane preparation procedure was based on protocols developed at the SET 
research group (See Toh et al., 2007a; See Toh et al., 2007b).  
 
Lenzing P84 membranes were prepared by dissolving the polymer in mixtures of 
DMF and 1,4-dioxane and stirring at room temperature until a homogeneous dope 
solution was obtained. The dope solution was then allowed to stand for 24 h in order 
to remove air bubbles. The dope solution was cast in 250 μm films on a 
polypropylene backing material. Solvent was allowed to evaporate for a few seconds 
before immersing the film in a precipitation water bath at room temperature during 
~24 h. The membrane was then washed with IPA to remove traces of DMF and water, 
and subsequently washed with MeOH before being immersed in the cross-linking 
solution. The cross-linking reaction was carried out at r.t., using 10 eq. HDA per mol 
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of imide groups present in the membrane, and MeOH as solvent. The reaction 
solution was stirred for ~12 h., after which the membrane was thoroughly washed 
with IPA and soaked in a preserving solution of PEG12 (MW ~600 g mol-1):IPA 
(60:40 v/v) for ~12 h. The membrane was then removed from the preserving solution, 
allowed to dry, and stored in pockets. 
 
MatrimidTM 5218 was dissolved in mixtures of THF and NMP and stirred at room 
temperature until a homogeneous dope solution was obtained. The dope solution was 
then allowed to stand for 24 h in order to remove air bubbles. The dope solution was 
cast in 250 μm films on a polypropylene backing material. Solvent was allowed to 
evaporate for a few seconds before immersing the film in a precipitation water bath at 
room temperature during ~ 24 h. The membrane was then washed with IPA to remove 
traces of NMP and water before being immersed in the cross-linking solution. The 
cross-linking reaction was carried out at r.t., using 10 eq. of EDA per mol of imide 
groups present in the membrane, and IPA as solvent. The reaction solution was stirred 
for ~12 h., after which the membrane was thoroughly washed with IPA and preserved 
in IPA. 
 
2.3.3 OSN batch experiments 
Ceramic membranes were purchased as monochannel tubes (l = 500 mm, do/di = 10/7 
mm) with glass endsealings (~13 mm on both ends) and used in stainless steel 
housings. Polymeric membranes were used in a dead-end SEPA ST (Osmonics, USA) 
filtration cell. A schematic of both OSN apparatus can be found in Appendix B.1. 
Membrane disks were cut to the dimensions of the cell and were washed to remove 
the preserving solution by permeating a significant volume (~ 50 ml) of pure OSN 
solvent. Pure OSN solvent was then recirculated through the membrane until the flux 
reached steady state. Only after this were rejection experiments conducted in order to 
ensure reproducibility (Gibbins et al., 2002). For rejection experiments, the system 
was pressurised until half of the solution feed volume (Vf) was permeated. Samples of 
the feed, permeate, and retentate were collected and analysed in order to determine 
the rejection (Ri, %) values (Equation 2.1). 
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Equation 2.1                                                                                         
 
Where Ci,p (g m-3) is the concentration of compound i in the permeate, and Ci,r (g m-
3) is the concentration of compound i in the retentate. Solute mass balances (MB) 
were calculated using Equation 2.2..  
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Where Ci,p is the concentration of solute i in the permeate (g l-1), Ci,r is the 
concentration of solute i in the retentate (g l-1), and Ci,f is the concentration of solute i 
in the feed (g l-1). Polystyrene oligomers were analysed by HPLC. Concentration of 
pyTFA, nucleosides, and nucleoside phosphoramidites was determined using UV 
spectrometry, scanned between 200 – 350 nm. MW curves in the range of 200 – 1,000 
g mol-1 were characterised by HPLC using the a mixture of polystyrene oligomers 
(See Toh et al., 2007b). 
 
2.3.4 OSN diafiltrations 
Constant volume diafiltrations were performed for the purification of reaction 
mixtures, and after the membrane had been characterised by batch rejection 
experiments. A similar set-up to batch experiments was used, with a small 
modification in the filtration apparatus: constant feed volume was maintained by 
supplying fresh solvent to the cell by means of a HPLC pump. Diafiltrations were 
monitored by analysing the permeate line by HPLC and Thin Layer Chromatography 
(TLC) to determine when all the impurities had been completely washed out from the 
retentate solution. Solute rejection (Ri, %) was determined using Equation 2.3 (see 
Appendix B.4. for the derivation) 
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2.3.5 Analytical techniques 
Reactions were monitored by TLC using silica pre-coated glass plates. Potassium 
permanganate, p-anisaldehyde, and 0.1 % v/v H2SO4 in EtOH were used as stains for 
compound detection and identification. Analysis of polystyrene oligomers for MW 
curve characterisation of OSN membranes was performed in a Gilson HPLC system 
with a Gilson 118 UV/vis detector, set at 264 nm. The HPLC was equipped with an 
ACE5-C18-300 column (Advanced Chromatography Technologies, ACT, UK). The 
mobile phase was composed of 35 % v/v analytical grade water and 65 % v/v THF, 
with 0.1 % v/v TFA. Batch rejection of pyTFA, nucleosides, and nucleoside 
phosphoramidites was determined using a UV Shimadzu UV-2010 PC spectrometer, 
scanned between 200-400 nm, and absorbance registered at the wavelength of Absmax. 
Monitoring of diafiltration experiments was performed on an Agilent HPLC system, 
equipped with a RP HPLC column (ACE C-18, 250 mm × 4.6 mm i.d., 5 μm silica 
particles, 300 Å pore size) (Advanced Chromatography Technologies, ACT, UK). 
The mobile phase was composed of a gradient starting at 60 % MeCN/10 mM 
NH4OAc ramping to 90 % MeCN/10 mM NH4OAc over 15 min at a flow rate of 1.0 
ml min-1, and then kept at 90 % MeCN/10 mM NH4OAc for 8 min (Xie et al., 2005). 
 
Nuclear Magnetic Resonance (NMR) analysis was performed using a Brüker 250, 400 
or 500MHz Fourier transform spectrometers using an internal deuterium lock. The 
values of coupling constants (J) are given in Hertz and the chemical shifts are denoted 
in parts per million (ppm).  
 
2.3.6 Synthesis 
The protocol for the synthesis of nucleoside phosphoramidites was adapted from the 
literature (Sanghvi et al., 2000; Xie et al., 2005). 5’-O-Dmt-dT and pyTFA (1.2 eq. 
per mol of nucleoside) were co-evaporated 3 × with dry MeCN and dissolved in dry 
MeCN. 2-Cyanoethyl-N,N,N’,N’-tetraisopropyl phosphoramidite (1.2 eq. per mol of 
nucleoside) was added and the solution stirred until completion under an inert 
nitrogen atmosphere. The reaction was followed by TLC (EtOAc:hexane, 4:1 v/v) and 
upon consumption of the starting nucleoside, the reaction was quenched with the 
addition of excess of Et3N and stirred for ~15 min. The reaction mixture was diluted 
in MeCN + 0.5 % v/v Et3N for OSN purification. The product was purified by 
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diafiltration to give 5’-O-Dmt-dT-3’-(2-cyanoethyl-N,N-diisopropyl) 
phosphoramidite.  
 
2.4 Results and Discussion 
 
2.4.1 Membrane selection 
Several different membranes were tested for this research. A commercial ceramic 
OSN membrane was investigated, as well as polymeric membranes prepared in this 
laboratory. A summary of the composition and properties of the membranes used can 
be seen in Table 2-1, Table 2-2, and Table 2-3. 
 
The polymer materials used for the preparation of membranes were Lenzing P84 
(Figure 2.2) and MatrimidTM5218 (Figure 2.3). These are solvent resistant polyimides, 
extensively used in the preparation of membranes for gas separation and 
pervaporation (Qiao and Chung, 2006; Tin et al., 2003). Membranes prepared from PI 
by phase inversion are integrally skinned asymmetric membranes. A typical SEM 
image of the asymmetric morphology of the membranes is depicted in Figure 8.3 
(Appendix B.2.), showing the presence of a thin nodular layer at the top, and a 
microporous bottom layer.  
 
N N R1,2
O
O O
O
O
R1=
CH3
80%
R2=
H2
C 20%
 
Figure 2.2 – Chemical structure of Lenzing P84 
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Figure 2.3 – Chemical structure of MatrimidTM5218 
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Recently (See Toh et al., 2007a) it has been reported that chemical cross-linking with 
diamines (Figure 2.4) expands the chemical stability of such membranes to aggressive 
- namely polar aprotic solvents such as DMF and NMP – and high-swelling solvents 
such as DCM.  
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Figure 2.4 - Polyimide cross-linking reaction 
 
The influence of membrane formation parameters, such as dope solution composition, 
polymer percentagem, evaporation time, solvent:co-solvent ratio, etc, has been proven 
to produce changes in membrane morphology and performance parameters (See-Toh 
et al., 2007). Most notably, See-Toh et al., 2008) observed that a change of the 
solvent:co-solvent ratio in the dope solution of Lenzing P84 membranes allowed for 
some degree of control over the MWCO curve. Higher concentrations of DMF 
(solvent) induced an increase in the mean pore size and in the standard deviation of 
pore size, generating membranes with higher MWCO, although at the expense of 
selectivity. Neverthless, this feature was used in order to prepare several Lenzing P84 
membranes (Table 2-1) in search of a membrane with appropriate properties. Cross-
linked MatrimidTM 5218 membranes were prepared with a single composition (Table 
2-2). Both types of membranes were prepared with 2 % (w/w) of the additive maleic 
acid, acting as a suppressor of macrovoids in the bottom layer, which are detrimental 
structures for the membrane performance. 
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Table 2-1 – Composition of the OSN membranes tested for the synthesis of 
nucleoside phosphoramidites: Polymer, Lenzing P84; 2 % (w/w) maleic acid; HDA 
(diamine cross-linker) added in 10 eq. per mol of imide groups  
Membrane Polymer 
(% w/w) 
Solvent composition 
(DMF:dioxane) 
M1 18 1:3 
M2 22 2:1 
M3 24 1:1 
M4 24 2:1 
 
Table 2-2 – Composition of the OSN membranes tested for the synthesis of 
nucleoside phosphoramidites: Polymer, MatrimidTM 5218; 2 % (w/w) maleic acid; 
HDA (diamine cross-linker) added in 10 eq. per mol of imide groups 
Membrane Polymer 
(% w/w) 
Solvent composition 
(THF:NMP) 
M5 26 2:1 
 
Table 2-3 – composition and properties of the ceramic membrane used in this research 
Membrane Material 
 
MWCO (g mol-1)(a) 
Inopor@nano450 TiO2 450 
(a) as specified by manufacturer 
 
The MWCO curves of all the membranes were characterised using the standard 
polystyrene method introduced by See Toh et al., 2007b). Results can be seen in 
Figure 2.5 and Figure 2.6. 
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Figure 2.5 – Comparison of the MWCO curves of the PI membranes prepared: P= 10 
bar; r.t.; solvent= MeCN. 
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Figure 2.6 - Rejection properties of Inopor@nano450 (Table 2-3): P= 10 bar; r.t.; 
solvent= MeCN; concentration of solutes (pyTFA and 5’-O-Dmt-dT 
phosphoramidite), ~1 % w/w. 
 
Comparison of the MWCO curves between polymeric and ceramic membranes 
showed that Inopor@nano450 did not present the appropriate properties. Although the 
rejection for low MW species was lower in comparison to polymeric membranes 
(which would allow for a faster removal of impurities and, therefore, less solvent 
consumption), the rejection of higher MW species was insufficient to allow for a 
process without major product losses. This was later confirmed when the rejection of 
5’-O-Dmt-dT phosphoramidite was tested (94 %, Table 8-1 in Appendix B.3.).  
 
Mass losses can be calculated from mass balances to the OSN process. Diafiltration 
was the process used for the separation of all reaction mixtures in this thesis, as it is 
the OSN design that allows for complete removal of impurities. In order to achieve 
that, pure solvent is constantly added to the OSN cell at the same flow rate of 
permeation, in order to maintain a constant volume inside the OSN cell. This mass 
loss estimation was performed by plotting the equation of the concentration profile of 
solute i in the OSN cell (for derivation of the equation, see Appendix B.4.).  
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( )[ ]'0,, 1exp iriri RvolsCC −−∗=   
Equation 2.4 
 
Where Ci,r is the concentration of solute i in the retentate (g m-3), Ci,r0 is the 
concentration of solute i in the retentate at t = 0 (feed) (g m-3), Ri’ (-) is the rejection 
of solute i, and vols the number of diafiltration volumes (vols) (-). With a rejection of 
41 % for pyTFA (Table 8-1 in Appendix B.3.), 10 vols would be required for 
complete removal, meaning a loss of 46 % of nucleoside phosphoramidite. 
 
Membrane M5 was found to have the most appropriate properties needed for such 
process. The MWCO curve showed the highest difference between low and high MW 
species. At the same time, ~ 100 % rejection for species with MW above ~600 g mol-1 
was observed, meaning that less product loss was predictable. All the membranes 
were also tested for the rejection of compounds of interest. A summary of those 
results can be seen in Table 8-1 (Appendix B.3.). Membrane M5 showed a rejection 
for the nucleoside amidite of 99.7 %, the highest in all membranes tested, thus, this 
membrane was selected for the synthesis of 5’-O-Dmt-dT phosphoramidites. 
Reproducibility of this membrane was ascertained by the preparation and 
characterisation of repeated batches (Appendix B.5.) 
 
2.4.2 Synthesis of nucleoside phosphoramidites 
5’-O-Dmt phosphoramidites were synthesised using a protocol based on those 
reported in the literature (Sanghvi, 2000; Xie et al., 2005). 
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Figure 2.7 – Synthesis of 5’-O-Dmt-dT phosphoramidites. 
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The same procedure was also applied to the synthesis of a nucleoside 
phosphoramidite using flash chromatography, in order to compare the purity of the 
product to the nucleoside phosphoramidites purified by OSN. A summary of the 
results can be seen in Table 2-4.  
 
Table 2-4 – Synthesis conditions and process and product characterisation: ratio of 
nucleoside:tetraphos:activator 1:1.2:1.2 
Scale 
(mmol of 
nucleoside) 
Solvent 
consumption 
(l per g of 
product) 
Reaction 
time (h) 
Purification 
Process(a) 
Mass 
Yield 
(%)(b) 
Purity 
(%)(c) 
 
1 1.6 20 FCC 23 >95 
1 0.53 24 OSN 61 ~90 
0.25 2 24 OSN 25 ~90 
(a) FCC: flash column chromatography, OSN: organic solvent nanofiltration 
(b) percentage of mass recovered to theoretical mass expected, based on 100% 
conversion of starting nucleoside; 100*(%)
, prodt
prod
m
m
yieldmass =  
(c) based on 31P-NMR 
 
 
The structure of the nucleoside phosphoramidites was confirmed by 1H- and 31P-
NMR. Figure 2.8 shows the 31P-NMR spectrum of a 5’-O-Dmt-dT amidite purified by 
OSN. 
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Figure 2.8 – 31P-NMR spectrum of a 5’-O-Dmt-dT phosphoramidite purified by OSN. 
 
Synthesis using OSN showed yields (61 and 25 %) far below those expected from the 
rejection of 5’-O-Dmt-dT phosphoramidite determined in batch experiments. This 
was due to rejection below 100 % during diafiltration. In fact, HPLC monitoring of 
the diafiltration process shows that product was permeating through the membrane 
after some time (Figure 2.9). Over long diafiltration processes rejection below 100 % 
has great impact in process. For example, using the same procedure for estimations as 
described before, over 15 vols, rejection of 96 % leads to 37 % mass losses. 
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Figure 2.9 – HPLC monitoring of OSN. Peak a corresponds to PyTFA, b is an 
unknown impurity, c is the identified dimer, d and e correspond to the nucleoside 
phosphoramidite. 
 
HPLC analysis of the OSN diafiltration showed that the phosphoramidite was 
permeating throught the membrane (Figure 2.9). Estimation of the rejection of 5’-O-
Dmt-dT phosphoramidite based on mass yields was not possible, since it was shown 
by NMR and HPLC analysis that the samples were not 100 % pure. HPLC 
chromatogram shows a species with elution time very close to the product. 31P-NMR 
revealed a peak at ~ 140 ppm (Figure 2.8), meaning that the impurity was coupled to a 
phosphite group. It was postulated that such impurity could be a dimer (see Figure 
2.10 for the proposed chemical structure of the dimer) resulting from activation of 
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newly formed phosphoramidites followed by displacement by nucleophilic attack of 
the 3’-OH of a starting nucleoside. This is in agreement with data pulished in the 
literature where the presence of such dimer using pyTFA as activator was identified 
and the mechanism proposed (Xie et al., 2005). 31P-NMR estimations of the content 
of dimer contamination indicate ~ 3 % (molar ratio). Apart from dimer contamination, 
the nucleoside phosphoramidites were also contaminated with P(V) species, possibly 
due to tetraphos and phosphoramidite hydrolysis through handling and OSN. The 
purity of the nucleoside phosphoramidites was estimated to be ~ 80 %. 
 
T
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Figure 2.10 – Structure of the dimer contaminant (Xie et al., 2005). 
 
2.5 Conclusions 
The synthesis of nucleoside phosphoramidites using OSN was investigated. Initial 
screening of polymeric and ceramic membranes identified those that could potentially 
be used for this application. It was found that the only commercially available ceramic 
membrane with an appropriate range of NF did not present the appropriate selectivity 
to yield an efficient and competitive process, with process losses estimated to be ~ 46 
%. Several cross-linked polymeric membranes from 2 different polymers (Lenzing 
P84 and MatrimidTM 5218) were prepared, with varying compositions of dope 
solution. It was shown that the variation of solvent:co-solvent composition altered the 
rejection properties of Lenzing P84 membranes. Neverthless, the shift in these 
properties is accompanied by a loss in selectivity, suggesting that the presence of less 
volatile co-solvent leads to a wider pore size distribution. Cross-linked MatrimidTM 
5218 (M5, Table 2-2) membranes showed rejection properties more suitable for the 
proposed process with efficient separation and low solvent consumption for 
minimised product losses. This membrane was, therefore, selected for this application. 
 
5’-O-Dmt-dT phosphoramidites were synthesised and purified using OSN, and 
compared to flash column chromatography. Process yields using OSN proved to be 
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lower than column chromatography (Sanghvi, 2000) and extractive work-ups (Xie et 
al., 2005). The low yields (61 and 25 %) were due to product rejection lower than 
100%. At the same time, it was found the presence of dimer contaminant that was not 
removed by OSN. P(V) species were also identified by 31P-NMR, that estimated the 
purity of the nucleoside phosphoramidites to be ~ 90 %. 
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3. Membrane enhanced synthesis of DNA 
oligonucleotides:  use of linear soluble supports 
 
3.1 Summary 
This research focused on the synthesis of PEG-nucleosides and PEG-dinucleotides in 
order to prove the principle of MEOS, as an alternative process for the synthesis of 
oligonucleotides. Linear PEGs were chosen as support, since this is the most common 
and successful support in liquid phase synthesis. Therefore, the chemistries are widely 
reported and well precedented. That way, the novelty of the MEOS process – the 
introduction of an OSN membrane as the intermediate separation step – would be the 
only variable in the study. Linear MeOPEG112 (~ 5,000 g mol-1) was chosen, being the 
most common PEG for such use. At the same time, its high MW – relative to 
oligonucleotide monomers – would provide a sufficient difference in MW useful for 
the separation. 
 
Ceramic membranes – commercially available from Inopor, Germany – were tested as 
well as polymeric membranes prepared in this laboratory, using Lenzing P84 as the 
polymer material. This material was chosen due to well reported resistance to a wide 
range of organic solvents. The polymeric membranes used were chemically cross-
linked in order to further increase its resistance to more aggressive organic solvents. 
Both types of membranes were characterised by determining their rejection 
performance towards the most important reactants used in the synthesis of 
oligonucleotides, namely, soluble PEG supports and building blocks, since these 
constitute the most challenging separations in the process. 
 
Two scenarios were encountered, showing that the membranes used did not provide 
the necessary selectivity characteristics. The first, in which supports and support-
nucleoside conjugates were both highly rejected – leading to no product loss – but 
monomers were also highly rejected, leading to no separation. In a second scenario, 
impurities were washed out, but at the cost of lower support/support-nucleoside 
rejection, leading to very low process yields. 
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3.2 Introduction 
Speed, simplicity, and easy intermediate separation, led to the establishment of SPS 
using phosphoramidite chemistry as the method of choice for most antisense drugs 
and id the technology of choice in current oligonucleotide synthesis (Sanghvi, 2000). 
Nevethless, SPS is not free of drawbacks. Its 2-phase reaction nature limits the 
capability for practical scale up to multigram manufacture, necessary to supply the 
new demand for large quantities of antisense drug candidates, to which SolPS seems 
more adequate (Reese, 2005). Also, when attempted, large quantities of high-cost 
monomers and high swelling expensive solid supports are required hindering the 
development of SPS on a large scale (Montserrat et al., 1994; Sanghvi, 2000). 
 
LPS has been suggested for the synthesis of peptides (Bayer and Mutter, 1972) and 
oligonucleotides (Bonora et al., 2000; Bonora et al., 1990; Bonora et al., 2001; 
Colonna et al., 1991; Scremin and Bonora, 1993). Reactions carried out in 
homogeneous solution allow for better mass transfer rates and faster reaction rates. 
Therefore, LPS is more amenable to scale up with cost savings. However, reported 
examples to date rely on precipitation for the intermediate separations, which is not a 
practical method for multistep synthesis (Haag, 2001). 
 
Recently, a process named MEPS has been introduced for the synthesis of peptides, 
which uses OSN membranes for the intermediate separation steps (So et al., 2010). 
The same approach is attempted in this research. 
 
3.3 Objectives 
The main objective of this Chapter was to prove the concept of the MEOS process for 
the synthesis of oligonucleotides. In order to do so, the synthesis of oligonucleotide 
dimers was proposed, using different OSN membranes, in order to determine the best 
combination of support/membrane. The specific objectives included: 
(i) Investigation of the performance characteristics of commercially available 
membranes with MWCO in the range of interest (~ 1,000 – 2,000 g mol-1); 
(ii) Preparation and MWCO characterisation of a collection of polymeric 
membranes with MWCO in the range of interest (~ 1,000 – 2,000 g mol-1); 
and, 
(iii) Synthesis of oligonucleotide dimers using selected membranes. 
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3.4 Materials and methods 
 
3.4.1 Materials 
All materials used in this Chapter are listed in Appendix A. 
 
3.4.2 Membrane preparation 
The membrane preparation procedure was similar to the described in Chapter 2, with 
minor changes. Lenzing P84 was dissolved in mixtures of DMF and 1,4-dioxane and 
stirred at room temperature until a homogeneous dope solution was obtained. The 
dope solution was then allowed to stand for ~ 24 h in order to remove air bubbles. The 
dope solution was cast in 250 μm films on an appropriate backing material 
(polypropylene or polyester). Solvent was allowed to evaporate for a few seconds 
before the film was immersed in a precipitation water bath at room temperature for ~ 
12 h. The membrane was then washed in IPA to remove traces of DMF and water, 
and subsequently immersed in the cross-linking solution. The cross-linking reaction 
was carried out at r.t., using 10 eq. of HDA per mol of imide groups present in the 
membrane, and IPA as solvent. The reaction solution was stirred for ~12h., after 
which the membrane was thoroughly washed with IPA and soaked in a preserving 
solution of PEG12 (MW ~ 600 g mol-1):IPA (60:40 v/v) for ~12 h. The membrane was 
then removed from the preserving solution, allowed to dry, and stored in pockets.  
 
3.4.3 OSN batch experiments 
The procedure for OSN batch experiments was the same as described in Chapter 2.  
 
PEG samples were analysed by Gel Permeation Chromatography (GPC), with a prior 
solvent exchange from the OSN solvent to NMP.  
 
3.4.4 OSN diafiltrations 
The procedure for OSN diafiltration experiments was the same as described in 
Chapter 2. 
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3.4.5 Analytical techniques 
Where appropriate, reactions were monitored by TLC using silica pre-coated glass 
plates. Potassium permanganate, p-anisaldehyde, and 0.1 % v/v H2SO4 in EtOH were 
used as stains for compound detection and identification. Monitoring of OSN 
experiments was performed on a Waters GPC system, equipped with a Waters 
Styragel HT2 GPC column and using N-methyl pyrrolidone (NMP) as mobile phase, 
at 100 ºC and constant flow rate of 0.5 ml min-1. Detection was provided by a Gilson 
132 refractive index (RI) detector and Waters 996 Photodiode Array detector at 266 
nm. Polystyrene detection was performed by HPLC on an Agilent 1100 HPLC 
system, equipped with UV detection at 264 nm. Separation was achieved using an 
ACE 5-C18-300 column (Advanced Chromatography Technologies, ACT, UK), and a 
mobile phase composed of a mixture of analytical grade water and THF, 35:65 v/v + 
0.1 % v/v trifluoroacetic acid. Concentration of nucleoside succinates and 
phosphoramidites was measured in a Shimadzu UV-201 PC UV spectrometer, 
scanned between 200 – 350 nm. Nuclear Magnetic Resonance (NMR) analysis was 
performed using a Brüker 250, 400 or 500MHz Fourier transform spectrometers using 
an internal deuterium lock. Mass spectra were recorded on a VG 70/70 Hybrid 
spectrometer using Chemical Ionisation (CI), Electron Impact (EI) or Fast Atom 
Bombardment (FAB +ve) where stated. 
 
3.4.6 Synthesis of 5’-O-Dmt-nucleoside-3’-O-succinates 
Adapted from Kumar et al., 1993; Song, 2001). 
B
O
OH
DmtO
OO O
B
O
DmtO
O OH
O
O+
i) DCM, Et3N, DMAP
 
Figure 3.1 – Synthesis of 5’-O-Dmt-nucleoside-3’-O-succinates; B = ABz, GiBu, CBz, T 
 
5’-O-Dmt-nucleoside was co-evaporated from dry MeCN (3 × x ml) and dissolved in 
dry DCM. 4-Dimethylaminopyridine (DMAP) (0.5 eq. per mmol of nucleoside) and 
Et3N (4 eq. per mmol of nucleoside) were added to the stirred solution. Succinic 
anhydride was then slowly added (1.5 mmol per mmol of nucleoside) and the solution 
stirred at r.t. under nitrogen atmosphere until completion. The reaction was monitored 
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by TLC (CHCl3:MeOH, 9:1 v/v) and quenched by the addition of an excess of DI 
water once the starting nucleoside was completely consumed. The reaction mixture 
was diluted with DCM and washed with Et3NH+HCO3- and DI water. The aqueous 
layer was extracted with further DCM, the organic phase collected, dried over 
MgSO4, filtered and evaporated under reduced pressure to give 5’-O-nucleoside-3’-O-
succinate as a white solid. 
 
3.4.7 General procedure for oligonucleotide synthesis 
Adapted from Bonora et al., 1993). 
Attachment to the support 
B
O
DmtO
O OH
O
O + MeOPEG112
i) DCM, DIC,
NMI, Et3N
B
O
DmtO
O OPEG112OMe
O
O
 
Figure 3.2 – Attachment of 5’-O-Dmt-nucleoside-3’-O-succinate to the soluble 
support; B = ABz, GiBu, CBz, T. 
 
MeOPEG112 and 5’-O-Dmt-nucleoside-3’-O-succinate (3 eq. per mmol of –OH 
groups in the support) were co-evaporated from dry MeCN (3 ×  x ml) and dissolved 
in dry DCM. Et3N (2 eq. per mmol of 5’-O-Dmt-nucleoside-3’-O-succinate) and NMI 
(2eq. per mmol of –OH groups in the support) were added to the stirred solution. 
Diisopropylcarbodiimide (DIC) (1.67 eq per mmol of –OH groups in the support) was 
added and the solution stirred overnight at r.t. under nitrogen atmosphere. The 
reaction was quenched with an excess of DI water, filtered, and diluted with DCM for 
OSN separation, to give 5’-O-Dmt-nucleoside-3’-O-succ-O-PEG112OMe. Reaction 
conversion was estimated by 1H-NMR integral ration of the acylated PEG -CH2O to 
PEG –OCH3. 
 
Capping 
R-OH +
i) DCM, 2,6-lutidine, NMI
O
O O
R-O
O
 
Figure 3.3 – Capping of unreacted –OH groups 
5’-O-Dmt-nucleoside-3’-O-succ-O-PEG112OMe was co-evaporated with dry 3 × 
MeCN and dissolved in dry DCM. 2,6-Lutidine (10 % v/v), NMI (10% v/v), and 
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acetic anhydride (Ac2O) (10 %v/v) were added in this order to the stirred solution, 
under nitrogen. After ~30 min, the solution as diluted with further DCM for OSN 
separation. 
 
Detritylation 
i) DCM, DCA, pyrrole
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Figure 3.4 – Detritylation reaction; B = ABz, GiBu, CBz, T 
5’-O-Dmt-nucleoside-3’-O-succ-O-PEG112OMe was co-evaporated from dry 3 × 
MeCN and dissolved in dry DCM. Pyrrole (10 eq. per mmol of Dmt groups) and 
dichloroacetic acid (DCA) (3 % v/v) were added in this order to the stirred solution, 
under nitrogen. The reaction was monitored by TLC (EtOAc:acetone:water, 5:10:1 
v/v). The plates were developed with 0.1 % v/v H2SO4, to reveal Dmt-bearing 
compounds. When the support-bound product (Rf = 0) showed no Dmt groups, the 
reaction was quenched with an excess of Et3N, diluted with further DCM and taken 
for OSN separation to give 5’-HO-nucleoside-3’-O-succ-O-PEG112OMe. 
 
Coupling 
i) MeCN, PyTFA, NMI
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Figure 3.5 – Phosphoramidite coupling reaction; B = ABz, GiBu, CBz, T 
5’-HO-nucleoside-3’-O-succ-O-PEG112OMe and pyTFA (1 eq. per mmol of –OH 
groups) were  3 × co-evaporated from dry MeCN and dissolved in dry MeCN. NMI (2 
eq, per mmol of –OH groups) was added to the stirred solution. 5’-O-Dmt-nucleoside 
phosphoramidite (2 eq. per mmol of –OH groups) was 3 × co-evaporated with dry 
MeCN, dissolved in a minimum volume of dry MeCN, and added to the previous 
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solution. The reaction was stirred under nitrogen for ~ 30 min, to give the crude 5’-O-
Dmt-nucleoside-3’-βCe-phosphite-nucleoside-3’-O-succ-O-PEG112OMe. 
 
Oxidation 
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Figure 3.6 – Oxidation reaction; B = ABz, GiBu, CBz, T. 
5’-O-Dmt-nucleoside-3’-βCe-phosphite-nucleoside-3’-O-succ-O-PEG112OMe was 3 × 
co-evaporated from dry MeCN and dissolved in a 1.1 M solution of TBHP in dry 
MeCN. The reaction was stirred under nitrogen for 15 min, diluted with DCM and 
taken for OSN separation to give 5’-O-Dmt-nucleoside-3’-βCe-phosphate-nucleoside-
3’-O-succ-O-PEG112OMe. 
 
3.5 Results and discussion 
Synthesis of oligonucleotide dimers was attempted using ceramic and polymeric 
membranes. The results are presented and discussed separately. 
 
3.5.1 Ceramic membranes 
Ceramic membranes are commercially available with different performance properties 
and made of different materials. Inopor (Germany) provides a reasonable catalogue of 
membranes from which the following membranes were chosen (Table 3-1), based on 
the data provided by the manufacturer. An example of a SEM picture of the top layer 
(ZrO2) of Inopor@ultra is provided in Appendix C.1. as an illustration of the typical 
morphology of these membranes.  
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Table 3-1 – composition and properties of the commercial membranes used in this 
research 
Membrane Material 
 
Surface Mean 
pore size 
(nm) 
Open 
porosity 
(%) 
MWCO 
(g mol-1)(a) 
Inopor@ultra2000 ZrO2 Hydrophobic 3 30 – 50 2,000 
Inopor@nano750 TiO2 Hydrophilic 1 30 – 40 750 
(a) as specified by manufacturer 
 
Selection of the membranes was based on the determination of the discrimination 
between the species in oligonucleotide synthesis; PEG-bound oligonucleotide and 
DNA monomers, which are the reactants with highest MW. MeOPEG112 was used as 
support, and was therefore, chosen as the key species to estimate product rejection. 
Rejection of 5’-O-Dmt-dABz-3’-O-succinate was also tested, since it is the monomer 
used to couple the first nucleoside to the support, via a succinyl ester linkage. The 
rejection data of these species for the 2 ceramic membranes tested is presented in the 
following Table 3-2 
 
Table 3-2 - Rejection data for the membranes tested; P= 8 bar; r.t.; solvent= MeCN; 
concentration of solutes, MeOPEG112 =  ~5 g l-1, others, ~1 % w/w 
Membrane MeOPEG112 
(g mol-1) 
Mass 
Balance 
(%) 
5’-O-Dmt-dABz-
3’-O-succinate 
(757 g mol-1) 
Mass 
Balance 
(%) 
Inopor@ultra2000 99.97 129 55 93 
Inopor@nano750 100 85 83 130 
 
Both membranes showed a very high MeOPEG112 rejection, essential to avoid product 
loses. Using the data from single compound rejection, it was estimated that the 
number of vols needed to purify the reaction solution from stage 1 (coupling of 5’-O-
Dmt-nucleoside-3’-O-succinate to MeOPEG112)  using Inopor@ultra2000 would be 
12-15 volumes. This estimation was performed using the same calculations as in 
Chapter 2. It was assumed that 5’-O-Dmt-nucleoside-3’-O-succinate, being the 
impurity with higher MW, would be the most rejected reactant. Figure 3.7 shows the 
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plots of the concentration profiles in the OSN cell for MeOPEG112 (R= 99.97 %) and 
5’-O-Dmt-nucleoside-3’-O-succinate (R= 55 %). Also in Figure 3.7 is depicted the 
effect of minor changes in rejection on the process yield. For example, after 10 vols, a 
compound with 99.97 % rejection will be retained in ~ 100 %, while for a compound 
with rejection of 98 %, only ~ 80 % of the material would be retained.  
 
Vols (-)
0 5 10 15 20
C
i,r
/C
i,r
0 (
-)
0.0
0.2
0.4
0.6
0.8
1.0
R = 99.97 %
R = 99.50 %
R = 99.00 %
R = 98.00 %
R = 54.70 %
 
Figure 3.7 – Estimated vols (-) for compounds with different rejection values. 
Compound with R = 54.7 % corresponds to 5’-O-Dmt-dABz-3’-O-succinate (Table 
3-2) 
 
A first attempt was performed using Inopor@ultra2000 to purify the reaction medium 
of the coupling of 5’-O-Dmt- dABz -3’-O-succinate to MeOPEG112. Figure 3.8 shows 
the 1H-NMR of the product. 5’-O-Dmt-dABz-3’-O-succ-O-PEG112OMe was isolated 
with a yield of 32 %. The reaction conversion was estimated by comparing the peak 
integration of the nucleoside to the –OMe of the opposite PEG terminal.  
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Figure 3.8 – 1H-NMR of 5’-O-Dmt-dABz-3’-O-PEG112OMe; estimated conversion of 
97.5 %; CDCl3 
 
The rejection of 5’-O-Dmt-dABz-3’-O-succ-O-PEG112OMe was estimated to be 92 %, 
which is considerably below the rejection observed for MeOPEG112. The values are 
not directly comparable, since they were determined under different OSN operation 
conditions. At the same time, the rejection of 5’-O-Dmt-dABz-3’-O-succ-O-
PEG112OMe is determined after product isolation. Losses due to product handling 
(recovery from OSN apparatus may not be quantitative) should not be discounted. 
Neverthless, TLC and GPC analysis of the permeates during diafiltration identified 
traces of product being permeated.   
 
Table 3-3 presents the data for a runs of the synthesis of 5’-O-Dmt-dTpdABz-3’-O-
succ-O-PEG112OMe.  
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Table 3-3 – Synthesis performance data using Inopor@ultra2000; support, 
MeOPEG112 
Membrane Inopor@ultra2000 
Oligo 5’-O-Dmt-dTpdABz-3’-O-succ-O-PEG112OMe 
 Yield (%) Vols (-) Rejection (%) 
Stage Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 
Attachment to support 24 50 27 16 99 96 
Capping 96 76 4 5 99 95 
Detritylation 62 61 10 10 94 95 
Coupling/Oxidation 39 43 8 20 88 96 
Overall yield (%) 5.6 9.7   
 
Overall yields observed were extremely low, and not comparable to the yields that can 
be achieved with SPS and LPS. The reason for this was that rejection of the growing 
oligonucleotide was consistently below the optimum 100 %, therefore, generating 
losses over the process. Again, these were below the rejection observed for 
MeOPEG112. At the same time, no increase in rejection was noticeable after the 
coupling of the second nucleotide (and consequent increase in MW). In fact, in Run 1, 
there was a decrease in rejection from 94 % to 88 %. 
 
Aiming to increase product rejection, a synthesis using a support with higher MW was 
attempted (Table 3-4). No improvement in process yields was observed. In fact, a 
decrease in rejection is observed. The reason for such difference may derive from the 
fact that in this synthesis, a bifunctional PEG was used. That meant that the 
introduction of 2 hydrophobic functionalities (protected nucleosides) on each end of 
the PEG may increase the affinity towards the hydrophobic surface of the membrane, 
therefore increasing permeation of the product. 
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Table 3-4 - Synthesis performance data using Inopor@ultra2000; support PEG226 
Membrane Inopor@ultra2000 
Oligo (5’-O-Dmt-dABzpdABz-3’-O-succ-O)2-PEG226 
Stage Yield (%) Vols (-) Rejection (%) 
Attachment to support 38 11 91 
Capping 66 5 78 
Detritylation 49 5 86 
Coupling/Oxidation 58 15 96 
Overall yield (%) 3.5   
 
Inopor@nano750 was then tested. Being a membrane with lower MWCO, higher 
rejection values would be expected for the product as well as for the remaining 
reactants, therefore leading to higher solvent consumption (Table 3-5). 
 
Table 3-5 – Synthesis performance data using Inopor@nano750; support, MeOPEG112 
Membrane Inopor@nano750 
Oligo 5’-O-Dmt-dTpdABz-3’-O-PEG112OMe 
Stage Yield (%) Vols (-) Rejection (%) 
Attachment to support 91 30 99.7 
Capping 70 7 95 
Detritylation 64 9 95 
Coupling/Oxidation --- --- --- 
 
It was observed, though, that after the coupling stage, there was no separation. The 
nucleoside phosphoramidite in excess was not being washed out, proved by TLC and 
GPC analysis (Figure 3.9). This result is rather surpring taking into account the 
similar MWs of 5’-O-Dmt-dABz-3’-O-succinate (757 g mol-1) and 5’-O-Dmt-dT 
phosphoramidite (745 g mol-1). Two reasons may be speculated for this result. Firstly, 
evolution of membrane performance (fouling) and, secondly, a difference in 
hydrophobicity between succinates and phosphoramidites leading to different 
permeation rates.  
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Figure 3.9 – Purity profile of the product during the OSN separation after the 
coupling/oxidation reactions, assessed by GPC: % Area defined by Equation 3.1; 
detectors, UV at 266 nm, and RI 
 
100*%
areaTotal
signalproductofAreaArea =
 
Equation 3.1 
 
3.5.2 Polymeric membranes 
Several Lenzing P84 membranes were cast with varying compositions. By using a 
method reported by See-Toh et al., 2008) of varying solvent composition in the dope 
solution, it was aimed to determine if membranes could be cast with varying 
MWCOs, but approximately at ~ 1,000 g mol-1. The list of membranes prepared and 
their composition is shown in Table 3-6. 
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Table 3-6 – Composition of the polymeric membranes tested for the synthesis of 
oligonucleotides: 2 % (w/w) maleic acid; HDA (diamine cross-linker) added in 10 eq. 
per mol of imide groups 
Membrane Polymer 
(% w/w) 
Solvent composition 
(DMF:dioxane) 
M1 22 3:1 
M2 22 4:1 
M3 24 2:1 
M4 24 2.5:1 
M5 24 3:1 
M6 24 5:1 
 
The MWCO curves of these membranes were determined using polystyrene standards 
(See Toh et al., 2007b) and PEG solutions with various MWs (Figure 3.10). 
Molecular weight (g mol-1)
0 10000 20000 30000 40000
R
ej
ec
tio
n 
(%
)
0
20
40
60
80
100
M1
M2
M4
M5
M6
 
Figure 3.10 – MWCO curves for the membranes prepared for the synthesis of 
oligonucleotides 
 
The MWCO of membranes made of Lenzing P84 could be tuned to a certain degree, 
as suggested by Livingston and co-workers (See-Toh et al., 2008). Higher 
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concentrations of DMF in the dope solution increased the MWCO. However, due to 
the increase in the standard deviation (pore size distribution) of the pores, the 
sigmoidal shape of the curve is lost. Therefore, losing discrimination between species 
with close MW (M6). M3 and M4 were chosen to be used for synthetic purposes, 
since the MWCO suggested better performances. 
 
Rejection of MeOPEG112 and 5’-O-Dmt-dABz-3’-O-succinate were then determined 
for membranes M3 and M4 (Table 3-7). M4 showed a very high rejection for 5’-O-
Dmt-dABz-3’-O-succinate, and so was discarded for synthetic purposes, since 
separation would be difficult and highly solvent consuming. 
 
Table 3-7 - Rejection data for membranes M3 and M4; P= 8 bar; r.t.; solvent= DCM; 
concentration of solutes, MeOPEG112 =  ~5 g l-1, others, ~1 % w/w 
Membrane MeOPEG112 
(g mol-1) 
Mass 
Balance 
(%) 
5’-O-Dmt-dABz-
3’-O-succinate 
(757 g mol-1) 
Mass 
Balance 
(%) 
M3 89 76 --- --- 
M4 98 95 83 91 
 
The synthesis of 5’-O-Dmt-dABz-3’-O-succ-O-PEG112OMe was then performed and 
the reaction mixture purified using M3. The data from that experiment can be seen in 
Table 3-8 and the 1H-NMR spectrum of the product in Figure 3.11. 
 
Table 3-8 – Synthesis performance data using M3: support, MeOPEG112 
Membrane M3 
Oligo 5’-O-Dmt-dABz-3’-O-succ-O-PEG112OMe 
Stage Yield (%) Vols (-) Rejection (%) 
Attachment to support 59 7 92 
 
As in previous experiments, rejection of the product was not sufficient to yield an 
efficient separation (yield = 59 %). Neverthless, the synthesis of a dimer was 
attempted. 
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Figure 3.11 - 1H-NMR of 5’-O-Dmt-dABz-3’-O-succ-O-PEG112OMe; estimated 
conversion of 86 % 
 
5’-O-Dmt-dTpdT-3’-O-succ-O-PEG112OMe was synthesised. However, and as 
observed for the ceramic membrane Inopor@nano750, there was no separation after 
the coupling of nucleoside phosphoramidite (and oxidation to phosphate) leading to 
the accumulation of the monomer. Non removal of 5’-O-Dmt-dT amidite was 
confirmed by GPC. The plateau reached in the purity profile plotted in Figure 3.12 
was due to the presence of the monomer. 
 
Table 3-9 – Synthesis performance data 
Membrane M3 
Oligo 5’-O-Dmt-dTdT-3’-O-PEG112OMe 
Support MeOPEG112, ~5,000 g mol-1 
Stage Yield (%) Vols (-) Rejection (%) 
Attachment to support 73 15 97 
Capping 74 5 94 
Detritylation 76 10 97 
Coupling/Oxidation --- --- --- 
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Figure 3.12 - Purity profile of the product during the OSN separation after the 
coupling/oxidation reactions, assessed by GPC: % Area defined by Equation 3.1; 
detectors, UV at 266 nm, and RI. 
 
3.6 Conclusions 
The synthesis of oligonucleotide dimers was attempted. The ceramic membranes 
tested proved to have two distinct selectivity characteristics. Inopor@nano750 
performed no separation after the first coupling of a nucleoside phosphoramidite, 
preventing its use for chain elongation. On the other hand, Inopor@ultra2000 allowed 
for the synthesis of dimers, proving the principle of the MEOS process feasibility. 
However, due to insufficient product rejection (≤ 99.8 %) severe product losses were 
encountered, leading to an inefficient process, unable to compete with tpical SPS, 
SolP, and LPS typical process yields. In fact, long chain elongations would not be 
possible with the proposed MEOS. A collection of polymeric membranes was cast 
with MWCO in the range of interest. However, the same problem of no separation 
between species was found. It was shown by simple mass balance calculations that in 
order to achieve optimum yields (90+ %), 100 % rejection for the support-bound 
oligonucleotide is absolutely necessary. 
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4. Membrane enhanced synthesis of DNA 
oligonucleotides: development of branched soluble supports 
 
4.1 Summary 
This research focused on the synthesis of branched PEG derivatives since this is the 
most popular and successful polymer applied to LPS due to PEG unique properties. 
Although it was foreseen that applications are not restricted to LPS of 
oligonucleotides, these supports were developed taking into account their application 
in MEOS. Some of the properties, i.e. chemical stability, loading, solubility profile, 
can be envisaged to be useful for LPS methods of other classes of molecules. The 
basic strategy behind the method described consists of reacting an excess of PEG with 
another organic molecule that acts as a branch point (Figure 4.1), generating a 
branched product with c number of arms.  The excess PEG can then separated from 
the product by OSN, using the difference in MW (c × MW of PEG) as the 
determining physical-chemical separation property.  Different chemistries were 
attempted. PEG ethers, due to the inherent chemical robustness were first attempted, 
unsuccessfully. Silyl ether, and phosphate, and carboxylic esters provided successful 
results. 
 
4.2 Introduction 
Liquid phase organic synthesis has led into the development of several polymer-based 
supports that allow reactions to be carried out in solution whilst introducing a 
physical-chemical property on which to base separation of product, by-products and 
excess reactants (Gravert and Janda, 1997). The most common support in LPS is 
linear MeOPEG112 (MW ~ 5,000 g mol-1). Although soluble in many organic solvents 
and easily precipitated, it has the disadvantage of its rather poor loading (~ 200 μmol 
g-1). In order to overcome this and to achieve higher synthetic yields, branched or 
multiarm PEG derivatives with higher loadings have been synthesised and used in 
LPS (Haag, 2001).  
 
We have observed in the previous Chapter that linear PEGs (~ 5,000 and ~ 10,000 g 
mol-1) did not provide rejection values able to yield an efficient MEOS process. In 
order to achiveve that goal, higher rejection of the growing oligonucleotide is 
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necessary. Zheng et al., 2008) investigated the relationship between molecular shape 
of small molecules with similar chemical formula (and MW) in order to develop an 
appropriate size descriptor for OSN modelling and rejection prediction. It was 
observed that branched molecules had higher rejection values compared to linear and 
cyclic molecules with similar MW. Therefore, it was decided to attempt the MEOS 
process with branched PEG derivatives. 
 
4-Arm PEG with different funcitonalities have been used in the synthesis of β-lactams 
by LPS using precipitation as the intermediation separation technique (Benaglia et al., 
1998). BnOPEG-OH has been coupled to a multifunctional cyclotriphosphazene and 
subsequently hydrogenalised to yield a 6-arm branched PEG with free –OH groups. 
This support then proved useful for LPS by further derivatisation using Mitsunobu 
etherification (Reed and Janda, 2000). Other multiarm and branched PEGs (as well as 
other polymers) and the procedures for their synthesis have recently been reviewed 
(Lapienis, 2009). 
 
This chapter describes a novel synthetic method for the preparation of branched PEG 
derivatives for the MEOS process, based on a simple and scalable synthetic 
procedure. 
 
4.2.1 Objectives 
The main objective of this Chapter was to develop a simple and facile synthetic 
method to prepare branched PEG-based soluble supports to be used in the membrane 
enhanced oligonucleotide synthesis in order to overcome the limitations identified in 
Chapter 2. The specific objectives included: 
(i) Preparation of diverse branched PEGs 
(ii) Investigation of the feasibility of OSN as a purification technology for the 
synthesis of branched PEGs 
(iii) Analysis and characterisation of the chemical structure of the prepared 
supports 
 
The key features of this research ojective can be summarised by Figure 4.1 . 
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PEGn
(excess)
A (PEGn)c-A PEGn
OSN
(PEGn)c-A  
Figure 4.1 - General schematic for the synthesis of branched PEGs: A, branch point 
organic molecule; c, number or PEG branches 
 
4.3 Material and methods 
4.3.1 Materials 
All materials are listed in Appendix A. 
 
4.3.2 Membrane preparation 
The membrane preparation procedure was similar to the described in Chapter 3. 
 
4.3.3 OSN batch experiments 
The procedure for OSN bactch experiments was the same as described in Chapter 3. 
In this case, however, 2 different OSN cells were used: a dead-end SEPA ST 
(Osmonics, USA) or a METCell (Membrane Extraction Technology, UK) filtration 
cell. The former for initial experiments, the latter when the overall speed of process 
was increased, as it allows for the use of a larger membrane area. SEPA ST has an 
effective membrane ares of 12 cm2 while METCell has 51 cm2. 
 
4.3.4 OSN diafiltrations 
The procedure for OSN diafiltration experiments was the same as described in 
Chapter 3. 
 
4.3.5 Analytical techniques 
The same analytical techniques and equipment used in Chapter 3 were used for these 
invstigations. 
 
1H-NMR characterisation of PEG termini was performed by a method reported 
elsewhere (Jo et al., 2001): NMR samples of PEG and PEG derivatives were 
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dissolved in a 5 % v/v TFAA solution in CDCl3 and analysed. TFAA acylates PEG –
OH termini to completion, causing a downfield shift of the adjacent –CH2 signal, and 
allowing for characterisation and signal integration (Behravesh et al., 2002; Tessmar 
et al., 2002).  
 
4.3.6 Synthesis 
The synthetic protocols for this Chapter can be seen in Appendix D.1.. 
 
4.3.7 Hydrolysis studies 
A sample of branched PEG was weighed (100 mg) and dissolved in THF containing 
0.5 % v/v of DI water (10 ml). Aliquots (100 μl) of a 0.01 M stock solution of p-
toluenesulfonic acid monohydrate were periodically added to the stirred solution and 
allowed to react. After ~30 min of acid addition, a sample was collected (100 μl), 
quenched, and analysed by GPC. The hydrolysis was followed by the decrease in the 
RI signal of the product and the detection of PEG at the respective retention time. 
 
 
4.4 Results and Discussion 
Figure 4.2 shows a flowsheet describing the process used for the synthesis of 
branched PEGs. 
 
 
Figure 4.2 - process flowsheet for the synthesis of branched PEGs 
Stage 3 – 
OSN 
Stage 1 - 
Reaction 
PEG 
Branch point 
Catalyst 
Final product – 
branched PEG 
Unreacted 
PEG 
Low MW 
reactants and 
by-products 
Solvent 
Stage 2 – 
Aq. Work-up 
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Four different classes of branched PEGs were attempted: branched PEG ethers, 
branched silyl ethers, and carboxyl and phosphate esters. The results are described in 
the following Sections. 
 
4.4.1 Synthesis of branched PEG ethers 
Polyethers have the advantage of providing a support backbone chemically stable 
towards a variety of synthetic conditions. Therefore, the first synthetic approach was 
aimed at the synthesis of a branched PEG with an ether linkage at the branch point. 
The synthetic route is depicted in Figure 4.3.  
 
HO OH
OH
TsO OTs
OTs
i) TsCl, pyridine
ii) Aq. work-up
PEGnO OPEGn
i) PEG, NaH, DMF
ii) Aq. work-up
PEGnO OPEGn
OPEGn
PEGnO OPEGn
Me
OPEGn
i) PEG, 1 % (w/v) CSA, DCM
ii) Aq. work-up
24
21
 
Figure 4.3 - Synthesis of branched PEG ethers, synthetic strategy 1 
 
2-Hydroxymethyl-1,3-propanediol was chosen as the branch point, leading to a 3-arm 
branched product. The first step consisted of a tosylation reaction based on the 
protocol developed by Tipson for the synthesis of sulfonic esters Tipson, 1944, 
followed by the displacement of the tosylate group by PEG under strong nucleophilic 
conditions. Initial reaction conditions (1.2 eq. TsCl per mol of -OH groups, -5 to 0 ºC, 
2 h) were not sufficient to drive the reaction to completion. TLC development of the 
crude product showed 3 different species, suggesting a mixture of mono-, di-, and tri-
sulfonated alcohol. This was later confirmed by 1H-NMR analysis, showing the 
Imperial College London 
 101
presence of 3 distinctive peaks (doublets) in the region of 3.9-4.2 ppm, corresponding 
to the substituted –CH2-. Aromatic tosylate protons also appeared splitted as 6 
doublets (Figure 4.4).  
 
 
 
 
 
Figure 4.4 - 1H-NMR spectrum of compound 24 
 
In order to increase conversion and isolate the desired tri-substituted product, the 
original protocol was changed. Different reaction conditions and work-ups were tried. 
It was found that the pure product precipitated with the addition of dilute HCl during 
work-up, and that it could be crystallised from EtOAc. Crystallisation was therefore 
used as an isolation procedure, which led to higher yields, after reactions carried out 
at r.t.. Neverthless, yields were not reproducible and never above 28%. Table 4-1 
presents a summary of the reaction/isolation procedures tested and respective yields. 
Figure 1.1 shows the 1H-NMR of the pure isolated product.  
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Figure 4.5 - 1H-NMR of pure compound 24. 
 
Table 4-1 - Reaction conditions 
Reaction 
Scale 
(mmol) 
TsCl eq. 
per -OH 
Temp. (ºC) Work-up Yield (%) 
1 1.2 r.t. Extraction with diethyl ether 19 
2 2 50 Extraction with diethyl ether * 
3 2 50 Extraction with diethyl ether * 
2 3 r.t. Extraction with diethyl ether * 
1.5 2 r.t. Cryst. (EtOAc) 28 
4 2 r.t. Cryst. (EtOAc) 4 
1 2 r.t. Extraction with diethyl ether 7 
* incomplete reaction 
 
The second step of the proposed synthetic route consisted in the displacement of tosyl 
groups by nucleophilic attack from PEG in order to form a branched ether. The 
reactivity of –OH PEG termini  correlates inversely with MW. Thus, it was decided to 
first attempt the displacement of tosyl groups using PEG3 (MW 194.2 g mol-1) in 
Imperial College London 
 103
order to test the reaction under stronger nucleophilic conditions. It was found that 
under the strongly basic conditions, elimination of tosylate leaving group took place, 
leading to compound 21 (Figure 4.3). Compound was treated with 1 % (w/v) 
camphorsulfonic acid (CSA) and further PEG diol in DCM, but no change was 
observed. 
 
Due to the failure of the previous approach and the difficulties encountered it was 
decided to reverse the synthetic strategy (Figure 4.6). This time, the chosen branch 
point was 2-hydroxymethyl-2-methyl-1,3-propanediol, due to the presence of a 
methyl group which would provide a reference for NMR interpretation. Tosylation of 
PEG3 was effective and yielded a very clean product (Figure 4.7). However, 
displacement of tosylate groups failed, even under harsh conditions (NaH, 90 ºC). 
 
i) TsCl, Et3N, DCM
ii) Aq. work-up
iii) Column chromatography.
i)CH3(CH2OH)3, NaH, 
DMF
ii) Aq. work-up
HO O OHn TsO
O OTsn
TsOPEGnO OPEGnOTs
OPEGnOTs
Me
PEGnO OPEGn
OPEGn
Me
 
Figure 4.6 - Synthesis of branched PEG ethers, synthetic strategy 2 
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Figure 4.7 - 1H-NMR of compound TsO-PEG3-OTs. 
 
The failure on the synthesis of branched polyethers under relatively simple and easy 
synthetic conditions led to consideration of different approaches, described in the 
following section.  
 
4.4.2 Synthesis of branched PEG silyl ether, and phosphate and carboxylic 
esters 
 
A silyl ether, and phosphate and carboxylic esters were synthesised, using PEGs with 
two MWs, ~ 2,000 and ~ 3,000 g mol-1 (Figure 4.8, Table 4-4).  
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Figure 4.8 – Synthesis of the branched PEG supports prepared 
 
The novelty of this strategy resides in the ability to use cheap and readily available 
PEG diol in large excess which can be removed by OSN. In fact, the use of a large 
PEG excess is essential, in order to prevent high MW cross-linked by-products that 
would hamper OSN purification (compound i), Figure 4.9). However, the use of a 
large excess PEG introduces water in the process, entrapped in the PEG. Because of 
the large excess, the moisture content can be high in comparison to the amount of 
branch point moles in reaction, increasing the chances to obtain partial hydrolysis of 
this reagent leading to di-substituted by-products (compound ii), Figure 4.9). 
 
PEGn A (PEGn)c-A PEGn
(PEGn)c-1-A-PEGn-A-(PEGn)c-1
(PEGn)c-1-A
possible by-products
i)
ii)
i) high MW
ii) partial hydrolysis  
Figure 4.9 - Chemical structure of possible by-products 
 
 The initial task was the preparation and selection of an appropriate membrane for the 
purification of such reaction mixtures.  
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4.4.3 Membrane performance characterisation 
A polyimide (Lenzing P84) membrane was prepared, with the following composition 
(Table 4-2). This composition was selected taking into account the results discussed 
in (Chapter 3). 
 
Table 4-2 – Composition of the OSN membrane used for the synthesis of branched 
PEG esters 
Membrane Polymer 
(% w/w) 
Solvent composition 
(DMF:dioxane) 
Additive  
(maleic acid)  
(% w/w) 
Crosslinker 
(HDA) 
M1 22 3:1 2 10 eq 
 
The performance of the membrane was characterised through batch rejection tests of 
PEG with different MWs, ranging from 2,000 to 35,000 g mol-1. The lower OSN 
range, from 200 to 1,000 g mol-1 was characterised by the rejection of polystyrene 
oligomers. The membrane was prepared aiming for as larger a difference as possible 
between the rejection of the product branched PEGs and linear PEGs. It was believed 
that the geometry of the branched PEGs would increase to rejection of these species in 
comparison to a linear PEG of a similar MW (Zheng et al., 2008). Figure 4.10 shows 
the MWCO curve for membrane M1, as previously determined (Chapter 3). Although 
the MWCO curve suggests that rejection of 100 % is never achieved, that fact could 
be attributed to leaks in the nanofiltration system and/or to experimental errors.  
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Membrane characterisation
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Figure 4.10 - MWCO for membrane M1: dead-end batch filtration; solvent, MeCN; 
Vp= 0.5*Vf. 
 
The MWCO curve for this membrane suggested that it could be used for the 
separation desired. Therefore, rejection tests for appropriate PEGs were repeated for 
this membrane, in order to characterise new disks from different batches with the 
same composition and with the conditions in which they were going to be used in the 
planned synthetic diafiltrations. 
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Table 4-3 – PEG rejection for membrane M1: dead-end batch filtration; P = 8 bar; 
solvent, DCM; Vp= 0.5*Vf. 
M1 
batch 1 
Sepacell 
PEGn, MW (g mol-1) R (%) Average flux 
(l m-2 h-1) 
Mass 
Balance (%) 
 PEG44, ~2,000 58 315 ± 22 105 
 PEG67, ~3,000 83 233 ± 33 127 
 MeOPEG112, ~5,000 78 228 ± 7.2 57 
 PEG226, ~10,000 99 147 ± 11 101 
M1 
batch 2 
Sepacell 
PEGn, MW (g mol-1) R (%) Average flux 
(l m-2 h-1) 
Mass 
Balance (%) 
 PEG44, ~2,000 73 178 ± 3 95 
 MeOPEG112, ~5,000 75 165 ± 2 95 
 PEG226, ~10,000 88 98 ± 7 114 
M1 
batch 2 
METCell 
PEGn, MW (g mol-1) R (%) Average flux 
(l m-2 h-1) 
Mass 
Balance (%) 
 PEG44, ~2,000 73 66 ± 2 97 
 PEG67, ~3,000 97 50 ± 3 94 
 MeOPEG112, ~5,000 95 133 ± 4 97 
 PEG226, ~10,000 94 103 ± 3 26 
 
Average membrane fluxes are considerably high, which should be considered as an 
advantage to the process. Standard deviations are quite high, relating to the major 
decrease in flux that was observed during filtrations due to membrane compaction. 
The increase in osmotic pressure (Silva and Livingston, 2006) and concentration 
polarisation should account for this effect (Peeva et al., 2004). Similarly, it is 
noticeable that there is a decreasing trend of average membrane flux with increasing 
PEG MW. Since the concentration of all PEG solutions was the same (~5 g l-1), 
differences in viscosity are probably responsible for the observed fluxes.  
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4.4.4 OSN purification 
Table 4-4  and Table 4-5 summarise the results of the branched PEG esters 
synthesised. 
 
Table 4-4 - Reaction yields 
Entry Branch point 
 
Reaction scale 
(mmol of 
branch point) 
PEGn, 
MW (g mol-1) 
Product 
MW 
(g mol-1) 
Mass 
Yield 
(%) 
1 PhSiCl3 0.72 PEG44, ~2,000 6,000 31 
2 POCl3 0.65 PEG44, ~2,000 6,000 42 
3 POCl3 0.33 PEG67, ~3,000 9,000 50 
4 Ph-1,3,5-(COCl)3 1.05 PEG44, ~2,000 6,000 62 
5 Ph-1,3,5-(COCl)3 0.50 PEG67, ~3,000 9,000 56 
 
Table 4-5 – OSN data: constant V diafiltration; Vf = 100 ml; P = 7 bar; solvent, DCM 
Entry vols 
 
Product R (%) Average flux 
(l m-2 h-1) 
Solvent per g of 
product (l g-1) 
1 12 92.2 63 ± 14 0.96 
2 15 96.4 94 ± 13 1.22 
3 50 98.6 93 ± 20 3.30 
4 12 96.1 25 ± 6 0.59 
5 49 95.5 26 ± 3 3.93 
 
Relatively high solvent consumption was observed for the 9,000 g mol-1 derivatives, 
due to the higher rejection of PEG67. It was attempted to increase the concentration of 
the solution but – possibly due to increased viscosity – the flux decreased drastically. 
The GPC chromatograms below (Figure 4.11) show the separation achieved using the 
OSN membrane. 
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Figure 4.11 - GPC chromatograms of the OSN separations (Table 4-4 and Table 4-5), 
showing the removal of excess PEG: Entry 1, PhSi-(O-PEG44)3, a) feed, b) pure; 
Entry 2, O=P-(O-PEG44)3, a) feed, b) pure; Entry 3, O=P-(O-PEG67)3, a) feed, b) pure; 
Entry 4, Benzene-1,3,5-(CO2-PEG44)3, a) feed, b) pure; Entry 5, Benzene-1,3,5-(CO2-
PEG67)3, a) feed, b) pure  
 
The structures of the branched PEGs were confirmed by 1H-NMR. Starting PEG was 
characterised using an indirect method, in order to help NMR interpretation of the 
products. Acylation of –OH termini with trifluoroacetic anhydride (TFAA) 
(Behravesh et al., 2002; Jo et al., 2001; Tessmar et al., 2002) and integration of the 
signal and comparison to the PEG repeating unit –CH2O allowed to determine the 
average number of polymer repeat units relative to terminal methylenes in the starting 
PEG samples. It was observed that there were minor deviations from the values 
theoretically estimated (see Appendix D.2.). Experimentally, it was determined that 
PEG with MW ~2,000 and 3,000 g mol-1 have, respectively, 45 and 70 repeating units 
(PEG45 and PEG70, compared to the expected PEG44 and PEG67). 
 
The characterisation of starting PEG allowed for integration of peaks relative to the 
PEG backbone –CH2O. Coupling of PEG to the branch point was indicated by the 
downfield shift of the substituted PEG termini (See appendix C for full NMR spectra). 
Samples of the feed (crude reaction mixture) and OSN purified PEGs were analysed 
by MS. Appendix C presents the MS spectra of the purified samples. All samples 
show more than 1 signal. Three hypotheses are suggested for the compounds of MW 
close to 2,000 and 3,000 g mol-1 (~ 1/3 of the MW expected for the product):  
(i) unreacted PEG, present due to inefficient OSN purification; 
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(ii) mono-substituted branch points resulting from hydrolysis of the highly 
reactive reactive R-Cl groups; and,  
(iii) fragmentation resulting from the MS ionisation conditions.  
Hypothesis (i) is unlikely after analysis of the GPC chromatograms which show no 
detectable PEG (Figure 4.11), and due to the small difference of MW when compared 
to the MS spectra of pure PEG44 and PEG67 (Appendix C). Hypothesis (ii) is also 
unlikely since it is expected that the geometry of mono-substituted branch point 
would not be considerably different from linear PEG, therefore it would be washed 
out during OSN purification, as well as detectable in the GPC chromatograms. For the 
presence of compounds with MW of ~2/3, the previous hypothesis (ii) and (iii) could 
also be argued, but for di-substituted branch points. It becomes more difficult to 
support hypothesis (iii) since it is not possible to predict if such compound would 
have a high OSN rejection and when it would be eluted in the GPC. In fact, it could 
account for the non-Gaussian shape of the product peaks in the GPC chromatography. 
It is worth mentioning that if such compound(s) are a hydrolysis by-product that 
cannot be purified by OSN, it does not constitute a major problem drawback for the 
use as supports for oligonucleotide synthesis, as its most important characteristic is to 
be retained by OSN membranes. Nevertheless, a decrease in loading capacity and 
process efficiency would be observed. 
 
In order to better characterise the products, further NMR studies were conducted. For 
these studies, the benzene-1,3,5-tricarbonyl trichloride was chosen as the model, since 
the presence of the aromatic protons could be used as a reference. Not only do they 
provide a distinctive peak for integration, but also the signal will differ depending on 
whether the aromatic ring is mono-, di-, or tri-substituted. In fact, observation of the 
1H-NMR shows that apart from the main aromatic singlet, three minor peaks appear 
near by. Based on the assumption that these impurities were product of partial reagent 
hydrolysis, Et3N was added to the NMR samples, on the assumption that any 
carboxylic acid groups present would be ionised by the base and resolve the NMR 
peaks. Addition of Et3N showed the appearance of 2 new peaks (a doublet and a 
triplet) and 2 other peaks (Figure 4.12).  
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Figure 4.12 - 1H-NMR spectra of the aromatic region (8.5-9 ppm) of benzene-1,3,5-
(CO2-PEG44)3: CDCl3 (top), CDCl3 + Et3N (bottom) 
 
In order to further confirm the presence of these hydrolysis by-products, a model 
experiment was carried out. Reactions were performed under the same conditions  but 
using MeOPEG44. The formation of cross-linked by-products would then be 
impossible and, by decreasing the molar ratio of PEG to branch point, the formation 
of mono-, di-, or tri-substituted products could be favoured. This experiment helped to 
confirm the identity of the additional aromatic peaks (doublet and triplet) as 
hydrolysis products (see Appendix D.3.). Based on NMR integrations of the product 
sample, it was determined that these account for ~ 10 % (molar ratio). Further 
evidence of the presence of di-substituted by-products resulting results from the 
analysis of the 31P-NMR spectrum of O=P-(O-PEG44)3 (Appendix D.3.). Upfield to 
the phosphate triester signal a second small peak is present that should correspond to 
the hydrolysed phosphate diester.  
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In order to identify the presence of cross-linked by-products the product was also 
characterised by treatment with TFAA. The presence of considerable cross-linked 
contaminants would mean that the ratio of free –OH termini to branch point 
substituted –CH2O would be less than 1:1. 
 
 
 
 
Figure 4.13 - 1H-NMR spectra of the –CH2OR region (4.25-4.75 ppm) of benzene-
1,3,5-(CO2PEG44)3: CDCl3 (top), CDCl3 + 5% v/v TFAA (bottom). 
 
Within the error of NMR integration, it was concluded that cross-linked by-products 
were present in only trace quantities. It is worth mentioning that contamination with 
cross-linked species does not affect the use of these branched PEG as supports for 
oligonucleotide synthesis, since they still provide reactive sites for synthesis, and, 
being a larger MW species, OSN rejection is not affected.  
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Finally, the new branched PEGs were investigated in terms of chemical stability. A 
simple acid-catalysed hydrolysis test was performed. The silyl ether branched PEG 
proved to be considerably less stable as it totally hydrolysed in the presence of 0.0002 
mM of catalytic acid Appendix C.  
 
4.5 Conclusions 
The synthesis of branched supports for oligonucleotide synthesis was examined. PEG 
based branched polymers were synthesised using a novel methodology that depends 
upon OSN separation. A silyl ether, and phosphate and carboxylic esters of 3-arm 
branched PEGs with 2 ranges of MW (~ 6,000 and 9,000 g mol-1 with loadings of, 
500 μmol g-1 and 333 μmol g-1, respectively) were prepared in good yields and 
characterised.  MS, GPC, and NMR analysis proved the chemical structure of the 
compounds. NMR analysis identified the presence of trace impurities (10 % molar 
ratio, or less). NMR analysis of a model reaction suggests that the impurities were of 
2 natures: i) mono- and di- substituted by-products, resulting from partial reagent 
hydrolysis; and, ii) having two branch point molecules reacting with both termini of a 
single PEG chain. 
 
The novel methodology used for the synthesis of branched PEGs used a simple 
synthetic procedure and easy purification. A OSN membrane with MWCO close to 
the upper OSN range was shown to be stable during the purification of the reaction 
mixtures, for long filtrations in a high swelling solvent, DCM (up to 50 vols, 36h). 
Reproducibility of the membrane was shown by the use of 2 independently prepared 
batches. Chemical stability of the compounds was investigated through acid-catalysed 
hydrolysis. The silyl ether derivative had lower stability in comparison to phosphate 
and carboxylic esters. 
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5. Membrane enhanced synthesis of DNA 
oligonucleotides: use of branched molecular supports 
 
5.1 Summary 
This research focused on the synthesis of oligonucleotide dimers, in order to prove the 
principle of MEOS, as an alternative process for the synthesis of oligonucleotides. 
Branched PEGs were chosen as the support, since previous results (Chapter 3) 
showed that linear PEGs did not guarantee the appropriate rejection, therefore, 
yielding processes with extremely poor yields and not allowing for the synthesis of 
longer chain oligonucleotides. The supports used here were developed in Chapter 4. 
 
A polymeric Lenzing P84 membrane was used for the synthesis of the dimers. Two 
branched PEG phosphate and carboxylic ester, with MW ~ 9,000 g mol-1 and loading 
of 333 μmol g-1 were used as supports. An increase of between 1.5 to 6 fold in 
synthetic yields was achieved compared to the synthesis using linear PEGs was 
obtained and a dApdA dimer was synthesised, in which the most significant impurity 
was PEG. 
 
5.2 Introduction 
The MEOS process using linear PEGs as supports showed poor yields (Chapter 3). 
Therefore, the branched supports developed in Chapter 3 appeared promising 
candidates for the process, if the observation that branched molecules have higher 
rejection values compared to linear and cyclic molecules with similar MW holds true 
in this case (Zheng et al., 2008). Thus, it was decided to attempt the MEOS process 
with the novel branched PEG derivatives. 
 
5.3 Objectives 
The main objective of this Chapter was to use branched PEGs as supports for the 
MEOS process, in order to investigate if improvements in process yields would be 
obtained. In order to do so, the synthesis of oligonucleotide dimers was proposed, 
using a previously selected OSN membrane. The specific objectives included: 
(i) Investigate the performance of the selected OSN membrane in the 
synthesis of oligonucleotides 
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(ii) Investigate the usefulness of the developed supports for DNA chemistry 
(iii) Synthesis of oligonucleotide dimers using the selected combination of 
membrane/support, and investigate possible improvements in the MEOS 
process yields. 
 
5.4 Materials and methods 
 
5.4.1 Materials 
All materials are listed in Appendix A. 
 
5.4.2 Membrane preparation 
The procedure for the preparation of polymeric membranes was the same as described 
in Chapter 3.  
 
5.4.3 OSN batch experiments 
The procedure for OSN batch experiments was the same as described in Chapter 3. In 
this case, however, only a dead-end METCell (Membrane Extraction Technology, 
UK) filtration cell was used with a membrane effective area of 51 cm2. 
 
5.4.4 OSN diafiltrations 
The procedure for OSN diafiltration experiments was the same as described in 
Chapter 3. 
 
5.4.5 Analytical techniques 
The analytical techniques were the same as used in Chapter 3. 
 
5.4.6 Synthesis of 5’-O-Dmt-nucleoside-3’-O-succinates 
The protocol for the synthesis of nucleoside succinates was adapted from the literature 
(Kumar et al., 1993; Song, 2001) and described in Chapter 3. 
 
5.4.7 General procedure for oligonucleotide synthesis 
The procedure for the synthesis of oligoucleotide dimers was the same as previously 
described in Chapter 3. 
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5.4.8 Cleavage from the support and deprotection  
The final support-oligonucleotide was dissolved in a 30 % NH3 (aq) solution (25 ml 
per gram of support-oligonucleotide) and stirred overnight at 60 0C and nitrogen 
atmosphere. The solution was then allowed to cool, evaporated to dryness under 
reduced pressure, and co-evaporated with water a few times until no ammonia was 
present. The crude material was then dissolved in a minimum volume of CHCl3 and 
precipitated with a large excess of EtOAc. The solution was centrifuged to yield the 
Dmt-protected dimer. Removal of the 5’-O-Dmt protection was achieved by treating 
the dimer with 80 % acetic acid (5 ml per 20 mg of material) for 30 min. The solution 
was evaporated under reduced pressure and co-evaporated with EtOH a few times 
until no acetic acid was present. The residue was then dissolved in 20 ml of water and 
washed with diethyl ether. The aqueous solution was then evaporated under reduced 
pressure to yield the fully unprotected dimer.  
 
5.5 Results and discussion 
Based on evidence from the acid catalysed hydrolysis studies in previous research 
(Chapter 4), it was clear that the silyl ether PEG derivative would not be appropriate 
for oligonucleotide synthesis, since it is the least chemically stable support. At the 
same time, from observations in Chapter 3, the derivatives with MW of ~ 6,000 g 
mol-1 would probably not guarantee the desired rejection of 100 % for the support-
oligonucleotide, and that has been shown previously to be an essential requirement for 
an efficient process (see Chapter 3). Therefore, it was decided to use the ~ 9,000 g 
mol-1 derivatives. The membrane used in these studies was the same Lenzing P84 
membrane applied in Chapter 4 for the synthesis of branched PEGs, as it showed 
appropriate chemical stability in DCM and a high rejection for these compounds. 
 
Rejection of the supports had already been determined to be 98.6 % for O=P-(O-
PEG67)3 and 95.5 % for benzene-1,3,5-(CO2-PEG67)3 (Chapter 4). These values were 
compared to the rejection of PEG226 (Table 5-1). The measured rejection for PEG226 
was slightly higher than for both supports, suggesting that the branched shape of the 
supports did not yield a clear advantage to the process. However, such conclusion 
could be precipitated because the conditions for the determination of the rejection 
values were not exactly similar, and, the small differences could be due to analytical 
errors. Aditionally, the fact that the branched supports are trifunctional, means that 
Imperial College London 
 119
after quantitative coupling of 5’-O-Dmt-nucleoside succinates, the support-succinate 
has a considerably higher MW. 
 
Table 5-1 - Rejection data for the M1; P= 8 bar; r.t.; solvent = DCM + 0.5 % v/v 
Et3N; concentration of solutes, 5’-O-Dmt-dABz-3’-O-succinate = ~ 0.2 % w/w, 
PEG226, ~ 5 g l-1 
Membrane 5’-O-Dmt-dABz-3’-O-
succinate 
(757 g mol-1) 
Mass 
Balance (%) 
PEG226 
(~ 10,000 g mol-1) 
Mass 
Balance 
(%) 
M1 29 79 99 101 
 
The supports were then used for the synthesis of dimers. Estimation of diafiltration 
volumes, using the value of 28.8 % for rejection of succinate, was 9 vols. Data for the 
synthesis of (5’-O-Dmt-dABzpdABz-3’-O-succ-O-PEG67-O)3-P=O is shown in Table 
5-2. 
 
Table 5-2 – Synthesis performance data using O=P-(O-PEG67)3 
Membrane M1 
Oligo (5’-O-Dmt-dABzpdABz-3’-O-succ-O-PEG67-O)3-P=O 
Stage Yield (%) Vols (-) Rejection (%) 
Attachment to support 63 12 96 
Capping 92 6 99 
Detritylation 95 8 99.3 
Coupling/Oxidation 94 12 99.5 
Overall yield (%) 45   
 
A considerable increase in overall yields between 4 to 10 fold was observed, using the 
O=P-(O-PEG67)3 as a support. However, it was observed by TLC and GPC analysis of 
the permeates during filtration steps, that product started to permeate during the 
filtration step post-capping. At the same time, a new high MW compound seemed to 
be appearing in the GPC chromatograms. Comparison of the 31P-NMR spectra of (5’-
O-Dmt-dABz-3’-O-succ-O-PEG67-O)3-P=O to (5’-O-Dmt-dABzpdABz-3’-O-succ-O-
PEG67-O)3-P=O showed the increase of intensity of the peak at -1.98 ppm during the 
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synthesis. It was suggested before (Chapter 4) that this peak was the di-substituted by-
product from partial reagent hydrolysis in the synthesis of the branched PEG. This 
increase in intensity suggested that degradation of the support was occurring. 
 
 
 
Figure 5.1 - 31P-NMR spectra of the OSN purified (5’-O-Dmt-dABz-3’-O-succ-O-
PEG67-O)3-P=O (top) and (5’-O-Dmt-dABzpdABz-3’-O-succ-O-PEG67-O)3-P=O 
(bottom) showing the increase in the signal at -1.98 ppm, possibly due to degradation 
of the support;  solvent, CDCl3. 
 
Two runs of the synthesis of a dimer using benzene-1,3,5-(CO2-PEG67)3 as the support 
were performed (Table 5-3). 
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Table 5-3 – Syntheses performance data using benzene-1,3,5-(CO2-PEG67)3 as support 
Membrane M1 
Oligo 1,3,5-(5’-O-Dmt-dABzpdABz-3’-O-succ-O-PEG67-O)3-
benzene 
 Yield (%) Vols (-) Rejection (%) 
Stage Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 
Attachment to support 76 93 14 11 98 99 
Capping 72 66 8 6 96 93 
Detritylation 82 60 6 6 96 91 
Coupling/Oxidation 68 39 7 6 94 84 
Overall yield  (%) 30 14   
 
A decrease in yields in comparison to the previous synthesis was observed using the 
phosphate ester support. Although not relevant, an increase (~ 1.5 to 6 fold) in 
comparison to the synthesis on linear PEGs was still observed. The decrease in yields 
in comparison to the previous example may be attributed to membrane unstability. 
GPC analysis showed that in both examples, product was detected in the permeates. 
However, in Run 1 no produt was detected in the permeate of the first synthetic step. 
Neverthless, the detritylation step already showed the product permeating (Figure 
5.2). This observation suggests that the membrane used may not be sufficiently stable 
to the conditions of synthesis and an evolution in performance was inevitable 
(decrease in rejection). Similar membranes performed in a stable way for the 
synthesis of olgonucleotides using linear PEGs and DCM as OSN solvent (Chapter 3), 
which may also suggest that the current observation was due to a defective batch, with 
incomplete cross-linking reaction. 
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Figure 5.2 – GPC chromatograms of the permeate samples of Run 1 (top) and Run 2 
(bottom) (Table 5-3). 
 
Despite the fact that the yields were poor, example 2 using benzene-1,3,5-(CO2-
PEG67)3 showed good intermediate NMR data (Appendix D.6.). Therefore, this was 
used as an example to continue the synthesis, i.e. cleavage from support and full 
dimer deprotection. Figure 5.3 shows the NMR spectra of dApdA. Peak asignment 
was assisted by COSY NMR experiments and comparison to NMR spectra of 
deoxyadenosine. NMR reveals PEG as the major impurity, stressing the need to 
further purify the dimer chromatographically. Figure 5.4 presents the MS spectrum of 
the HPLC fraction containing dApdA (calculated mass, 563.15). 
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Figure 5.3 – 1H- and 31P-NMR spectra of the fully unprotected dimer dAdA; solvent, 
D2O. 
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Figure 5.4 – MS spectrum of the fully unprotected dimer dAdA (calculated mass 
563.15). 
 
5.6 Conclusions 
Three support-bound oligonucleotide dimers were synthesised using novel branched 
PEG supports and a cross-linked polymeric Lenzing P84 membrane. Dinucleotide 
synthesis using the phosphate ester support O=P-(O-PEG67)3 (MW ~ 9,000 g mol-1, 
loading 333 μmol g-1) showed an improvement in yield (mass recovery) of between 4 
to 10 fold (45 %) in comparison to synthesis performed on linear PEG (Chapter 3). 
However, 31P-NMR analysis revealed the appearance of a new signal, suggesting that 
a by-product was being formed during synthesis, possibly due to unstability of the 
support. Two dimers were synthesised using the carboxylic ester support benzene-
1,3,5-(CO2-PEG67)3 (MW ~ 9,000 g mol-1, loading 333 μmol g-1). Lower yields were 
observed when compared to the previous synthesis. It was found that the stability of 
the OSN membrane used was not sufficient, as GPC analyses of the permeates 
revealed that product started to permeate through the membrane after the first 
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synthetic steps. Neverthless, an improvement of ~ 1.5 to 6 fold (14 and 30 %) in 
comparison to synthesis using linear supports was still observed.  
 
After Run 2 of the synthesis using the carboxylic ester support the dimer was cleaved 
from the support and fully deprotected. The dimer dApdA was analysed by NMR and 
MS, proving the structure and the principle of the MEOS process. The use of 
branched PEGs as supports for oligonucleotide synthesis in combination with OSN 
also proved to be advantageous. NMR identified PEG as the main contaminant, 
stressing the need for further purification of the final oligonucleotide. 
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6. Synthesis of heterobifunctional polyethylene glycols 
 
6.1 Summary 
This research focused on the development of a novel strategy for the synthesis of 
heterobifunctional PEGs. The proposed method overcomes a long time limitation in 
the synthesis of high MW PEGs, i.e. the separation of unreacted PEG from a mixture 
of mono-, and di-functionalised PEG.  
 
The key feature of the method here described was disclosed in Chapter 4. Reacting an 
excess of PEG with another organic molecule that acts as a branch point (Figure 4.1), 
generates a branched product with c number of arms and the excess PEG can then be 
separated by OSN and recovered, using the difference in MW (c × MW of PEG) as 
the determining physical-chemical separation property.  The resulting branched PEG 
has a c × number of free –OH groups that can be functionalised. After cleavage from 
the branch point, the remaining terminus of the PEG chains can also be 
functionalised. Different chemistries for the attachment of PEG to the branch point – 
silyl ether and carboxyl ester linkages - were attempted. PEG silyl ethers were shown 
to be relatively unstable while carboxyl esters allowed for the synthesis of 
monoamino and monoazido PEG derivatives with good quality. 
 
6.2 Introduction 
Two broad types of method to synthesise heterobifunctional PEGs exist (Thompson et 
al., 2008): 
(i) ring-opening polymerisation of EO starting from an anionic initiator, 
followed by termination with another functionality; and, 
(ii) derivatisation of one terminus, starting from PEG diol, followed by 
separation of the resulting mixture of unreacted PEG, mono-, and di-
functional PEG. 
 
Ring-opening polymerisation requires strict control of reaction conditions: 
(i) the presence of trace quantities of water will also initiate EO 
polymerisation leading to the formation of PEG diol as a by-product, an 
decreasing the MW of the product – leading to wider MW distributions – 
Imperial College London 
 127
and compromising further chemistries and applications (Thompson et al., 
2008); 
(ii) EO is toxic and explosive EO (Thompson et al., 2008; Zalipsky, 1993). 
 
Several synthetic strategies have been used in order to synthesise PEG with useful 
functionalities (thiol, carboxylic acids, amine, maleimide and others), using different 
anionic initiators (Bentley et al., 2002; Yokoyama et al., 1992; Zeng and Allen, 
2006).  
 
Synthesis starting from PEG diol results in a resulting mixture containing mono-, di-
functionalised and unreacted PEG. Yields are therefore decrease and purification of 
the desired product can be tedious, and require laborious procedures (Reed and Janda, 
2000). This problem is even greater for high MW PEGs, since the difference in 
physical and chemical properties of the 3 species is minimal (Huang, 1992; 
Thompson et al., 2008). Chromatographic procedures (Philips and Snow, 1994; 
Zalipsky, 1993) and grafting the product to polymer matrices (Huang, 1992; Huang 
and Hu, 1993) are some of the proposed ways to overcome this difficulty. However, a 
simple and flexible synthetic method has yet to be published. 
  
6.3 Objectives 
The main objective of this Chapter was to develop a totally novel synthetic method 
for the preparation of heterobifunctional polymers, namely, PEG. OSN was assessed 
as an alternative separation technology in order to overcome a long-time limitation in 
the synthesis of such compounds. The specific objectives included: 
(i) preparation of 2 different heterobifunctional PEGs; and, 
(ii) Analysis and characterisation of the chemical structure of the compounds 
synthesised 
 
The overall objective can be summarised by Figure 6.1. 
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HZ-PEGn-ZH
(excess)
A (HZ-PEGn-Z)c-A HZ-PEG-ZH
OSN
(HZ-PEGn-Z)c-A
(X-PEGn-Z)c-AX-PEGn-Y
Z= O, S, CO2, NH...
X-PEGn-ZH  
Figure 6.1 - General schematic of the synthetic method for heterobifunctional PEGs 
 
6.4 Materials and Methods 
 
6.4.1 Materials 
All materials are listed in Appendix A. 
 
6.4.2 Analytical techniques 
The analytical techniques used were the same as in Chapter 4. 
 
6.4.3 Synthesis 
The synthetic protocols for this Chapter can be seen in Appendix F.1.. 
 
6.5 Results and Discussion 
The proposed synthetic method was investigated by the synthesis of 2 different 
heterobifunctional PEGs, with MW ~2,000 g mol-1: HO-PEG44-NH2 and HO-PEG44-
N3. This MW was chosen since it is relevant for medical applications and it is high 
enough to produce a relevant separation challenge. The novel feature of this research 
lies in the first synthetic step (Figure 6.1), in which linear PEG is coupled to the 
branch point molecule (i.e., monofunctionalising c linear PEG chains) and the excess 
PEG is removed by OSN. This specific feature of the method described in this 
Chapter was, in fact, already investigated in Chapter 4. Therefore, the details of such 
will not be repeated. Two were selected for the purpose of preparing 
heterobifunctional PEGs: Ph-Si-(O-PEG44)3 and benzene-1,3,5-(CO2-PEG44)3. This 
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would allow testing the robustness of silyl ethers and carboxylic esters for the 
chemistry used to functionalise the termini that are not coupled to the branch point. 
 
6.5.1 Silyl ether 
Ph-Si-(O-PEG44)3 synthesised was modified using the synthetic route depicted in 
Figure 6.2. The first step consisted of mesylation of the free –OH termini, followed by 
the displacement of the mesylate groups with potassium phthalimide. It was observed 
that the silyl ether bond was not stable enough for the synthesis, breaking down 
during the mesylation step, to give HO-PEG44-Phth. Most likely, the synthetic 
chemistries were not responsile for breaking the silyl ether bond, but instead, the 
aqueous work-up. Acid-catalysed hydrolysis studies of Ph-Si-(O-PEG44)3 (see 
Chapter 4) already pointed out to the lower chemical stability of this compound in 
comparison to phosphate and carboxylic esters. Nevertheless it was possible to 
differentiate PEG termini, introducing a electrophile on one end, proving the principle 
of the synthetic method. In fact, it can be envisaged that silyl ethers may provide a 
good support when mild synthetic conditions are desired, providing an easy way of 
cleaving the PEG chains from the branch point.  
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Ph Si
Cl
Cl
Cl
+
i) DCM, 4eq. imidazole
ii) aq. work-up, OSN
yield = 31 %
Ph Si
O-PEG44
O-PEG44
PEG-44O
i) DCM, 5 eq. MsCl, 
2 eq. Et3N 
ii) aq. work-up
Ph Si
O-PEG44-OMs
O-PEG44-OMs
MsO-PEG-44O
i) DMF, 10 eq. KPhth
ii) aq. wash
iii) ether prec.
Ph Si
O-PEG44-Phth
O-PEG44-Phth
Phth-PEG-44O
HO-PEG44-Phth
yield = 52 %
(10 eq.)
PEG44
yield = 62 %
 
Figure 6.2 – Synthesis of HO-PEG44-Phth 
  
The structure of HO-PEG44-Phth was analysed by NMR (all NMR spectra can be 
found in Appendix F.2.) and the quality assessed (Table 6-1) by the TFA anhydride 
method, previously reported (Behravesh et al., 2002; Jo et al., 2001; Tessmar et al., 
2002). 
 
6.5.2 Carboxylic esters 
The ester bonds in the benzene-1,3,5-(CO2-PEG44)3 support were found to be stable to 
the chemistries used for the synthesis of HO-PEG44-NH2 and HO-PEG44-N3. 
Therefore, it was used to synthesise 2 batches of each, in order to prove repeatability 
and improve the reaction and work-up conditions, with the aim of increasing yields. 
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(10 eq.)+
i) DCM, 6 eq. NMI
ii) aq. work-up, OSNCl
Cl
Cl
O
O
O
PEG44 O-PEG44
O-PEG44
O-PEG44
O
O
O
yield = 62 %
O-PEG44-OMs
O-PEG44-OMs
O-PEG44-OMs
O
O
O
i) DCM, 5 eq. MsCl,
2 eq. Et3N;
ii) aq. work-up
yield = 93 %
i) DMF, 10 eq. KPhth, 80 ºC
ii) Aq. wash
iii) ether prec.
O-PEG44-Phth
O-PEG44-Phth
O-PEG44-Phth
O
O
O
yield = 68 %
i) 10% N2H4.H2O; EtOH
ii) Aq. work-up.
HO-PEG44-NH2
yield = 58 %  
Figure 6.3 - Synthesis of HO-PEG44-NH2 (batch 1) 
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(10 eq.)+
i) DCM, 6 eq. NMI
ii) aq. work-up, OSNCl
Cl
Cl
O
O
O
PEG44 O-PEG44
O-PEG44
O-PEG44
O
O
O
yield = 62 %
O-PEG44-OMs
O-PEG44-OMs
O-PEG44-OMs
O
O
O
i) DCM, 2 eq. MsCl,
2 eq. Et3N;
ii) aq. work-up
yield = 82 %
i) DMF, 10 eq. KPhth, 80 ºC
ii) Aq. wash
iii) ether prec.
O-PEG44-Phth
O-PEG44-Phth
O-PEG44-Phth
O
O
O
yield = 58 %
i) 10% N2H4.H2O; EtOH
ii) Aq. work-up.
HO-PEG44-NH2
yield = 76 %  
Figure 6.4 - Synthesis of HO-PEG44-NH2 (batch 2) 
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(10 eq.)+
i) DCM, 6 eq. NMI
ii) Aq. Work-up, OSNCl
Cl
Cl
O
O
O
PEG44
O-PEG44
O-PEG44
O-PEG44
O
O
O
yield = 62 %
O-PEG44-OMs
O-PEG44-OMs
O-PEG44-OMs
O
O
O
i) DCM, 5 eq. MsCl,
 2 eq. Et3N
 ii) Aq. work-up
yield = 89 %
i) DMF:H20 (12:1), 6 eq. NaN3,
0.4 eq. NaHCO3
ii) Aq. work-up
iii) ether prec.
O-PEG44-N3
O-PEG44-N3
O-PEG44-N3
O
O
O
yield = 39 %
i) 35 % NH3 (aq) 
ii) Aq. work-up
HO-PEG44-N3
yield = 88 %  
Figure 6.5 - Synthesis of HO-PEG44-N3 (batch 1) 
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(10 eq.)+
i) DCM, 6 eq. NMI
ii) Aq. Work-up, OSNCl
Cl
Cl
O
O
O
PEG44
O-PEG44
O-PEG44
O-PEG44
O
O
O
yield = 62 %
O-PEG44-OMs
O-PEG44-OMs
O-PEG44-OMs
O
O
O
i) DCM, 5 eq. MsCl,
 2 eq. Et3N
 ii) Aq. work-up
yield = 90 %
i) DMF:H20 (12:1), 6 eq. NaN3,
0.4 eq. NaHCO3
ii) Aq. work-up
iii) ether prec.
O-PEG44-N3
O-PEG44-N3
O-PEG44-N3
O
O
O
yield = 72 %
i) 35 % NH3 (aq), 
50 oC 
ii) Aq. work-up
HO-PEG44-N3
yield = 83 %  
Figure 6.6 – Synthesis of HO-PEG44-N3 (batch 2) 
 
 
Analysis of the samples was not trivial using NMR due to the relative low intensity of 
the substituted –CH2O signal compared to the signal of the backbone -CH2.  
Aditionally, the unsubstituted -OH termini are not resolved from the backbone –
CH2O. Moreover, the latter most often appears as a very broad signal, not allowing 
for accurate integrations. The method chosen for estimation of the degree of 
conversion and purity was described by Jo et al., 2001). TFAA anhydride was added 
to the NMR tube prior to analysis to acylate PEG termini to completion, causing a 
downfield shift of the signal, and allowing for characterisation and signal integration 
(Behravesh et al., 2002; Tessmar et al., 2002). The same method was applied for 
characterisation of unreacted PEG, as previously described in Chapter 4. Another 
difficulty arises from the analysis of groups with exchangeable protons (e.g. –OH, –
NH2) that often produce broad and difficult to integrate signals (Postma et al., 2006). 
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Table 6-1 – Reaction yields and analysis of the heterobifunctional PEGs synthesised 
 Overall Yield (%) Purity(a) (%) 
HO-PEG44-Phth 10 98 
HO-PEG44-NH2 (batch 1) 23 100 
HO-PEG44-NH2 (batch 2) 22 96 
HO-PEG44-N3 (batch 1) 19 99 
HO-PEG44-N3 (batch 2) 33 97 
HO-PEG44-NH2(b) --- 97 
(a) Estimated by 1H-NMR, after acylation of –OH (and, when appropriate, -NH2) 
groups and by comparison of the downfield acylated peaks with CH2R (R = -Phth, -
N3, -NHTFA). 
(b) Model compound supplied by CreativePegWorks (USA). 
 
6.6 Conclusion 
The three heterobifunctional PEGs HO-PEG44-Phth, HO-PEG44-NH2, and HO-PEG44-
N3 were synthesised in good yields and purity. The novel method presented here 
allowed for the synthesis of these compounds in a flexible and simple synthetic 
procedure. It overcame previous limitations in the synthesis of heterobifunctional 
PEGs starting from PEG diol: having to rely on cumbersome separation technologies 
to separate a mixture of mono- and di-functionalised, plus unreacted PEG. OSN 
combined with a novel synthetic procedure proved to be an efficient, reliable, and 
scalable alternative technology. It also has advantage over anionic ring opening 
polymerisation, since it uses cheaper starting materials, avoids the use of explosive 
and toxic EO, and does not require such strict control of reaction conditions. 
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7. Conclusions and Future work 
7.1 Introduction 
In this Chapter the main conclusions of this research will be summarised and 
discussed within the context of OSN application to the fields of oligonucleotide 
synthesis, heterobifunctional polymer synthesis, and organic general synthesis. 
Possible directions of future research in this area are also discussed. 
 
7.2 MEOS process 
Several advances in synthetic chemistry have been taken over the last decade (driven 
by the pursuit of new drugs and other valuable compounds) that allowed for the 
synthesis of very complex organic molecules. Combinatorial synthesis and automated 
organic synthesis (e.g. SPS) have been able to provide several new compounds. 
However, expectations nowadays are that compounds must be manufactured fast, 
efficiently, cheaply, safely, and on large scales (Curran, 1998). 
 
The ability to perform and analyse reactions, as well as characterise compounds, has 
developed considerably. However, purification has not advanced to the same degree, 
apart from chromatography which has seen improvements, although this can still be 
expensive and time-consuming. Most often, purification represents the most costly 
step in organic synthesis due to time and resources that need to be allocated to it 
(Curran, 1998). 
 
Oligonucleotide synthesis is no exception in the field of organic synthesis. SPS 
revolutionised the field and became the state-of-the-art technology, by introducing a 
method that allowed for simple, automated, and fast purification of intermediates. The 
simplicity of SPS allowed for the development of novel and more efficient 
chemistries, but the challenge of cheap large scale production remains. Latter, LPS 
was suggested as an alternative to allow cheap large scale manufacture of antisense 
drugs. But challenges still remain in the development of high loading supports that 
allow for efficient reactions and purification. Current methods are based on support 
precipitation, a separation technology not suitable for multistep synthesis (Haag, 
2001). 
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OSN is a relatively recent technology with great potential to be used in organic 
synthesis. This research project attempted to introduce OSN into the synthesis of 
oligonucleotides, in a process named MEOS.  
 
The MEOS process combines OSN separation with LPS chemistry, using soluble 
poymer supports. The first syntheses with the MEOS process used linear PEG as the 
support, the most common soluble support in LPS. 
 
Several OSN membranes were characterised in terms of their performance, namely, 
the MWCO curve that characterises selectivity. Commercially available ceramic 
membranes were tested and it was found that, in combination with either MeOPEG112 
or PEG226 as supports, the process was not efficient enough for practical synthesis. 
Inopor@ultra2000 allowed for the separation of the growing oligonucleotide from 
excess reactants and by-products. However, the rejection of the product was 
insufficient to allow for a high synthetic yield. Simple calculations based on the mass 
balance of the process showed that even high rejections of 95+ % can lead to massive 
product losses over the course of long filtrations. Inopor@nano750 had too low 
MWCO for the process, not separating the support-bound oligonucleotide from excess 
nucleoside phosphoramidite. Remarkably, nucleoside succinate (with similar MW as 
the phosphoramidite) was able to permeate through the membrane. The difference in 
behaviour is suggested to be due to different hydrophobicity of the compounds and 
their interaction with the membrane surface. 
 
Several cross-linked polymeric OSN membranes made from Lenzing P84 were 
prepared and their performance characterised. A method reported in the literature and 
further developed in the SET research group was used to change the MWCO and tune 
the selectivity (See-Toh et al., 2008). Varying the ratio of solvent:co-solvent 
(DMF:1,4 dioxane) in the composition of the dope solution allowed variation of the 
MWCO. An increase in the MWCO was observed with an increased concentration of 
solvent (DMF). However, the increase in MWCO was accompanied by an increase in 
the standard variation of pore size (pore size distribution) meaning that a sharp 
separation between species of close MW was not possible. The membranes tested 
showed 100 % rejection for the support-bound oligonucleotide. However, separation 
from the excess nucleoside phosphoramidites was not observed. As for 
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Inopor@nano750, nucleoside succinates did permeate through the membrane, but not 
phosphoramidites.  
 
In order to overcome this problem, it was decided to develop new supports for the 
synthesis. Rejection of branched molecules had been reported to be higher than linear 
and cyclic molecules with similar chemical formulae and MW (Zheng et al., 2008), so 
it was decided to investigate the MEOS process using branched supports.  
 
Branched PEGs were synthesised using a novel separation method. Excess PEG was 
reacted with small multifunctional molecules acting as branch points, and the products 
purified from excess PEG using a cross-linked Lenzing P84 membrane. Using this 
method for the synthesis of branched PEGs, 5 different PEGs were synthesised in 
good yields in a simple and cheap process. PhSiCl3, POCl3, and benzene-1,3,5-
(COCl3) were used as branch points, reacted with PEG with MWs of 2,000 and 3,000 
g mol-1 to provide trifunctional branched PEGs with MWs of ~ 6,000 and  9,000 g 
mol-1. NMR analysis of the compounds revealed the presence of trace impurities 
resulting from partial hydrolysis of the branch point and traces of PEG bridging two 
branch point molecules. In this investigation, OSN proved to be successful, and the 
cross-linked membranes stable in DCM (a very aggressive solvent for polymeric 
membranes) and in long filtrations (up to 50 diafiltration volumes, 36h of operation).  
 
The novel supports were investigated for use in the MEOS process. O=P-(O-PEG67)3 
and benzene-1,3,5-(CO2-PEG67)3 (both ~ 9,000 g mol-1 and loading of 333 μmol g-1) 
were used in the synthesis of oligonucleotide dimers. For these experiments, a cross-
linked Lenzing P84 membrane was prepared. Under these conditions, the MEOS 
process showed an increase in yields when compared to syntheses using linear PEGs. 
O=P-(O-PEG67)3 showed the greatest improvement, but, 31P-NMR analysis suggested 
that phosphate triester bond was not stable and was degrading. Experiments using 
benzene-1,3,5-(CO2-PEG67)3 also provided an increase process yields. However, at 
this point it was determined that separation started to fail due to, most likely, 
membrane degradation and/or deformation occuring. GPC analysis showed that 
support-bound oligonucleotide started to permeate through the membrane after the 
first synthetic steps. Still, a fully unprotected dimer dApdA was synthesised and the 
structure proved by NMR and MS, showing PEG as the main contaminant. 
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OSN was also investigated for preparation of monomers for oligonucleotide synthesis, 
nucleoside phosphoramidites. 5’-O-Dmt-dT phosphoramidites were prepared using 
OSN as single purification step. For this, the performance of several OSN membranes 
was again characterised using a standard method for filtrations in the range of 200 to 
1,000 g mol-1 (See Toh et al., 2007b). It was concluded that membranes prepared 
from MatrimidTM 5218 had sharper MWCO curves than Lenzing P84, allowing for 
more selective separations. A cross-linked MatrimidTM 5218 was used for this process 
and proved to be able to separate nucleoside phosphoramidites from excess reactants. 
Yields of the process were, nevertheless low and not competitive with current state-
of-the-art techniques. This was because rejection of nucleoside phosphoramidites was 
not 100 % during the course of the whole process. Aditionally it was found that the 
product was contaminated with a dimer resulting from phosphoramidite activation 
with pyTFA. The dimer, being a high MW species, could not be separated by OSN, 
therefore, acknowledging for the need to use OSN in combination with very clean 
chemistries.  
 
7.3 Future work 
The optimisation and success of the MEOS process is highly dependent on the 
combination of support and OSN membrane used. This combination determines the 
selectivity of the separation process and the efficiency of the process. 
 
An optimum OSN membrane should present 100 % rejection for the support-bound 
oligonucleotide and very low rejection for the other reactants, especially the excess 
monomers. This would allow for a product of high quality in a fast process with low 
solvent consumption.  
 
One of the great advantages over SPS that the MEOS possesses is that it can sustain 
high reaction rates. OSN membranes separate molecules based on the difference in 
molecular size, and varying the size of the synthesis support can be used to increase 
this difference. However, using supports with very high MWs can be detrimental to 
the process, because they slow down the reaction rate, reduce the loading, and make 
solutions viscous,  
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Dendrimers could be investigated as alternative supports in the MEOS process. 
Dendrimers are highly branched molecules that should have high rejection in OSN 
membranes, allowing for an increase in process yields. However, care must be taken 
to investigate their reaction kinetics, since the presence of multiple reactive sites can 
increase steric hindrance and significantly decrease reaction rates. Aditionally, 
solubility of dendrimers in organic solvents such as MeCN and DCM must be taken 
into account, as well as solution viscosity. Very viscous solutions have a significant 
negative impact in OSN fluxes. Other supports should also be investigated. Branched 
PEGs, such as the ones described in this thesis are potential candidates. In this 
investigation trifunctional branch points were used to make the 3-arm branched PEGs. 
Branch points with more functionalities could be investigated as it would allow the 
preparation of bulkier supports with lower MW, with consequent increase in OSN 
rejection and in support loading. Attention should also be paid to the linkages used to 
construct the supports. In this investigation, carboxylic esters were stable under the 
synthetic conditions used. However, more robust linkages (e.g. ethers) should be 
investigated to allow for more aggressive synthetic conditions. Especially, 
considering the use of such supports for applications other than the synthesis of 
oligonucleotides. 
 
Apart from supports, further research efforts should be directed into the development 
of OSN membranes. Synthesis of oligonucleotides uses solvents that are aggressive to 
OSN membranes, such as DCM and MeCN. DCM, in particular, is a very high-
swelling solvent with consequences in membrane performance. Milder solvents could 
be used for the separation steps, but that would be detrimental to the process since 
additional solvent exchange steps would be required. Therefore, improvements in the 
chemical stability of OSN membranes should be investigated. Chemical stability of 
OSN membranes is related to dissolution, deformation or swelling of the membrane. 
Complex mechanisms underlie these phenomena and a better insight into these 
processes would enhance the development of more robust membranes. Chemical 
cross-linking of PI membranes has been shown to improve performance in aggressive 
solvents (See Toh et al., 2007a). However, little is still known about the reaction 
mechanisms, kinetics, and the impact on membrane morphology in the top separation 
layer. Apart from chemical stability, membrane selectivity should be improved, as 
well as methods to tune the MWCO. The known methods of affecting the 
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thermodynamics and kinetics of the phase inversion process by varying the 
composition of the dope solution (See-Toh et al., 2008) have provided a tool to 
achieve this. However, the change in MWCO should not be accompanied by an 
increase in pore size distribution that decreases selectivity. Another route that could 
be considered for the development of OSN membranes would be to increase the 
selectivity of membranes by introducing functionalities. For example, PI membranes 
have imide groups that are used for cross-linking. These groups could also be used to 
introduce functionalities to increase or decrease hydrophobicity of membranes and 
potentially increase or decrease selectivity towards compounds. 
 
The MEOS process could also be improved by investigating the use of OSN 
membranes for the recycling of reagents, especially, the costly nucleoside 
phosphoramidites. Membranes such as the ones used in this thesis (Chapter 2) could 
be investigated for the purification nucleoside phosphoramidites from the permeate 
streams of coupling reactions in MEOS process. In these streams, nucleoside 
phosphoramidites are the compounds with higher MW, so could potentially be 
recovered and reintroduced into the process with consequent saving in costs. The 
feasibility of such application should be investigated. 
 
7.4 Synthesis of heterobifunctional PEGs 
A novel method for the preparation of heterobifunctional polymers was described. 
Three heterobifunctional PEGs of MW ~ 2,000 g mol-1 were synthesised with –OH 
groups on one end and phthalimide, amine and azide groups on the opposite terminus. 
All the intermediates and modified PEGs were characterised by NMR, showing good 
quality and purity. The method allowed for a flexible, cheap, and simple synthetic 
procedure. The key feature of the method was the first synthetic step was described in 
Chapter 4: reacting excess PEG with a multifunctional branch point molecule, and 
subsequent purification using OSN, resulted in branched PEGs. These branched PEGs 
had free –OH groups available for further modification. These termini were modified 
and then the linear PEGs were cleaved from the branch point to yield the 
heterobifunctional PEGs.  
 
This method used a cheap starting material (PEG diol) that could be separated from 
the reaction mixture in a simple manner, whereas other reported methods require 
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complex separation procedures. A Lenzing P84 OSN membrane was used for this key 
separation step, showing good stability in the OSN solvent, DCM. Yields of the OSN 
separation were good although not optimised.   
 
7.5 Future work 
Heterobifunctional PEGs are used for several purposes. Conjugation with enzymes, 
proteins, lipids or small molecule drugs, construction of supramolecular delivery 
systems, etc. The examples presented in this thesis were used for proof of principle 
but further studies on the synthesis of other functionalities should be carried out. For 
example, DSPE-PEG for incorporation into liposomes, or PEG succinimidyl ester for 
congujation with proteins should be attempted.  
 
PEGs with MWs ranging from 2,000 to 40,000 g mol-1 are the most attractive for 
biomedical applications. Investigations on the feasibility of the method described here 
for MWs higher than 3,000 g mol-1 should be performed. Other MWs represent a 
challenge for OSN separation and membrane development, as one single membrane 
will not be applicable to all cases. Therefore, similar research as described in Section 
7.3 for the MEOS process should be pursued in order to improve OSN selectivity and 
to develop methodologies to tune the MWCO of membranes for each specific 
purpose. 
 
7.6 Synthesis 
Within this research, different applications of OSN were investigated in the fields of 
oligonuclotide synthesis and polymer (PEGs) synthesis, in order to gain insight into 
the potential of OSN as an alternative purification technology in the field of organic 
synthesis. The first objective of this investigation was to prove the concept of the 
MEOS process. Investigations started by using standard of LPS oligonucleotide 
chemistry adapted to the proposed MEOS process. These results lead to the 
development of novel chemistry for the synthesis of oligonucleotides, namely the 
development of a new soluble supports. The synthesis of these supports was 
performed using a novel methodology for the preparation of branched PEGs by OSN. 
Using these supports, the MEOS process was improved and the concept was found 
feasible, although as not efficient as hoped. 
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A second objective for this research resulted from the work carried out in the 
preparation of branched PEGs. The branched PEGs could be seen as intermediates for 
the synthesis of heterobifunctional PEGs, resulting in a novel synthetic method, that 
overcomes a long time limitation in the synthesis of such molecules starting from 
PEG diol. This novel method has the potential to be used in the preparation of other 
heterobifunctional polymers.  
 
By using these specific examples, the utility of the novel and emergent OSN 
technology to the field of organic synthesis was demonstrated, where purification still 
remains a challenge for the manufacture of drugs and other valuable compounds in an 
efficient, cheap and safe manner. 
 
It is therefore hoped that this work has contributed positively to the gain of insight 
into the field of OSN technology and the challenges ahead of it, as well as to the field 
of separations in organic synthesis.   
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8.  Appendix 
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Appendix A - Materials 
 
All chemicals were used as purchased, without further purification unless otherwise 
stated. Commercially available ceramic membranes were purchased from Inocermic 
GmbH (Germany). Lenzing P84 was supplied by HP Polymer GmbH (Austria). 
MatrimidTM5218 was supplied by Huntsman (USA). Polystyrene oligomers were 
purchased from Polymer Laboratories (UK). PEG (PEGn, MW ~600, ~1,000, ~2,000, 
~3,000, ~10,000, 20,000, and 35,000 g mol-1), α-methoxy-polyethylene glycol 
(MeOPEGn, ~2,000 and 5,000 g mol-1), 4-dimethylpyridine (DMAP), succinic 
anhydride, acetic anhydride (Ac2O), Diisopropylcarbodiimide (DIC),  N-
methylimidazole (NMI), imidazole, 2-hydroxymethyl-1,3-propanediol, 2-
hydroxymethyl-2-methyl-1,3-propanediol, p-toluenesulfonyl chloride, 
methanesulfonyl chloride, hydrazine hydrate, potassium phthalimide, p-
toluenesulfonic acid monohydrate, TFA, camphorsulfonic acid, trichlorophenylsilane 
(PhSiCl3), benzene-1,3,5-tricarbonyl trichloride, phosphorus oxychloride, sodium 
hydride (60 % dispersion in mineral oil), 2,6-lutidine, anhydrous MgSO4, 5.0-6.0 M 
tert-butyl-hydroperoxide in hexane (TBHP), anhydrous Na2SO4, pyridinium 
trifluoroacetate (PyTFA), triethylamine (Et3N), 1,2-ethanediamine (EDA), 1,6-
hexanediamine (HDA),  ammonium acetate, calcium hydride (CaH2) and molecular 
sieves (3 Å, 1.6 mm) were purchased from Sigma-Aldrich (UK). Sodium bicarbonate 
(NaHCO3) was supplied by BDH. Sodium azide was supplied by Fluka. Nucleosides, 
nucleoside phosphoramidites, and 2-cyanoethyl-N,N,N’,N’-tetraisopropyl 
phosphoramidite were purchased from ChemGenes (USA). HO-PEG44-NH2 was 
supplied by CreativePegWorks (USA). TFAA was purchased from Fluorochem Ltd 
(UK). Deutero chloroform (CDCl3) was supplied by Merck (Germany). Peptide 
synthesis grade dimethylformamide (DMF), HPLC grade N-methylpyrrolidone 
(NMP), 1,4-dioxane and tetrahydrofuran (THF) were purchased from Rathburn 
Chemicals Ltd (UK). GPR grade dichoromethane (DCM), chloroform (CHCl3), 
acetonitrile (MeCN), methanol (MeOH), ethanol (EtOH), isopropanol (IPA), hexane, 
and ethyl acetate (EtOAc) were supplied by BDH, and used with no further 
purification for OSN or TLC development. Dry toluene (TOL) was supplied from 
Imperial College London, Chemistry Department. 
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For reactions, MeCN and DCM were stirred at reflux (2 h) over calcium hydride 
(CaH2), distilled into molecular sieves (3 Å, 1.6 mm) and kept under nitrogen. Flash 
column chromatography was performed using Kieselgel silica gel (33 to 70 μm) 
supplied by BDH. Reactions were carried under nitrogen atmosphere and in oven-
dried glassware. 
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Appendix B - Chapter 2 supplementary information 
Imperial College London 
 162
B.1. Schematics of the OSN apparatus 
 
 
Figure 8.1 – Schematic of the OSN apparatus used for polymeric membranes 
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Figure 8.2 –Schematic of the OSN apparatus used for ceramic membranes 
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B.2. SEM images of PI membranes prepared by phase inversion 
 
 
Figure 8.3 – Example of cross-section SEM pictures from 22 % (w/w) Lenzing P84 
membranes prepared from different solvent composition of the dope solution (See-
Toh et al., 2008). 
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B.3. Rejection data of the membranes tested for the synthesis of nucleoside 
phosphoramidites 
  
Table 8-1 - Rejection data for the membranes tested; P= 30 bar; r.t.; solvent= MeCN; 
concentration of solutes (pyTFA and 5’-O-Dmt-dT phosphoramidite), ~1 % w/w 
Membrane PyTFA 
(193 g mol-1) 
Mass 
Balance 
(%) 
5’-O-DMT-dT 
phosphoramidite 
(745 g mol-1) 
Mass 
Balance 
(%) 
disk 2 58 89 88.0 91 M1 
disk 3 99 96 88 73 
disk 1 --- --- 92 77 M2 
disk 2 --- --- 97 97 
M3 79 77 98 86 
M4 45 89 92 77 
M5 61 80 100 101 
Inopor@nano450 40 99 94 97 
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B.4. Diafiltration mass balances to the OSN unit 
 
 
 
Figure B. – Flowchart of a constant volume diafiltration 
 
The overall mass balance to boundary A (OSN unit) [mass time-1] is 
 
dt
dVQQ rrppff ∗+∗=∗ ρρρ  
 
Where ρf is the density of the feed solution (kg m-3), ρp is the density of the permeate 
solution (kg m-3), and ρr is the density of the retentate (kg m-3). Qf and Qp are the 
volumetric flow rates of the permeate and feed streams (m-3 s-1). Vr is the volume of 
the retentate (m3). 
 
Since Vr is constant and assuming ρf = ρp 
 
QQQ pf ==      
Equation i 
 
Mass balance to solute i, boundary A [mass time-1] 
 
Fresh 
solvent 
 
 
Vp; Ci,p; Qp 
Vr; Ci,r 
Qp 
 
A
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( )
dt
VCd
CQ rripi
∗+∗= ,,0   
 
pi
ri
r CQdt
dC
V ,
, ∗−=∗  
Equation ii 
 
Where Ci,r is concentration of solute i in the retentate (g m-3), and Ci,p is concentration 
of solute i in the permeate (g m-3). 
 
Rejection (Ri’) of solute i [-] 
 
ri
pi
i C
C
R
,
,' 1−=  
Equation iii 
 
The overall mass balance to the permeate [mass time-1] 
 
dt
dV
Q ppp ∗=∗ ρρ  
 
dt
dV
Q p=  
Equation iv 
 
Solving Equation iii in order of Ci,p [mass volume-1] 
 
piriiri CCRC ,,
'
, −=∗  
 
( ) riipi CRC ,', 1 ∗−=  
Equation v 
 
Substituting Equation iv and Equation v in Equation ii  
 
Imperial College London 
 168
( )[ ]riiprir CRdtdVdtdCV ,', 1 ∗−∗−=∗  
 
( )
dt
dV
R
Vdt
dC
C
p
i
r
ri
ri
∗−∗−= ',
,
111  
 
Integrating between the boundary conditions 
 
(a) 0,,0 0,, === priri VCCt  
(b) ppriri VVCCtt === ,, ,,  
 
( ) pi
rri
ri VR
VC
C ∗−∗−=⎟⎟⎠
⎞
⎜⎜⎝
⎛ '
0,
, 11ln  
 
Defining diafiltration volumes [-] as 
 
vols
V
V
r
p =  
 
The concentration profile of solute i [mass volume-1], comes 
 
( )[ ]'0,, 1exp iriri RvolsCC −−∗=  
Equation vi 
 
And rejection (Ri’) of solute i [-] 
 
⎟⎟⎠
⎞
⎜⎜⎝
⎛∗+=
0,
,' ln11
ri
ri
i C
C
vols
R  
Equation vii 
 
Considering that 
 
r
ri
ri V
m
C ,, =  
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r
ri
ri V
m
C 0,0, =  
Where Ci,r0 is concentration of solute i in the retentate at t= 0 (g m-3), mi,r0 is the mass 
of solute i in the retentate at t= 0 (g), and mi,r is the mass of solute i in the retentate at 
any time (g), Equation vii can be re-written as  
 
( )yieldmass
volsm
m
vols
R
ri
ri
i ln
11ln11
0,
,' ∗+=⎟⎟⎠
⎞
⎜⎜⎝
⎛∗+=  
Equation viii 
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B.5. Reproducibility of MatrimidTM 5218 
 
Molecular weight (g mol-1)
0 200 400 600 800 1000 1200 1400
R
ej
ec
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n 
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)
0
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MWCO curve, batch 1
PyTFA (193 g mol-1), batch 1
5'-O-Dmt-dT amidite (745 g mol-1), batch 1
5'-O-Dmt-dGiBu amidite (839 g mol-1), batch 1
MWCO curve, batch 2
PyTFA, batch 2
5'-O-Dmt-dT amidite, batch 2
MWCO curve, batch 3 
 
Figure 8.4 – Rejection properties of independently prepared batches of 26 % w/w 
MatrimidTM 5218 (M5, Table 2-2): P= 30 bar; r.t.; solvent= MeCN; concentration of 
solutes (pyTFA, 5’-O-Dmt-dT phosphoramidite, and 5’-O-Dmt-dGiBu 
phosphoramidite), ~1 % w/w. 
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C.1. Reaction conditions and yields for the synthesis of 5’-O-Dmt-nucleoside-3’-
O-succinates 
B
O
OH
DmtO
OO O
B
O
DmtO
O OH
O
O+
i) DCM, Et3N, DMAP
 
Figure 8.5 – Synthesis of 5’-O-Dmt-nucleoside-3’-O-succinates; B = ABz, GiBu, CBz, T 
 
Table 8-2 - Reaction conditions and yields for the synthesis of 5’-O-Dmt-nucleoside-
3’-O-succinates 
Batch B Scale(a) Reaction time 
(h) 
Mass Yield (%) 
1 ABz 150 mg, 0.23 mmol 24 80 
2 ABz 2 g, 3 mmol 24 99 
3 ABz 5 g, 7.6 mmol 24 100 
4 ABz 5 g, 7.6 mmol 24 91 
5 ABz 5 g, 7.6 mmol 24 89 
6 ABz 5g, 7.6 mmol 18 83 
7 T 5g, 9.2 mmol 21 50 
8 ABz 5g, 7.6 mmol 24 100 
9 T 5g, 9.2 mmol 20 96 
10 ABz 2, 3 mmol 18 100 
11 ABz 5g, 7.6 mmol 1.5 89 
(a) quantity of starting material 
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C.2. SEM picture of Inopor@ultra2000 
 
 
Figure 8.6 –SEM picture showing the top layer of Inopor@ultra2000 
Imperial College London 
 174
Appendix D – Chapter 4 supplementary information 
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D.1. Synthesis 
 
Synthesis of branched PEG ethers, synthetic strategy 1 
p-Toluenesulfonic esters were prepared based on the protocol published by Tipson, 
1944). 2-hydroxymethyl-1,3-propanediol was dissolved in dry pyridine and cooled in 
an ice-salt bath. p-Toluenesulfonyl chloride (TsCl) was added (1.2 eq. per mol of –
OH), and after 2 h the reaction solution was diluted with 1 M HCl and extracted with 
2 volumes of diethyl ether. The organic fraction was washed with further dilute HCl 
until no pyridine was present, dried over anhydrous MgSO4, evaporated under 
reduced pressure, and the crude compound 25 was analysed by 1H-NMR. The reaction 
was monitored by TLC, using a solvent system of hexane:EtOAc (1:1) and the plates 
developed with potassium permanganate. Due to the presence of pyridine, TLC 
samples were subject to a similar acidic aqueous work-up. δH (400 MHz, CDCl3); 
2.48-2.43 (1H, m, J 2.4, CH), 2.49 (9H, s, 3 × CH3), 3.96-3.98 (6H, d, J 4.0, 3 × 
CH2OTs), 7.38 (6H, d, J 7.4,  3 ×Ar), 7.73 (6H, d, J 7.7, 3 ×Ar) ppm. 
 
PEG3 (MW 194.2 g mol-1, 10 eq. per mol of compound 25 (Figure 4.3) was co-
evaporated from MeCN (3 × 2 ml). 60 % NaH dispersion in mineral oil (4 eq. per mol 
of compound 25) and a minimum volume of DMF was added, to solubilise the 
mixture. To the stirred solution, was added compound 25, and the temperature raised 
to 80 ºC. The next day the reaction solution was allowed to cool, and was diluted with 
DI water. The aqueous phase was extracted with DCM (3 × volume of DI water), and 
the organic phase was further washed several times with DI water to ensure DMF 
removal. The organic fraction was then dried over anhydrous MgSO4, and evaporated 
under reduced pressure to give the crude product, that was taken for 1H-NMR 
analysis. 
 
Synthesis of branched PEG ethers, synthetic strategy 2 
p-Toluenesulfonic esters were prepared based on the protocol published by Tipson 
Tipson, 1944. PEG3 (MW 194.2 g mol-1) was coevaporated from TOL and dissolved 
in dry DCM. TsCl (2 eq. per mol of –OH) and Et3N (1.5 eq. per mol of PEG3) were 
added to the stirred solution. The reaction was monitored by TLC using a solvent 
system of DCM:MeOH (9:1). After completion, the reaction was quenched with an 
excess of DI water. The solution was diluted with DCM and washed with dilute 
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sodium bicarbonate and DI water. The aqueous fraction was extracted with further 
DCM. The organic fraction was dried over anhydrous MgSO4 and evaporated under 
reduced pressure. The crude material was purified by flash column chromatography, 
eluting with DCM:MeOH (9.5:0.5) to give TsOPEG3OTs. (1.2 g, 46 %). δH (400 
MHz, CDCl3); 2.32 (6H, s, 2 × CH3), 3.43 (8H, s, 4 × CH2), 3.55 (4H, t, J 3.6, 2 × 
CH2CH2OTs), 4.04 (4H, t, J 4.0, 2 × CH2OTs), 7.24 (4H, m, J 7.3,  2 ×Ar), 7.67 (4H, 
d, J 7.7, 2 ×Ar) ppm. 
 
2-Hydroxymethyl-2-methyl-1,3-propanediol and TsO-PEG3-OTs (10 eq. per mol of 2-
hydroxymethyl-2-methyl-1,3-propanediol) were coevaporated several times with 
MeCN, and dissolved in a minimum volume of dry DMF. 60 % NaH dispersion in 
mineral oil was added (3 eq. per mol of 2-hydroxymethyl-2-methyl-1,3-propanediol) 
and the solution stirred overnight. The reaction was quenched and diluted with DI 
water. The product was extracted with several volumes of DCM, and the organic 
fractions washed with further DI water. The organic fraction was dried over Na2SO4 
and evaporated under reduced pressure to give the crude material. This protocol was 
repeated at different temperatures (r.t., 50 ºC, and 90 ºC). 
 
Synthesis of Ph-Si-(O-PEG44)3 
PEG44 (~2,000 g mol-1, 14.4 g, 7.2 mmol) was co-evaporated with dry TOL (4 × 20 
ml) and dissolved in dry DCM (25 ml). Imidazole (0.230 g, 2.8 mmol) was added to 
the solution, stirred under nitrogen atmosphere at room temperature. 
Trichlorophenylsilane (0.115 ml, 0.71 mmol) was slowly added. The reaction was 
stirred overnight and quenched with DI water (3 ml). After 15 min, solution was 
diluted with DCM (100 ml) and washed with DI water (100 ml). The aqueous layer 
was extracted with further DCM (100 ml). The organic fractions were washed with DI 
water (200 ml), dried over anhydrous Na2SO4, and evaporated to dryness to give the 
crude material (13.1 g). This was re-dissolved in DCM for OSN purification. The 
product was washed with 12-15 diafiltration volumes (p= 7-8 atm, r.t.) to give Ph-Si-
(O-PEG44)3 (1.35 g, 31 %). δH (400 MHz, CDCl3); 3.46-3.89 (546H, m, 273 × OCH2), 
3.96 (6H, t, J 4.0, 3 × PhSiOCH2PEG), 7.36 (2H, t, J 7.4, Ar), 7.43 (1H, t, J 7.4, Ar), 
7.68 (2H, d, J 7.7, Ar) ppm. 
 
 
Imperial College London 
 177
Synthesis of O=P-(O-PEG44)3 
PEG44 (13.1 g, 6.5 mmol) was co-evaporated from dry TOL (4 × 20 mL) and 
dissolved in dry DCM (22 ml). NMI (0.210 ml, 0.98 mmol) was added to the solution, 
stirred under nitrogen atmosphere at room temperature. Then phosphorus oxychloride 
(0.060 ml, 0.65 mmol) was slowly added. After stirring for ~2 h, DI water was added 
(1.5 ml). After 15 min, solution was diluted with DCM (100 ml) and washed with DI 
water (100 ml). The aqueous layer was extracted with further DCM (100 ml). The 
organic fractions were collected, washed with DI water (200 ml), dried over 
anhydrous Na2SO4, and evaporated to dryness to give the crude material (10.1 g). This 
was re-dissolved in DCM for OSN purification. The product was washed with 12-15 
diafiltration volumes (p= 8 atm, r.t.) to give O=P-(O-PEG44)3 (1.23 g, 42 %). δH (400 
MHz, CDCl3); δH (400 MHz, CDCl3); 3.44-3.78 (546H, m, 273 × CH2), 4.15 (6H, b, J 
4.2, 3 × OPOCH2PEG). δP (162 MHz, CDCl3) -0.95 ppm. 
 
Synthesis of O=P-(O-PEG67)3 
PEG67 (10.2 g, 3.4 mmol) was co-evaporated from dry TOL (4 × 20 mL) and 
dissolved in dry DCM (23 ml). NMI (0.105 ml, 1.3 mmol) was added to the solution, 
stirred under nitrogen atmosphere at room temperature, then phosphorus oxychloride 
(0.031 ml, 0.33 mmol) was slowly added. After stirring for ~21 h,  DI water was 
added (1.5 ml). After 15 min,  solution was diluted with DCM (150 ml) and washed 
with DI water (150 ml). The aqueous layer was extracted with further DCM (150 ml). 
The combined organic fractions were washed with DI water (300 ml), dried over 
anhydrous MgSO4, and evaporated to dryness to give the crude material . This was re-
dissolved in DCM for OSN purification. The product was washed with 50 diafiltration 
volumes (p= 8 atm, r.t.) to give O=P-(O-PEG67)3 (1.52 g, 50 %). δH (400 MHz, 
CDCl3); δH (400 MHz, CDCl3); 3.49-3.84 (846H, m, 423 × OCH2), 4.21 (6H, b, 3 × 
OPOCH2PEG). δP (162 MHz, CDCl3) -0.87 ppm. 
 
Synthesis of benzene-1,3,5-(CO2-PEG44)3 
PEG44 (31.1 g, 15 mmol) was co-evaporated from dry TOL (3 × 60 ml) and dissolved 
in dry DCM (45 ml). NMI (0.720 ml, 9 mmol) was added to the solution, stirred under 
nitrogen atmosphere at room temperature, then enzene-1,3,5-tricarbonyl trichloride 
(0.420 g, 1.6 mmol) dissolved in further DCM (2 ml) was slowly added. After stirring 
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overnight, DI water was added. After 30 min, the solution was diluted with DCM 
(400 ml) and washed with half saturated NaHCO3 (250 ml). The aqueous layer was 
extracted with further DCM (200 ml). The combined organic fractions were washed 
with 0.1 M HCl (600 ml), dried over anhydrous MgSO4, and evaporated to dryness to 
give the crude material (28.8 g). The crude material was re-dissolved in DCM for 
OSN purification. The product was washed with 12-15 diafiltration volumes (p= 8 
atm, r.t.) to yield benzene-1,3,5-(CO2-PEG44)3 (4.63 g, 62 %). δH (400 MHz, CDCl3); 
3.45-3.82 (540H, m, 270 × OCH2), 3.86 (6H, t, J 3.8, 3 × CO2CH2CH2PEG), 4.53 
(6H, t, J 4.5, 3 × CO2CH2), 8.86 (3H, s, Ar) ppm. 
 
Synthesis of benzene-1,3,5-(CO2-PEG67)3 
PEG67 (15.5 g, 5 mmol) was co-evaporated with from TOL (4 × 50 ml) and dissolved 
in dry DCM (25 ml). NMI (0.240 ml, 3 mmol) was added to the solution, stirred under 
nitrogen atmosphere at room temperature, then benzene-1,3,5-tricarbonyl trichloride 
(0.138 g, 0.5 mmol) dissolved in further DCM (5 ml) was slowly added. After stirring 
overnight DI water was added. After 30 min, solution was diluted with DCM (200 ml) 
and washed with DI water (200 ml) then 0.1 M HCl (aq) (200 ml). The aqueous layer 
was extracted with further DCM (400 ml). The combined organic fractions were 
washed with 1 M HCl (600 ml), dried over anhydrous MgSO4, and evaporated to 
dryness to give the crude material (13.4 g). The crude material was re-dissolved in 
DCM for OSN purification. The product was washed with 50 diafiltration volumes 
(p= 8 atm, r.t.) to yield benzene-1,3,5-(CO2-PEG67)3 (2.67 g, 56 %). δH (400 MHz, 
CDCl3); 3.47-3.85 (840H, m, 420 × OCH2), 3.88 (6H, t, J 3.8, 3 × 
CO2CH2CH2OPEG), 4.55 (6H, t, J 4.6, 3 × CO2CH2), 8.88 (3H, s, Ar) ppm. 
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D.2. PEG analysis 
 
Theoretical calculations of n (Equation i) 
 
HO O OHn  
Figure 8.7 - chemical structure of PEGn 
 
Repeat unit: -CH2OCH2-, 44 g mol-1 
End termini: -CH2OH, 31 g mol-1 
 
44
312∗−= PEGofMWn  
Equation i 
 
Table 8-3 - theoretical calculations of n for several PEGs. 
MW of PEG  
(g mol-1) 
N Theoretical 1H-NMR ratio  
of –CH2OH to repeating unit –CH2 
194.2 3 1:3 
600 12 1:12 
1,000 21 1:21 
2,000 44 1:44 
3,000 67 1:67 
5,000 112 1:112 
10,000 226 1:226 
20,000 453 1:453 
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Experimental 1H-NMR calculations (Jo et al., 2001) 
 
HO O OHn
i) 5 % v/v TFA anhydride
in CDCl3 TFAO O OTFAn  
Figure 8.8 - chemistry of the PEG characterisation method (Jo et al., 2001). 
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Figure 8.9 – 1H-NMR spectra, showing the downfield shift in the signal of acylated 
PEG termini: 1, PEG44; 2, TFAOPEG44OTFA; 3, TFAOPEG70OTFA 
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D.3. NMR spectra of the branched PEGs prepared 
 
 
Figure 8.10 – 1H-NMR spectrum of the OSN purified PhSi-(O-PEG44)3; solvent, 
CDCl3. 
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Figure 8.11 - 1H (top) and 31P-NMR (bottom) spectra of the OSN purified O=P-(O-
PEG44)3; solvent, CDCl3. 
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Figure 8.12 - 1H (top) and 31P-NMR (bottom) spectra of the OSN purified O=P-(O-
PEG67)3; solvent, CDCl3. 
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Figure 8.13 - 1H-NMR spectrum of the OSN purified benzene-1,3,5-(CO2-PEG44)3; 
solvent, CDCl3. 
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Figure 8.14 - 1H-NMR spectrum of the OSN purified benzene-1,3,5-(CO2-PEG67)3; 
solvent, CDCl3. 
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D.4. MS spectra of the branched PEGs prepared 
 
 
Figure 8.15 - MS spectrum of OSN purified PhSi-(OPEG44)3. 
 
 
Figure 8.16 - MS spectrum of OSN purified O=P-(OPEG44)3. 
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Figure 8.17 – MS spectrum of OSN purified O=P-(OPEG70)3. 
 
 
Figure 8.18 – MS spectrum of OSN purified benzene-1,3,5-(CO2PEG44)3. 
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Figure 8.19 - MS spectrum of OSN purified benzene-1,3,5-(CO2PEG70)3.  
 
 
Figure 8.20 – MS spectrum of PEG44. 
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Figure 8.21 – MS spectrum of PEG70. 
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D.5. Model reaction for the identification of hydrolysis by-products 
 
CO2PEG44OMe
CO2PEG44OMeMeOPEG44O2C
H H
H
CO2PEG44OMe
CO2PEG44OMeHO2C
H H
H
CO2PEG44OMe
CO2HHO2C
H H
H
CO2Cl
CO2ClClO2C
H H
H
i) MeOPEG44 ,NMI, DCM
ii) Aq. work-up
mono-substituted bis-substituted tris-substituted  
Figure 8.22 – Model reaction for the investigation of hydrolysis by-products. 
 
Table 8-4 – Model reaction stoichiometry. 
Reaction MeOPEG44:branch point ratio 
1 10:1 
2 2:1 
3 1:1 
4 0.4:1 
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Figure 8.23 – 1H-NMR spectrum of the aromatic region of reaction 1 crude product; 
10:1 MeOPEG44:branch point ratio, CDCl3 + Et3N. 
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Figure 8.24 - 1H-NMR spectrum of the aromatic region of reaction 2 crude product; 
2:1 MeOPEG44:branch point ratio, CDCl3 + Et3N. 
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Figure 8.25 - 1H-NMR spectrum of the aromatic region of reaction 3 crude product; 
1:1 MeOPEG44:branch point ratio, CDCl3 + Et3N. 
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RCV R158+Et3N
 
Figure 8.26 - 1H-NMR spectrum of the aromatic region of reaction 4 crude product; 
0.4:1 MeOPEG44:branch point ratio, CDCl3 + Et3N. 
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D.6. Acid catalysed hydrolysis of branched PEGs 
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Figure 8.27 – Stability of branched PEGs prepared towards acid-catalysed hydrolysis.  
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Appendix E – Chapter 5 supplementary information 
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E.1. NMR spectra of support bound oligonucleotide dimers 
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Figure 8.28 - 1H (top) and 31P-NMR (bottom) spectra of (5’-O-Dmt-dABzpdABz-3’-O-
succ-O-PEG67-O)3-P=O; solvent, CDCl3 
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Figure 8.29 - 1H (top) and 31P-NMR (bottom) spectra of 1,3,5-(5’-O-Dmt-dABzpdABz-
3’-O-succ-O-PEG67-O)3-benzene (Run 1); solvent, CDCl3 
 
Imperial College London 
 200
 
 
Figure 8.30 - 1H (top) and 31P-NMR (bottom) spectra of 1,3,5-(5’-O-Dmt-dABzpdABz-
3’-O-succ-O-PEG67-O)3-benzene (Run 2); solvent, CDCl3 
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Appendix F – Chapter 6 supplementary information 
Chapter 6 
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F.1. Synthesis 
 
Synthesis of HO-PEG44-Phth 
Ph-Si-(O-PEG44)3  
As described in Appendix D.1.  
 
Ph-Si-(O-PEG44-OMs)3  
Ph-Si-(O-PEG44)3 (0.300 g, 0.05 mmol) was co-evaporated from dry TOL (3 × 10 ml) 
and dissolved in dry DCM (3 mL). To the stirred solution at room temperature, under 
a nitrogen atmosphere, were added first triethylamine (Et3N) (0.045 ml, 0.30 mmol) 
then slowly methanesulfonyl chloride (MsCl) (0.060 ml, 0.75 mmol) . The reaction 
was stirred overnight (~15.5 h) and quenched with DI water (0.500 ml) for ~30 min. 
The reaction solution was then diluted with DCM (50 ml) and washed with DI water 
(1 × 50 ml), and NaHCO3 (50 ml). The aqueous layer was extracted with further 
DCM (100 ml). The combined organic fractions were dried over anhydrous Na2SO4, 
filtered, and evaporated to dryness to give Ph-Si-(O-PEG44-OMs)3 (0.192 g, 62 %). δH 
(400 MHz, CDCl3); 3.02 (9H, s, SO2CH3), 3.38-3.76 (546H, m, 273 × OCH2), 3.89 
(6H, t, J 3.9, 3 × PhSiOCH2), 4.31 (6H, t, J 4.3, 3 × CH2OMs), 7.36 (2H, t, J 7.4, Ar), 
7.43 (1H, t, J 7.4, Ar), 7.61 (2H, d, J 7.6, Ar) ppm. 
 
Ph-Si-(O-PEG44-Phth)3  
Ph-Si-(O-PEG44-OMs)3 (0.192 g, 0.03 mmol) was co-evaporated from dry TOL (2 × 5 
ml) and dissolved in dry dimethylformamide (DMF) (20 ml). Potassium phthalimide 
(0.187 g, 10 mmol) was added to the stirred solution under nitrogen atmosphere, and 
the temperature increased to 70 ºC. After 3 h, the solution was allowed to cool, diluted 
with DCM (100 ml) and washed with DI water (100ml). The aqueous layer was 
extracted with further DCM (100 ml). The combined organic fractions were washed 
with NaHCO3/ Na2CO3 (200 ml), dried over anhydrous Na2SO4, and evaporated to 
concentrate the solution. The crude solution was then stirred, cooled in an ice-bath 
and the product precipitated with the addition of diethyl ether (~15 vols), to give Ph-
Si-(O-PEG44-Phth)3. The crude material was co-evaporated 3 times from CDCl3, to 
yield HO-PEG44-Phth (0.098 g, 52 %). δH (400 MHz, CDCl3); 3.44-3.82 (182H, m, 
CH2OH + 90 × CH2), 3.88 (6H, t, J 3.9, 3 × PEGCH2Phth), 7.70-7.72 (2H, m, Phth), 
7.82-7.84 (2H, m, Phth) ppm. 
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Synthesis of HO-PEG44-NH2 (batch 1) 
Benzene-1,3,5-(CO2-PEG44)3  
As described in Appendix D.1..  
 
Benzene-1,3,5-(CO2-PEG44-OMs)3  
Benzene-1,3,5-(CO2-PEG44)3 (1.028 g, 0.16 mmol) was co-evaporated from dry TOL 
(3 × 15 ml) and dissolved in dry DCM (6 ml). Et3N (0.136 ml, 0.98 mmol) was added 
to the solution, stirred under nitrogen atmosphere at room temperature. MsCl (0.190 
ml, 2.44 mmol) was slowly added to the previous solution. The reaction was allowed 
to react for ~7 h and quenched with DI water (0.500 ml) for ~30 min. The reaction 
solution was then diluted with DCM (150 ml) and washed with half saturated 
NaHCO3 (150 ml) and DI water (150 ml). The aqueous layer was extracted with 
further DCM (300 ml). The organic fractions were then collected, dried over 
anhydrous MgSO4, filtered, and evaporated to dryness to give crude benzene-1,3,5-
(CO2-PEG44-OMs)3 (0.96 g, 93 %). δH (400 MHz, CDCl3); 3.11 (9H, s, SO2CH3), 
3.47-3.85 (528H, m, 264 × CH2), 3.78 (6H, t, J 3.8, 3 × PEGCH2CH2OMs), 3.87-3.89 
(6H, t, J 3.9, 3 × CO2CH2CH2PEG), 4.40 (6H, t, J 4.4, 3 × PEGCH2OMs), 4.55 (6H, 
t, J 4.6, 3 × CO2CH2PEG), 8.88 (3H, s, Ar) ppm. 
 
Benzene-1,3,5-(CO2-PEG44-Phth)3  
Benzene-1,3,5-(CO2-PEG44-OMs)3 (0.850 g, 0.13 mmol) was co-evaporated from dry 
acetonitrile (MeCN) (3 × 10 ml) and dissolved in dry DMF (60 ml). Potassium 
phthalimide (0.740 g, 4 mmol) was added to the stirred solution under nitrogen 
atmosphere, and the temperature increased to 70 ºC. After 15 h, the solution was 
allowed to cool, diluted with DCM (150 ml) and washed with DI water (150 ml). The 
aqueous layer was extracted with further DCM (150 ml), the organic fractions 
collected, dried over anhydrous MgSO4, and evaporated to concentrate the solution. 
The crude solution was then stirred, cooled down in an ice-bath and the product 
precipitated with the addition of ~15 vols of diethyl ether, to give benzene-1,3,5-
(CO2-PEG44-Phth)3 (0.593 g, 68%). δH (400 MHz, CDCl3); 3.48-3.85 (528H, m, 264 × 
CH2), 3.88 (6H, t, J 3.9, 3 × CO2CH2CH2PEG), 3.92 (6H, t, J 3.9, 3 × PEGCH2Phth), 
4.56 (6H, t, J 4.6, 3 × CO2CH2PEG), 7.73-7.75 (6H, m, 3 × Phth), 7.86-7.88 (6H, m, 
3 × Phth), 8.89 (3H, s, Ar) ppm. 
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HO-PEG44-NH2   
Benzene-1,3,5-(CO2-PEG44-Phth)3 (0.593 g, 0.09 mmol) was co-evaporated from dry 
TOL (2 × 5 ml) and dissolved in 10% (v/v) hydrazine hydrate solution in EtOH (6 
ml). The solution was stirred at r.t. for approximately 12 h and quenched by the 
addition of acetone (5 ml) and stirred for 15 min. The solution was then diluted with 
DCM (100 ml) and washed with 5% (w/v) NaCl (150 ml). The aqueous layer was 
extracted with further DCM (2 × 100 ml), the organic fractions collected, dried over 
anhydrous MgSO4, and evaporated under vacuum. The resulting crude product was 
co-evaporated under reduced pressure with DI water (3 × 2 ml) to give HO-PEG44-
NH2 (0.315 g, 58%). δH (400 MHz, CDCl3); 3.15 (2H, b, CH2NH2), 3.41-3.87 (184H, 
m, 92 × CH2). 
 
Synthesis of HO-PEG44-NH2 (batch 2) 
Benzene-1,3,5-(CO2-PEG44-OMs)3  
Benzene-1,3,5-(CO2-PEG44)3 (1.023g , 0.17 mmol) was co-evaporated from dry 
MeCN (3 × 5 ml) and dissolved in dry DCM (7 ml). Et3N (0.137 ml, 0.98 mmol) was 
added to the solution, stirred under nitrogen atmosphere at room temperature. MsCl 
(0.77 ml, 0.98mmol) was slowly added to the previous solution. The reaction was 
allowed to react for ~12 h and quenched with of DI water (1 ml) for ~40 min. The 
reaction solution was then diluted with DCM (150 ml) and washed with half saturated 
NaHCO3 (1 × 150ml). The organic layer was collected, dried over anhydrous MgSO4, 
and evaporated to dryness to yield benzene-1,3,5-(CO2-PEG44-OMs)3 (0.873g, 82 %). 
δH (400 MHz, CDCl3); 3.11 (9H, s, SO2CH3), 3.48-3.89 (528H, m, 264 × CH2), 3.8 
(6H, t, J 3.8, 3 × PEGCH2CH2OMs), 3.88 (6H, t, J 3.9, 3 × CO2CH2CH2PEG), 4.40 
(6H, t, J 4.4, 3 × PEGCH2OMs), 4.55 (6H, t, J 4.6, 3 × CO2CH2PEG), 8.89 (3H, s, 
Ar) ppm. 
 
Benzene-1,3,5-(CO2-PEG44-Phth)3  
Benzene-1,3,5-(CO2-PEG44-OMs)3 (0.873 g, 0.13 mmol) was co-evaporated from dry 
acetonitrile (MeCN) (3 × 7 ml) and dissolved in dry DMF (60 ml). Potassium 
phthalimide (0.797 g, 4 mmol) was added to the stirred solution under nitrogen 
atmosphere, and the temperature increased to 80 ºC. After 3 h, the solution was 
allowed to cool, diluted with DCM (150 ml) and washed with DI water (200 ml). The 
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aqueous layer was extracted with further DCM (200 ml), the organic fractions 
collected, dried over anhydrous MgSO4, and evaporated to concentrate the solution. 
The crude solution was then stirred, cooled in an ice-bath and the product precipitated 
with the addition of ~15 vols of diethyl ether, to give benzene-1,3,5-(CO2-PEG44-
Phth)3 (0.447 g, 50 %). δH (400 MHz, CDCl3); 3.47-3.85 (528H, m, 264 × CH2), 3.88 
(6H, t, J 3.9, 3 × CO2CH2CH2PEG), 3.92 (6H, t, J 3.9, 3 × PEGCH2Phth), 4.55 (6H, t, 
J 4.6, 3 × CO2CH2PEG), 7.73-7.75 (6H, m, J 7.7, 3 × Phth), 7.85-7.88 (6H, m, J 7.9, 
3 × Phth), 8.89 (3H, s, Ar) ppm. 
 
HO-PEG44-NH2  
Benzene-1,3,5-(CO2-PEG44-Phth)3 (0.447 g, 0.07 mmol) was co-evaporated from dry 
MeCN (2 × 5 ml) and dissolved in 10% (v/v) hydrazine hydrate solution in EtOH (6 
ml). The solution was stirred at room temperature for approximately 17 h and 
quenched by the addition of acetone (4.4 ml), stirred for 15 min. The solution was 
then diluted with DCM (120 ml) and washed with 5 % (w/v) NaCl (120 ml). The 
aqueous layer was extracted with further DCM (2 × 150 ml), the organic fractions 
combined, dried over anhydrous MgSO4, and evaporated under vacuum to give HO-
PEG44-NH2 (0.313 g, 76 %). δH (400 MHz, CDCl3); 3.15 (2H, t, J 3.2, CH2NH2), 
3.46-3.89 (184H, m, 92 × CH2). 
 
Synthesis of HO-PEG44-N3 (batch 1) 
Benzene-1,3,5-(CO2-PEG44-OMs)3  
Benzene-1,3,5-(CO2-PEG44)3 (1.046 g, 0.16mmol) was co-evaporated from dry 
MeCN (3 × 5 ml) and dissolved in dry DCM (8 ml). Et3N (0.140 ml, 1 mmol) was 
added to the solution, stirred under nitrogen atmosphere at room temperature. MsCl 
(0.080 ml, 1 mmol) was slowly added to the previous solution. The reaction was 
stirred for ~13 h and quenched with DI water (0.500 ml) for ~30 min. The reaction 
solution was then diluted with DCM (150 ml) and washed with half saturated 
NaHCO3 (1 × 150 ml). The aqueous layer was extracted with further DCM (150 ml). 
The organic fractions were then collected, dried over anhydrous MgSO4, and 
evaporated to dryness to yield benzene-1,3,5-(CO2-PEG44-OMs)3 (0.965 g, 89 %). δH 
(400 MHz, CDCl3); 3.10 (9H, s, SO2CH3), 3.48-3.85 (528H, m, 264 × CH2), 3.78 
(6H, t, J 3.8, 3 × PEGCH2CH2OMs), 3.88 (6H, t, J 3.9, 3 × CO2CH2CH2PEG), 4.40 
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(6H, m, J 4.4, 3 × PEGCH2OMs), 4.55 (6H, t, J 4.6, 3 × CO2CH2PEG), 8.88 (3H, s, 
Ar) ppm. 
 
Benzene-1,3,5-(CO2-PEG44-N3)3 
Benzene-1,3,5-(CO2-PEG44-OMs)3 (0.960 g, 0.15 mmol) was co-evaporated from dry 
MeCN (3 × 10 ml) and dissolved in DMF (3 ml). DI water (1:12 v/v, H2O:DMF) 
(0.250 ml) and NaHCO3 (24 mg) were added to the stirred solution. NaN3 (59 mg) 
was added, the temperature increased to 70 ºC and the solution allowed to react under 
nitrogen. After ~20 h, the solution was cooled, taken up in EtOAc (150 ml) and 
successively washed with half saturated NaHCO3 (120 ml), DI water (3 × 120 ml), 
and brine (120 ml). The aqueous layer was then extracted with DCM (2 × 600 ml). 
The combined organic fractions were dried over MgSO4, and evaporated under 
vacuum to give benzene-1,3,5-(CO2-PEG44-N3)3 (0.368 g, 39 %). δH (400 MHz, 
CDCl3); 3.42 (6H, t, J 3.4 CH2N3), 3.48-3.86 (534H, m, 267 × CH2), 3.88 (6H, t, J 
3.9, 3 × CO2CH2CH2PEG), 4.55 (6H, t, J 4.6, 3 × CO2CH2PEG), 8.89 (3H, s, Ar) 
ppm. 
 
HO-PEG44-N3  
Benzene-1,3,5-(CO2-PEG44-N3)3 (0.100 g, 0.016 mmol) was dissolved in 35 % v/v 
NH3 (aq) (2.5 ml) and stirred overnight. After ~16 h, the solution was evaporated 
under vacuum and co-evaporated with water until no ammonia was present. The 
residue was dissolved in DCM (50 ml) and washed with DI water (1 × 50 ml). The 
aqueous layer was extracted with further DCM (2 × 50 ml). The organic fractions 
were collected, dried over MgSO4, and evaporated under vacuum, to yield HO-PEG44-
N3 (0.086g, 88 %) δH (400 MHz, CDCl3); 3.37 (2H, t, J 3.4 CH2N3), 3.43-3.81 (182H, 
m, 91 × CH2) ppm. 
 
Synthesis of HO-PEG44-N3 (batch 2) 
Benzene-1,3,5-(CO2-PEG44-OMs)3  
Benzene-1,3,5-(CO2-PEG44)3 (0.505 g, 0.082 mmol) was co-evaporated from dry 
MeCN (3 × 4 ml) and dissolved in dry DCM (4 ml). Et3N (0.054 ml, 0.5 mmol) was 
added to the solution, stirred under nitrogen atmosphere at room temperature. MsCl 
(0.039 ml, 0.5 mmol) was slowly added to the previous solution. The reaction was 
stirred for ~17 h and quenched with DI water (0.500 ml) for ~30 min. The reaction 
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solution was then diluted with DCM (120 ml) and washed with half saturated 
NaHCO3 (120 ml). The aqueous layer was extracted with further DCM (2 × 120 ml). 
The organic fractions were then collected, dried over anhydrous MgSO4, filtered, and 
evaporated to dryness to yield benzene-1,3,5-(CO2-PEG44-OMs)3 (0.473 g, 90 %). δH 
(400 MHz, CDCl3); 3.11 (9H, s, SO2CH3), 3.47-3.85 (528H, m, 264 × CH2), 3.79 
(6H, t, J 3.8, 3 × PEGCH2CH2OMs), 3.88 (6H, t, J 3.9, 3 × CO2CH2CH2PEG), 4.40 
(6H, t, J 4.4, 3 × PEGCH2OMs), 4.55 (6H, t, J 4.6, 3 × CO2CH2PEG), 8.89 (3H, s, 
Ar) ppm. 
 
Benzene-1,3,5-(CO2-PEG44-N3)3 
Benzene-1,3,5-(CO2-PEG44-OMs)3 (0.473 g, 0.074 mmol) was co-evaporated from 
dry MeCN (3 × 5 ml) and dissolved in DMF (1.5 ml). DI water (1:12 v/v, H2O:DMF) 
(0.125 ml) and NaHCO3 (24 mg) were added to the stirred solution. NaN3 (34 mg) 
was added, the temperature increased to 70 ºC and the solution allowed to react under 
nitrogen. After ~24 h, the solution was cooled down, diluted with DCM (120 ml) and 
successively washed with half saturated NaHCO3 (120 ml), and brine (120 ml). The 
aqueous layer was then extracted with DCM (300 ml), the organic layer dried over 
MgSO4, and concentrated under vacuum, and precipitated with ~15 vols of diethyl 
ether. The precipitate was filtered and washed several times with cold diethyl ether to 
give benzene-1,3,5-(CO2-PEG44-N3)3 (0.330 g, 72 %). δH (400 MHz, CDCl3); 3.41 
(6H, t, J 3.4 CH2N3), 3.48-3.86 (534H, m, 267 × CH2), 3.88 (6H, t, J 3.9, 3 × 
CO2CH2CH2PEG), 4.55 (6H, t, J 4.6, 3 × CO2CH2PEG), 8.89 (3H, s, Ar) ppm. 
 
HO-PEG44-N3  
Benzene-1,3,5-(CO2-PEG44-N3)3 (0.330 g, 0.053 mmol) was dissolved in 35 % v/v 
NH3 (aq) (18 ml) and stirred under reflux (50 ºC) overnight. After ~16 h, the solution 
was allowed to cool, evaporated under vacuum and co-evaporated with water until no 
ammonia was present. The residue was dissolved in DCM (100 ml) and washed with 
DI water (100 ml). The aqueous layer was extracted with further DCM (100 ml). The 
organic fractions were collected, dried over MgSO4, and evaporated under vacuum, to 
yield HO-PEG44-N3 (0.268 g, 83 %) NMR δH (400 MHz, CDCl3); 3.37 (2H, t, J 3.4 
CH2N3), 3.44-3.81 (182H, m, 91 × CH2) ppm. 
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F.2. NMR spectra of heterobifunctional PEGs 
 
 
 
Figure 8.31 - 1H-NMR spectra of HO-PEG44-Phth: CDCl3 (top), CDCl3 + 5 % v/v 
TFAA (bottom) 
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Figure 8.32 - 1H-NMR spectra of HO-PEG44-NH2 (batch 1): CDCl3 (top), CDCl3 + 5 
% v/v TFAA (bottom) 
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Figure 8.33 - 1H-NMR spectra of HO-PEG44-NH2 (batch 2): CDCl3 (top), CDCl3 + 5 
% v/v TFAA (bottom) 
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Figure 8.34 - 1H-NMR spectra of HO-PEG44-N3 (batch 1): CDCl3 (top), CDCl3 + 5 % 
v/v TFAA (bottom) 
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Figure 8.35 - 1H-NMR spectra of HO-PEG44-N3 (batch 2): CDCl3 (top), CDCl3 + 5 % 
v/v TFA anhydride (bottom) 
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Figure 8.36 - 1H-NMR spectra of HO-PEG44-NH2 (model sample): CDCl3 (top), 
CDCl3 + 5 % v/v TFAA (bottom) 
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Figure 8.37 – 13C-NMR spectra of PEG44 (top) and model HO-PEG44-NH2 (bottom): 
CDCl3 
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Figure 8.38 – 13C-NMR spectra of the synthesised HO-PEG44-NH2 (batch 2) (top) and 
HO-PEG44-N3 (batch 2) (bottom): CDCl3 
 
 
